0000731766-23-000029.txt : 20230503 0000731766-23-000029.hdr.sgml : 20230503 20230503160505 ACCESSION NUMBER: 0000731766-23-000029 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITEDHEALTH GROUP INC CENTRAL INDEX KEY: 0000731766 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 411321939 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-10864 FILM NUMBER: 23883627 BUSINESS ADDRESS: STREET 1: UNITEDHEALTH GROUP CENTER STREET 2: 9900 BREN ROAD EAST CITY: MINNEAPOLIS STATE: MN ZIP: 55343 BUSINESS PHONE: 9529361300 MAIL ADDRESS: STREET 1: 9900 BREN ROAD EAST CITY: MINNETONKA STATE: MN ZIP: 55343 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP/ DATE OF NAME CHANGE: 20000309 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP DATE OF NAME CHANGE: 19920703 10-Q 1 unh-20230331.htm 10-Q unh-20230331
false2023Q1000073176612/315000007317662023-01-012023-03-3100007317662023-04-28xbrli:shares00007317662023-03-31iso4217:USD00007317662022-12-31iso4217:USDxbrli:shares00007317662022-01-012022-03-310000731766us-gaap:ProductMember2023-01-012023-03-310000731766us-gaap:ProductMember2022-01-012022-03-310000731766us-gaap:ServiceMember2023-01-012023-03-310000731766us-gaap:ServiceMember2022-01-012022-03-310000731766us-gaap:CommonStockMember2022-12-310000731766us-gaap:AdditionalPaidInCapitalMember2022-12-310000731766us-gaap:RetainedEarningsMember2022-12-310000731766us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000731766us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000731766us-gaap:NoncontrollingInterestMember2022-12-310000731766us-gaap:RetainedEarningsMember2023-01-012023-03-310000731766us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000731766us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310000731766us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000731766us-gaap:CommonStockMember2023-01-012023-03-310000731766us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000731766us-gaap:CommonStockMember2023-03-310000731766us-gaap:AdditionalPaidInCapitalMember2023-03-310000731766us-gaap:RetainedEarningsMember2023-03-310000731766us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310000731766us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000731766us-gaap:NoncontrollingInterestMember2023-03-310000731766us-gaap:CommonStockMember2021-12-310000731766us-gaap:AdditionalPaidInCapitalMember2021-12-310000731766us-gaap:RetainedEarningsMember2021-12-310000731766us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310000731766us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000731766us-gaap:NoncontrollingInterestMember2021-12-3100007317662021-12-310000731766us-gaap:RetainedEarningsMember2022-01-012022-03-310000731766us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000731766us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310000731766us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310000731766us-gaap:CommonStockMember2022-01-012022-03-310000731766us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000731766us-gaap:CommonStockMember2022-03-310000731766us-gaap:AdditionalPaidInCapitalMember2022-03-310000731766us-gaap:RetainedEarningsMember2022-03-310000731766us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-03-310000731766us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000731766us-gaap:NoncontrollingInterestMember2022-03-3100007317662022-03-310000731766unh:ProductsAndServicesMember2023-03-310000731766unh:ProductsAndServicesMember2022-12-3100007317662023-04-012023-03-31utr:Rate0000731766us-gaap:USTreasuryAndGovernmentMember2023-03-310000731766us-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000731766us-gaap:CorporateDebtSecuritiesMember2023-03-310000731766us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-03-310000731766us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2023-03-310000731766us-gaap:USTreasuryAndGovernmentMember2022-12-310000731766us-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000731766us-gaap:CorporateDebtSecuritiesMember2022-12-310000731766us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-12-310000731766us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2022-12-310000731766us-gaap:DebtSecuritiesMember2023-03-310000731766us-gaap:DebtSecuritiesMember2022-12-31xbrli:pure0000731766us-gaap:FairValueInputsLevel1Member2023-03-310000731766us-gaap:FairValueInputsLevel2Member2023-03-310000731766us-gaap:FairValueInputsLevel3Member2023-03-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2023-03-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2023-03-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2023-03-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2023-03-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2023-03-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-03-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-03-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-03-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-03-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2023-03-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2023-03-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2023-03-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:DebtSecuritiesMember2023-03-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMember2023-03-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:DebtSecuritiesMember2023-03-310000731766us-gaap:FairValueInputsLevel1Member2022-12-310000731766us-gaap:FairValueInputsLevel2Member2022-12-310000731766us-gaap:FairValueInputsLevel3Member2022-12-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2022-12-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2022-12-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2022-12-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-12-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-12-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-12-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2022-12-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2022-12-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2022-12-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:DebtSecuritiesMember2022-12-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMember2022-12-310000731766us-gaap:FairValueInputsLevel3Memberus-gaap:DebtSecuritiesMember2022-12-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2023-03-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsNonrecurringMember2023-03-310000731766us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2023-03-310000731766us-gaap:FairValueMeasurementsNonrecurringMember2023-03-310000731766us-gaap:LongTermDebtMember2023-03-310000731766us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-12-310000731766us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-12-310000731766us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310000731766us-gaap:FairValueMeasurementsNonrecurringMember2022-12-310000731766us-gaap:LongTermDebtMember2022-12-310000731766unh:A4250NotesDueJanuary2029Member2023-03-310000731766unh:A4500NotesDueApril2033Member2023-03-310000731766unh:A5050NotesDueApril2053Member2023-03-310000731766unh:A5200NotesDueApril2063Member2023-03-310000731766us-gaap:CommercialPaperMember2023-03-310000731766us-gaap:CustomerRelatedIntangibleAssetsMember2023-01-012023-03-310000731766unh:TrademarksAndTechnologyMember2023-01-012023-03-310000731766us-gaap:OtherIntangibleAssetsMember2023-01-012023-03-31unh:reportableSegments0000731766unh:OptumHealthMember2023-03-310000731766unh:OptumHealthMember2022-12-310000731766unh:OptumHealthMember2023-01-012023-03-310000731766unh:UnitedhealthcareMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumHealthMember2023-01-012023-03-310000731766unh:OptumInsightMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumRxMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310000731766unh:TotalOptumMemberunh:ExternalCustomersMember2023-01-012023-03-310000731766us-gaap:CorporateNonSegmentMemberunh:ExternalCustomersMember2023-01-012023-03-310000731766unh:ExternalCustomersMember2023-01-012023-03-310000731766unh:UnitedhealthcareMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductMemberunh:OptumHealthMember2023-01-012023-03-310000731766unh:OptumInsightMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumRxMemberus-gaap:ProductMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:IntersegmentEliminationMemberus-gaap:ProductMember2023-01-012023-03-310000731766unh:TotalOptumMemberunh:ExternalCustomersMemberus-gaap:ProductMember2023-01-012023-03-310000731766us-gaap:CorporateNonSegmentMemberunh:ExternalCustomersMemberus-gaap:ProductMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:ProductMember2023-01-012023-03-310000731766unh:UnitedhealthcareMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumHealthMemberus-gaap:ServiceMember2023-01-012023-03-310000731766unh:OptumInsightMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumRxMemberus-gaap:ServiceMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:IntersegmentEliminationMemberus-gaap:ServiceMember2023-01-012023-03-310000731766unh:TotalOptumMemberunh:ExternalCustomersMemberus-gaap:ServiceMember2023-01-012023-03-310000731766us-gaap:CorporateNonSegmentMemberunh:ExternalCustomersMemberus-gaap:ServiceMember2023-01-012023-03-310000731766unh:ExternalCustomersMemberus-gaap:ServiceMember2023-01-012023-03-310000731766unh:UnitedhealthcareMemberus-gaap:OperatingSegmentsMemberunh:IntersegmentMember2023-01-012023-03-310000731766us-gaap:OperatingSegmentsMemberunh:IntersegmentMemberunh:OptumHealthMember2023-01-012023-03-310000731766unh:OptumInsightMemberus-gaap:OperatingSegmentsMemberunh:IntersegmentMember2023-01-012023-03-310000731766us-gaap:OperatingSegmentsMemberunh:IntersegmentMemberunh:OptumRxMember2023-01-012023-03-310000731766unh:IntersegmentMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310000731766unh:TotalOptumMemberunh:IntersegmentMember2023-01-012023-03-310000731766us-gaap:CorporateNonSegmentMemberunh:IntersegmentMember2023-01-012023-03-310000731766unh:IntersegmentMember2023-01-012023-03-310000731766unh:UnitedhealthcareMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000731766us-gaap:OperatingSegmentsMemberunh:OptumHealthMember2023-01-012023-03-310000731766unh:OptumInsightMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000731766us-gaap:OperatingSegmentsMemberunh:OptumRxMember2023-01-012023-03-310000731766us-gaap:IntersegmentEliminationMember2023-01-012023-03-310000731766unh:TotalOptumMember2023-01-012023-03-310000731766us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000731766unh:UnitedhealthcareMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumHealthMember2022-01-012022-03-310000731766unh:OptumInsightMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumRxMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:IntersegmentEliminationMember2022-01-012022-03-310000731766unh:TotalOptumMemberunh:ExternalCustomersMember2022-01-012022-03-310000731766us-gaap:CorporateNonSegmentMemberunh:ExternalCustomersMember2022-01-012022-03-310000731766unh:ExternalCustomersMember2022-01-012022-03-310000731766unh:UnitedhealthcareMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductMemberunh:OptumHealthMember2022-01-012022-03-310000731766unh:OptumInsightMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumRxMemberus-gaap:ProductMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:IntersegmentEliminationMemberus-gaap:ProductMember2022-01-012022-03-310000731766unh:TotalOptumMemberunh:ExternalCustomersMemberus-gaap:ProductMember2022-01-012022-03-310000731766us-gaap:CorporateNonSegmentMemberunh:ExternalCustomersMemberus-gaap:ProductMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:ProductMember2022-01-012022-03-310000731766unh:UnitedhealthcareMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumHealthMemberus-gaap:ServiceMember2022-01-012022-03-310000731766unh:OptumInsightMemberunh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:OperatingSegmentsMemberunh:OptumRxMemberus-gaap:ServiceMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:IntersegmentEliminationMemberus-gaap:ServiceMember2022-01-012022-03-310000731766unh:TotalOptumMemberunh:ExternalCustomersMemberus-gaap:ServiceMember2022-01-012022-03-310000731766us-gaap:CorporateNonSegmentMemberunh:ExternalCustomersMemberus-gaap:ServiceMember2022-01-012022-03-310000731766unh:ExternalCustomersMemberus-gaap:ServiceMember2022-01-012022-03-310000731766unh:UnitedhealthcareMemberus-gaap:OperatingSegmentsMemberunh:IntersegmentMember2022-01-012022-03-310000731766us-gaap:OperatingSegmentsMemberunh:IntersegmentMemberunh:OptumHealthMember2022-01-012022-03-310000731766unh:OptumInsightMemberus-gaap:OperatingSegmentsMemberunh:IntersegmentMember2022-01-012022-03-310000731766us-gaap:OperatingSegmentsMemberunh:IntersegmentMemberunh:OptumRxMember2022-01-012022-03-310000731766unh:IntersegmentMemberus-gaap:IntersegmentEliminationMember2022-01-012022-03-310000731766unh:TotalOptumMemberunh:IntersegmentMember2022-01-012022-03-310000731766us-gaap:CorporateNonSegmentMemberunh:IntersegmentMember2022-01-012022-03-310000731766unh:IntersegmentMember2022-01-012022-03-310000731766unh:UnitedhealthcareMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000731766us-gaap:OperatingSegmentsMemberunh:OptumHealthMember2022-01-012022-03-310000731766unh:OptumInsightMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000731766us-gaap:OperatingSegmentsMemberunh:OptumRxMember2022-01-012022-03-310000731766us-gaap:IntersegmentEliminationMember2022-01-012022-03-310000731766unh:TotalOptumMember2022-01-012022-03-310000731766us-gaap:CorporateNonSegmentMember2022-01-012022-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________________________________ 
Form 10-Q
__________________________________________________________ 
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED March 31, 2023
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _______ TO _______
Commission File Number: 1-10864
__________________________________________________________ 
UHG(R)_CMYK.jpg
UnitedHealth Group Incorporated
(Exact name of registrant as specified in its charter)
 __________________________________________________________ 
Delaware 41-1321939
(State or other jurisdiction of
incorporation or organization)		 (I.R.S. Employer
Identification No.)
UnitedHealth Group Center 55343
9900 Bren Road East
Minnetonka,
Minnesota
(Address of principal executive offices) (Zip Code)
(952) 936-1300
(Registrant’s telephone number, including area code)
_________________________________________________________  
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.01 par valueUNHNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act
Large accelerated filer☒Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐ No ☒
As of April 28, 2023, there were 931,032,030 shares of the registrant’s Common Stock, $.01 par value per share, issued and outstanding.


UNITEDHEALTH GROUP
Table of Contents
 
  Page



PART I
ITEM 1.    FINANCIAL STATEMENTS
UnitedHealth Group
Condensed Consolidated Balance Sheets
(Unaudited)
(in millions, except per share data)March 31,
2023		December 31,
2022
Assets
Current assets:
Cash and cash equivalents$41,913 $23,365 
Short-term investments4,584 4,546 
Accounts receivable, net22,414 17,681 
Other current receivables, net14,696 12,769 
Assets under management3,837 4,087 
Prepaid expenses and other current assets6,451 6,621 
Total current assets93,895 69,069 
Long-term investments46,884 43,728 
Property, equipment and capitalized software, net
10,637 10,128 
Goodwill100,406 93,352 
Other intangible assets, net16,165 14,401 
Other assets15,692 15,027 
Total assets$283,679 $245,705 
Liabilities, redeemable noncontrolling interests and equity
Current liabilities:
Medical costs payable$31,809 $29,056 
Accounts payable and accrued liabilities29,856 27,715 
Short-term borrowings and current maturities of long-term debt9,931 3,110 
Unearned revenues14,487 3,075 
Other current liabilities30,399 26,281 
Total current liabilities116,482 89,237 
Long-term debt, less current maturities60,657 54,513 
Deferred income taxes2,834 2,769 
Other liabilities13,084 12,839 
Total liabilities193,057 159,358 
Commitments and contingencies (Note 6)
Redeemable noncontrolling interests4,801 4,897 
Equity:
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding
— — 
Common stock, $0.01 par value - 3,000 shares authorized; 932 and 934 issued and outstanding
9 9 
Retained earnings88,852 86,156 
Accumulated other comprehensive loss(7,549)(8,393)
Nonredeemable noncontrolling interests
4,509 3,678 
Total equity85,821 81,450 
Total liabilities, redeemable noncontrolling interests and equity$283,679 $245,705 
1
UnitedHealth Group
Condensed Consolidated Statements of Operations
(Unaudited)
 Three Months Ended March 31,
(in millions, except per share data)20232022
Revenues:
Premiums$72,786 $64,070 
Products10,267 9,340 
Services8,080 6,372 
Investment and other income798 367 
Total revenues91,931 80,149 
Operating costs:
Medical costs59,845 52,523 
Operating costs13,625 11,401 
Cost of products sold9,405 8,487 
Depreciation and amortization970 788 
Total operating costs83,845 73,199 
Earnings from operations8,086 6,950 
Interest expense(754)(433)
Earnings before income taxes7,332 6,517 
Provision for income taxes(1,558)(1,369)
Net earnings5,774 5,148 
Earnings attributable to noncontrolling interests(163)(121)
Net earnings attributable to UnitedHealth Group common shareholders$5,611 $5,027 
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic$6.01 $5.34 
Diluted$5.95 $5.27 
Basic weighted-average number of common shares outstanding933 941 
Dilutive effect of common share equivalents10 13 
Diluted weighted-average number of common shares outstanding943 954 
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents5 2 
2
UnitedHealth Group
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
 Three Months Ended March 31,
(in millions)20232022
Net earnings$5,774 $5,148 
Other comprehensive income (loss):
Gross unrealized gains (losses) on investment securities during the period640 (2,023)
Income tax effect(147)465 
Total unrealized gains (losses), net of tax493 (1,558)
Gross reclassification adjustment for net realized losses (gains) included in net earnings13 (3)
Income tax effect(3)1 
Total reclassification adjustment, net of tax
10 (2)
Total foreign currency translation gains341 918 
Other comprehensive income (loss)844 (642)
Comprehensive income6,618 4,506 
Comprehensive income attributable to noncontrolling interests(163)(121)
Comprehensive income attributable to UnitedHealth Group common shareholders
$6,455 $4,385 
3
UnitedHealth Group
Condensed Consolidated Statements of Changes in Equity
(Unaudited)
Common StockAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive
(Loss) Income		Nonredeemable Noncontrolling InterestsTotal
Equity
Three months ended March 31,
(in millions)		SharesAmountNet Unrealized (Losses) Gains on InvestmentsForeign Currency Translation (Losses) Gains
Balance at January 1, 2023934 $9 $— $86,156 $(2,778)$(5,615)$3,678 $81,450 
Net earnings
5,611 113 5,724 
Other comprehensive income503 341 844 
Issuances of common stock, and related tax effects
2 — 350 350 
Share-based compensation
366 366 
Common share repurchases(4)— (633)(1,378)(2,011)
Cash dividends paid on common shares ($1.65 per share)
(1,537)(1,537)
Redeemable noncontrolling interests fair value and other adjustments
(83)(83)
Acquisition and other adjustments of nonredeemable noncontrolling interests
819 819 
Distribution to nonredeemable noncontrolling interests
(101)(101)
Balance at March 31, 2023932 $9 $— $88,852 $(2,275)$(5,274)$4,509 $85,821 
Balance at January 1, 2022941 $10 $— $77,134 $423 $(5,807)$3,285 $75,045 
Net earnings
5,027 88 5,115 
Other comprehensive (loss) income(1,560)918 (642)
Issuances of common stock, and related tax effects
3 — 333 333 
Share-based compensation
282 282 
Common share repurchases(5)— (484)(2,016)(2,500)
Cash dividends paid on common shares ($1.45 per share)
(1,363)(1,363)
Redeemable noncontrolling interests fair value and other adjustments
(131)(131)
Acquisition and other adjustments of nonredeemable noncontrolling interests91 91 
Distribution to nonredeemable noncontrolling interests
(102)(102)
Balance at March 31, 2022939 $10 $— $78,782 $(1,137)$(4,889)$3,362 $76,128 
4
UnitedHealth Group
Condensed Consolidated Statements of Cash Flows
(Unaudited)
 Three Months Ended March 31,
(in millions)20232022
Operating activities
Net earnings$5,774 $5,148 
Noncash items:
Depreciation and amortization970 788 
Deferred income taxes(332)161 
Share-based compensation362 299 
Other, net69 17 
Net change in other operating items, net of effects from acquisitions and changes in AARP balances:
Accounts receivable(4,306)(4,521)
Other assets(1,875)(1,089)
Medical costs payable2,467 3,849 
Accounts payable and other liabilities1,796 589 
Unearned revenues11,402 78 
Cash flows from operating activities16,327 5,319 
Investing activities
Purchases of investments(4,894)(4,982)
Sales of investments456 1,591 
Maturities of investments2,119 1,759 
Cash paid for acquisitions, net of cash assumed(7,826)(1,231)
Purchases of property, equipment and capitalized software(760)(555)
Other, net(115)(255)
Cash flows used for investing activities(11,020)(3,673)
Financing activities
Common share repurchases(2,000)(2,500)
Cash dividends paid(1,537)(1,363)
Proceeds from common stock issuances344 551 
Repayments of long-term debt(1,375)(1,100)
Proceeds from short-term borrowings, net7,349 3,148 
Proceeds from issuance of long-term debt6,401 — 
Customer funds administered5,012 5,120 
Other, net(1,004)(1,552)
Cash flows from financing activities13,190 2,304 
Effect of exchange rate changes on cash and cash equivalents51 157 
Increase in cash and cash equivalents18,548 4,107 
Cash and cash equivalents, beginning of period23,365 21,375 
Cash and cash equivalents, end of period$41,913 $25,482 
5
UnitedHealth Group
Notes to the Condensed Consolidated Financial Statements
(Unaudited)
1.    Basis of Presentation
UnitedHealth Group Incorporated (individually and together with its subsidiaries, “UnitedHealth Group” and the “Company”) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations the Company is privileged to serve.
The Company has prepared the Condensed Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries. The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC), the Company has omitted certain footnote disclosures that would substantially duplicate the disclosures contained in its annual audited Consolidated Financial Statements. Therefore, these Condensed Consolidated Financial Statements should be read together with the Consolidated Financial Statements and the Notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC (2022 10-K). The accompanying Condensed Consolidated Financial Statements include all normal recurring adjustments necessary to present the interim financial statements fairly.
Use of Estimates
These Condensed Consolidated Financial Statements include certain amounts based on the Company’s best estimates and judgments. The Company’s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters that are inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.
Revenues - Products and Services
As of March 31, 2023 and December 31, 2022, accounts receivable related to products and services were $8.1 billion and $7.1 billion, respectively. Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracting having an original expected duration of one year or less, contracts where revenue recognized as invoiced and contracts with variable consideration related undelivered performance obligations, was $12.3 billion, of which approximately half is expected to be recognized in the next three years.
6
2.    Investments
A summary of debt securities by major security type is as follows:
(in millions)Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Fair
Value
March 31, 2023
Debt securities - available-for-sale:
U.S. government and agency obligations$4,760 $5 $(236)$4,529 
State and municipal obligations8,055 65 (365)7,755 
Corporate obligations24,149 59 (1,525)22,683 
U.S. agency mortgage-backed securities8,213 35 (708)7,540 
Non-U.S. agency mortgage-backed securities3,156 1 (283)2,874 
Total debt securities - available-for-sale48,333 165 (3,117)45,381 
Debt securities - held-to-maturity:
U.S. government and agency obligations594 — (10)584 
State and municipal obligations28 — (3)25 
Corporate obligations60 — — 60 
Total debt securities - held-to-maturity682 — (13)669 
Total debt securities$49,015 $165 $(3,130)$46,050 
December 31, 2022
Debt securities - available-for-sale:
U.S. government and agency obligations$4,093 $1 $(285)$3,809 
State and municipal obligations7,702 25 (479)7,248 
Corporate obligations23,675 17 (1,798)21,894 
U.S. agency mortgage-backed securities7,379 15 (808)6,586 
Non-U.S. agency mortgage-backed securities3,077 1 (294)2,784 
Total debt securities - available-for-sale45,926 59 (3,664)42,321 
Debt securities - held-to-maturity:
U.S. government and agency obligations578 — (14)564 
State and municipal obligations29 — (3)26 
Corporate obligations89 — — 89 
Total debt securities - held-to-maturity696 — (17)679 
Total debt securities$46,622 $59 $(3,681)$43,000 
The Company held $3.9 billion and $3.7 billion of equity securities as of March 31, 2023 and December 31, 2022, respectively. The Company’s investments in equity securities primarily consist of employee savings plan related investments, venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company’s investments included $1.5 billion of equity method investments in operating businesses in the health care sector as of March 31, 2023 and December 31, 2022. The allowance for credit losses on held-to-maturity securities at March 31, 2023 and December 31, 2022 was not material.
7
The amortized cost and fair value of debt securities as of March 31, 2023, by contractual maturity, were as follows:
Available-for-SaleHeld-to-Maturity
(in millions)Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value
Due in one year or less$4,722 $4,691 $377 $376 
Due after one year through five years14,356 13,708 261 254 
Due after five years through ten years12,240 11,217 24 22 
Due after ten years5,646 5,351 20 17 
U.S. agency mortgage-backed securities8,213 7,540 — — 
Non-U.S. agency mortgage-backed securities3,156 2,874 — — 
Total debt securities$48,333 $45,381 $682 $669 
The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:
 Less Than 12 Months12 Months or Greater Total
(in millions)Fair
Value		Gross
Unrealized
Losses		Fair
Value		Gross
Unrealized
Losses		Fair
Value		Gross
Unrealized
Losses
March 31, 2023
Debt securities - available-for-sale:
U.S. government and agency obligations
$1,279 $(12)$1,825 $(224)$3,104 $(236)
State and municipal obligations1,898 (30)3,110 (335)5,008 (365)
Corporate obligations6,337 (178)12,443 (1,347)18,780 (1,525)
U.S. agency mortgage-backed securities1,589 (55)4,274 (653)5,863 (708)
Non-U.S. agency mortgage-backed securities
783 (26)1,989 (257)2,772 (283)
Total debt securities - available-for-sale$11,886 $(301)$23,641 $(2,816)$35,527 $(3,117)
December 31, 2022
Debt securities - available-for-sale:
U.S. government and agency obligations
$2,007 $(96)$1,290 $(189)$3,297 $(285)
State and municipal obligations4,630 (288)1,178 (191)5,808 (479)
Corporate obligations13,003 (893)6,637 (905)19,640 (1,798)
U.S. agency mortgage-backed securities3,561 (345)2,239 (463)5,800 (808)
Non-U.S. agency mortgage-backed securities
1,698 (128)976 (166)2,674 (294)
Total debt securities - available-for-sale$24,899 $(1,750)$12,320 $(1,914)$37,219 $(3,664)
The Company’s unrealized losses from debt securities as of March 31, 2023 were generated from approximately 32,000 positions out of a total of 42,000 positions. The Company believes that it will collect the timely principal and interest due on its debt securities that have an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company’s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of March 31, 2023, the Company did not have the intent to sell any of the available-for-sale debt securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities at March 31, 2023 and December 31, 2022 was not material.
8
3.    Fair Value
Certain assets and liabilities are measured at fair value in the Condensed Consolidated Financial Statements or have fair values disclosed in the Notes to the Condensed Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP.
For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K.
The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:
(in millions)Quoted Prices
in Active
Markets
(Level 1)		Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
Fair and Carrying
Value
March 31, 2023
Cash and cash equivalents$41,851 $62 $— $41,913 
Debt securities - available-for-sale:
U.S. government and agency obligations4,122 407 — 4,529 
State and municipal obligations— 7,755 — 7,755 
Corporate obligations16 22,486 181 22,683 
U.S. agency mortgage-backed securities— 7,540 — 7,540 
Non-U.S. agency mortgage-backed securities— 2,874 — 2,874 
Total debt securities - available-for-sale4,138 41,062 181 45,381 
Equity securities2,128 35 70 2,233 
Assets under management 1,491 2,245 101 3,837 
Total assets at fair value$49,608 $43,404 $352 $93,364 
Percentage of total assets at fair value53 %46 %1 %100 %
December 31, 2022
Cash and cash equivalents$23,202 $163 $— $23,365 
Debt securities - available-for-sale:
U.S. government and agency obligations3,505 304 — 3,809 
State and municipal obligations— 7,248 — 7,248 
Corporate obligations7 21,695 192 21,894 
U.S. agency mortgage-backed securities— 6,586 — 6,586 
Non-U.S. agency mortgage-backed securities— 2,784 — 2,784 
Total debt securities - available-for-sale3,512 38,617 192 42,321 
Equity securities2,043 35 70 2,148 
Assets under management 1,788 2,203 96 4,087 
Total assets at fair value$30,545 $41,018 $358 $71,921 
Percentage of total assets at fair value42 %57 %1 %100 %
There were no transfers in or out of Level 3 financial assets or liabilities during the three months ended March 31, 2023 or 2022.
9
The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:
(in millions)Quoted Prices
in Active
Markets
(Level 1)		Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
Fair
Value		Total Carrying Value
March 31, 2023
Debt securities - held-to-maturity$595 $74 $— $669 $682 
Long-term debt and other financing obligations$— $60,307 $— $60,307 $62,360 
December 31, 2022
Debt securities - held-to-maturity$577 $102 $— $679 $696 
Long-term debt and other financing obligations$— $53,626 $— $53,626 $56,823 
Nonfinancial assets and liabilities or financial assets and liabilities that are measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. There were no significant fair value adjustments for these assets and liabilities recorded during the three months ended March 31, 2023 or 2022.
4.    Medical Costs Payable
The following table shows the components of the change in medical costs payable for the three months ended March 31:
(in millions)20232022
Medical costs payable, beginning of period$29,056 $24,483 
Acquisitions1 8 
Reported medical costs:
Current year60,315 52,813 
Prior years(470)(290)
Total reported medical costs59,845 52,523 
Medical payments:
Payments for current year
(35,087)(29,589)
Payments for prior years(22,006)(18,749)
Total medical payments(57,093)(48,338)
Medical costs payable, end of period$31,809 $28,676 
For the three months ended March 31, 2023 and 2022, prior years’ medical cost reserve development included no individual factors that were significant. Medical costs payable included reserves for claims incurred by insured customers but not yet reported to the Company of $21.7 billion and $20.0 billion at March 31, 2023 and December 31, 2022, respectively.
10
5.    Short-Term Borrowings and Long-Term Debt
In March 2023, the Company issued $6.5 billion of senior unsecured notes consisting of the following:
(in millions, except percentages)Par Value
4.250% notes due January 2029
$1,250 
4.500% notes due April 2033
1,500 
5.050% notes due April 2053
2,000 
5.200% notes due April 2063
1,750 
As of March 31, 2023, the Company had $8.2 billion of commercial paper outstanding, with a weighted-average annual interest rate of 5.2%.
For more information on the Company’s short-term borrowings, debt covenants and long-term debt, see Note 8 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K.
6.    Commitments and Contingencies
Legal Matters
The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company’s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.
The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.
Government Investigations, Audits and Reviews
The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by the Centers for Medicare and Medicaid Services (CMS), state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the Internal Revenue Service, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the Federal Deposit Insurance Corporation, the Consumer Financial Protection Bureau (CFPB), the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company’s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company’s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company’s health plans.
On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower’s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company’s motion to dismiss. In May 2018, the DOJ moved to dismiss the Company’s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government’s motion for partial summary judgment and dismissed the Company’s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.
11
7.    Business Combinations
During the three months ended March 31, 2023, the Company completed several business combinations for total consideration of $8.0 billion.
Acquired assets (liabilities) at acquisition date were:
(in millions)
Cash and cash equivalents$142 
Accounts receivable and other current assets530 
Property, equipment and other long-term assets659 
Other intangible assets2,141 
Total identifiable assets acquired3,472 
Medical costs payable(1)
Accounts payable and other current liabilities(467)
Other long-term liabilities(698)
Total identifiable liabilities acquired(1,166)
Total net identifiable assets2,306 
Goodwill6,646 
Redeemable noncontrolling interests(130)
Nonredeemable noncontrolling interests(819)
Net assets acquired$8,003 
The majority of goodwill is not deductible for income tax purposes. The preliminary purchase price allocations for the various business combinations are subject to adjustment as valuation analyses, primarily related to intangible assets and contingent liabilities, are finalized.
The acquisition date fair values and weighted-average useful lives assigned to intangible assets were:
(in millions, except years)Fair ValueWeighted-Average Useful Life
Acquired finite-lived intangible assets:
Customer-related$234 13 years
Trademarks and technology2205 years
Other1011 years
Total acquired finite-lived intangible assets464 9 years
Total acquired indefinite-lived intangible assets - operating licenses and certificates1,677 
Total acquired intangible assets$2,141 
The results of operations and financial condition of acquired entities have been included in the Company’s consolidated results and the results of the corresponding operating segment as of the date of acquisition. Through March 31, 2023, acquired entities impact on revenues and net earnings was not material.
Unaudited pro forma revenues and net earnings for the three months ended March 31, 2023 and 2022, as if the business combinations had occurred on January 1, 2022, were immaterial for both periods.
12
8.    Segment Financial Information
The Company’s four reportable segments are UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. For more information on the Company’s segments, see Part I, Item I, “Business” and Note 14 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K. Total assets at Optum Health increased to $80.4 billion as of March 31, 2023 compared to $69.0 billion as of December 31, 2022, primarily due to goodwill from business combinations of $5.9 billion.
The following tables present reportable segment financial information:
  Optum  
(in millions)UnitedHealthcareOptum HealthOptum InsightOptum RxOptum EliminationsOptumCorporate and
Eliminations		Consolidated
Three Months Ended March 31, 2023
Revenues - unaffiliated customers:
Premiums$67,458 $5,328 $— $— $— $5,328 $— $72,786 
Products— 44 40 10,183 — 10,267 — 10,267 
Services2,555 3,089 1,926 510 — 5,525 — 8,080 
Total revenues - unaffiliated customers
70,013 8,461 1,966 10,693 — 21,120 — 91,133 
Total revenues - affiliated customers
— 14,266 2,510 16,679 (859)32,596 (32,596)— 
Investment and other income
455 277 20 46 — 343 — 798 
Total revenues$70,468 $23,004 $4,496 $27,418 $(859)$54,059 $(32,596)$91,931 
Earnings from operations$4,343 $1,776 $907 $1,060 $— $3,743 $— $8,086 
Interest expense— — — — — — (754)(754)
Earnings before income taxes
$4,343 $1,776 $907 $1,060 $— $3,743 $(754)$7,332 
Three Months Ended March 31, 2022
Revenues - unaffiliated customers:
Premiums$59,937 $4,133 $— $— $— $4,133 $— $64,070 
Products— 6 40 9,294 — 9,340 — 9,340 
Services2,515 2,558 974 325 — 3,857 — 6,372 
Total revenues - unaffiliated customers
62,452 6,697 1,014 9,619 — 17,330 — 79,782 
Total revenues - affiliated customers
— 9,829 2,138 14,291 (553)25,705 (25,705)— 
Investment and other income
143 156 67 1 — 224 — 367 
Total revenues$62,595 $16,682 $3,219 $23,911 $(553)$43,259 $(25,705)$80,149 
Earnings from operations$3,798 $1,366 $847 $939 $— $3,152 $— $6,950 
Interest expense— — — — — — (433)(433)
Earnings before income taxes
$3,798 $1,366 $847 $939 $— $3,152 $(433)$6,517 

13
ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read together with the accompanying Condensed Consolidated Financial Statements and Notes and with our 2022 10-K, including the Consolidated Financial Statements and Notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in that report. Unless the context indicates otherwise, references to the terms “UnitedHealth Group,” the “Company,” “we,” “our” or “us” used throughout this Management’s Discussion and Analysis of Financial Condition and Results of Operations refer to UnitedHealth Group Incorporated and its consolidated subsidiaries.
Readers are cautioned that the statements, estimates, projections or outlook contained in this Management's Discussion and Analysis of Financial Condition and Results of Operations, including discussions regarding financial prospects, economic conditions, trends and uncertainties contained in this Item 2, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the results discussed or implied in the forward-looking statements. A description of some of the risks and uncertainties is set forth in Part I, Item 1A, “Risk Factors” in our 2022 10-K and in the discussion below.
EXECUTIVE OVERVIEW
General
UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.
We have four reportable segments:
•Optum Health;
•Optum Insight;
•Optum Rx; and
•UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State.
Further information on our business is presented in Part I, Item 1, “Business” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2022 10-K and additional information on our segments can be found in this Item 2 and in Note 8 of Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.
Business Trends
Our businesses participate in the United States, South America and certain other international health markets. We expect overall spending on health care to continue to grow in the future due to inflation, medical technology and pharmaceutical advancement, regulatory requirements, demographic trends in the population and national interest in health and well-being. The rate of market growth may be affected by a variety of factors, including macroeconomic conditions and regulatory changes, which could impact our results of operations, including our continued efforts to control health care costs.
Pricing Trends. To price our health care benefits, products and services, we start with our view of expected future costs, including inflation and labor market dynamics. We frequently evaluate and adjust our approach in each of the local markets we serve, considering all relevant factors, such as product positioning, price competitiveness and environmental, competitive, legislative and regulatory considerations, including minimum medical loss ratio thresholds and similar revenue adjustments. We will continue seeking to balance growth and profitability across all these dimensions.
The commercial risk market remains highly competitive in the small group, large group and individual segments. We expect broad-based competition to continue as the industry adapts to individual and employer needs.
Government programs in the community and senior sector tend to receive lower rates of increase than the commercial market due to governmental budget pressures and lower cost trends.
Medical Cost Trends. Our medical cost trends primarily relate to changes in unit costs, care activity and prescription drug costs. We endeavor to mitigate those increases by engaging physicians and consumers with information and helping them make clinically sound choices, with the objective of helping them achieve quality, affordable care.
14
Regulatory Trends and Uncertainties
Medicare Advantage Rates. Medicare Advantage rate notices over the years have at times resulted in industry base rates well below industry forward medical trend. For example, the Final Notice for 2024 rates resulted in an industry base rate decrease, well short of what is an increasing industry forward medical cost trend, creating continued pressure in the Medicare Advantage program. Further, substantial revisions to the risk adjustment model, which serves to adjust rates to reflect a patient’s health status and care resource needs, will result in reduced funding and potentially benefits for people, especially those with some of the greatest health and social challenges.

As a result of ongoing Medicare funding pressures, there are adjustments we can make to partially offset these rate pressures and reductions for a particular period. For example, we can seek to intensify our medical and operating cost management, make changes to the size and composition of our care provider networks, adjust member benefits and implement or increase the member premiums supplementing the monthly payments we receive from the government. Additionally, we decide annually on a county-by-county basis where we will offer Medicare Advantage plans.
SELECTED OPERATING PERFORMANCE AND OTHER SIGNIFICANT ITEMS
The following summarizes select first quarter 2023 year-over-year operating comparisons to first quarter 2022 and other financial results.
•Consolidated revenues grew 15%, UnitedHealthcare revenues grew 13% and Optum revenues grew 25%.
•UnitedHealthcare served 1.9 million more people, driven by growth across our U.S. businesses.
•Consolidated earnings from operations of $8.1 billion compared to $7.0 billion last year, included growth of 14% at UnitedHealthcare and 19% at Optum.
•Diluted earnings per common share were $5.95.
•Cash flows from operations for the three months ended March 31, 2023 were $16.3 billion.
•Return on equity was 28.2%.
15
RESULTS SUMMARY
The following table summarizes our consolidated results of operations and other financial information:
(in millions, except percentages and per share data)Three Months Ended
March 31,		Increase/(Decrease)
202320222023 vs. 2022
Revenues:
Premiums$72,786 $64,070 $8,716 14 %
Products10,267 9,340 927 10 
Services8,080 6,372 1,708 27 
Investment and other income798 367 431 117 
Total revenues91,931 80,149 11,782 15 
Operating costs:
Medical costs59,845 52,523 7,322 14 
Operating costs13,625 11,401 2,224 20 
Cost of products sold9,405 8,487 918 11 
Depreciation and amortization970 788 182 23 
Total operating costs83,845 73,199 10,646 15 
Earnings from operations8,086 6,950 1,136 16 
Interest expense(754)(433)(321)74 
Earnings before income taxes7,332 6,517 815 13 
Provision for income taxes(1,558)(1,369)(189)14 
Net earnings5,774 5,148 626 12 
Earnings attributable to noncontrolling interests(163)(121)(42)35 
Net earnings attributable to UnitedHealth Group common shareholders$5,611 $5,027 $584 12 %
Diluted earnings per share attributable to UnitedHealth Group common shareholders $5.95 $5.27 $0.68 13 %
Medical care ratio (a)82.2 %82.0 %0.2 %
Operating cost ratio14.8 14.2 0.6 
Operating margin8.8 8.7 0.1 
Tax rate21.2 21.0 0.2 
Net earnings margin (b)6.1 6.3 (0.2)
Return on equity (c)28.2 %27.8 %0.4 %
(a)Medical care ratio (MCR) is calculated as medical costs divided by premium revenue.
(b)Net earnings margin attributable to UnitedHealth Group shareholders.
(c)Return on equity is calculated as annualized net earnings attributable to UnitedHealth Group common shareholders divided by average shareholders’ equity. Average shareholders’ equity is calculated using the shareholders’ equity balance at the end of the preceding year and the shareholders’ equity balances at the end of each of the quarters in the year presented.
2023 RESULTS OF OPERATIONS COMPARED TO 2022 RESULTS OF OPERATIONS
Consolidated Financial Results
Revenues
The increases in revenues were primarily driven by growth in the number of people served through Medicare Advantage and Medicaid, pricing trends and growth across the Optum businesses.
Medical Costs and MCR
Medical costs increased primarily due to growth in people served through Medicare Advantage and Medicaid. The MCR increased as a result of business mix.
Operating Cost Ratio
The operating cost ratio increased primarily due to business mix and investments to support future growth, partially offset by continued productivity advances.
16
Reportable Segments
See Note 8 of Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this report for more information on our segments. We utilize various metrics to evaluate and manage our reportable segments, including people served by UnitedHealthcare by major market segment and funding arrangement, people served by Optum Health and adjusted scripts for Optum Rx. These metrics are the main drivers of revenue, earnings and cash flows at each business. The metrics also allow management and investors to evaluate and understand business mix, including the level and scope of services provided to people and pricing trends when comparing the metrics to revenue by segment.
The following table presents a summary of the reportable segment financial information:
 Three Months Ended
March 31,		Increase/(Decrease)
(in millions, except percentages)202320222023 vs. 2022
Revenues
UnitedHealthcare$70,468 $62,595 $7,873 13 %
Optum Health23,004 16,682 6,322 38 
Optum Insight4,496 3,219 1,277 40 
Optum Rx27,418 23,911 3,507 15 
Optum eliminations(859)(553)(306)55 
Optum54,059 43,259 10,800 25 
Eliminations(32,596)(25,705)(6,891)27 
Consolidated revenues$91,931 $80,149 $11,782 15 %
Earnings from operations
UnitedHealthcare$4,343 $3,798 $545 14 %
Optum Health1,776 1,366 410 30 
Optum Insight907 847 60 7 
Optum Rx1,060 939 121 13 
Optum3,743 3,152 591 19 
Consolidated earnings from operations$8,086 $6,950 $1,136 16 %
Operating margin
UnitedHealthcare6.2 %6.1 %0.1 %
Optum Health7.7 8.2 (0.5)
Optum Insight20.2 26.3 (6.1)
Optum Rx3.9 3.9 — 
Optum6.9 7.3 (0.4)
Consolidated operating margin8.8 %8.7 %0.1 %
17
UnitedHealthcare
The following table summarizes UnitedHealthcare revenues by business:
 Three Months Ended March 31,Increase/(Decrease)
(in millions, except percentages)202320222023 vs. 2022
UnitedHealthcare Employer & Individual - Domestic$16,544 $15,822 $722 5 %
UnitedHealthcare Employer & Individual - Global2,163 2,133 30 1 
UnitedHealthcare Employer & Individual - Total18,707 17,955 752 4 
UnitedHealthcare Medicare & Retirement33,006 29,100 3,906 13 
UnitedHealthcare Community & State18,755 15,540 3,215 21 
Total UnitedHealthcare revenues$70,468 $62,595 $7,873 13 %
The following table summarizes the number of people served by our UnitedHealthcare businesses, by major market segment and funding arrangement:
March 31,Increase/(Decrease)
(in thousands, except percentages)202320222023 vs. 2022
Commercial - Domestic:
Risk-based8,025 7,950 75 1 %
Fee-based19,325 18,460 865 5 
Total Commercial - Domestic27,350 26,410 940 4 
Medicare Advantage7,545 6,890 655 10 
Medicaid8,380 7,810 570 7 
Medicare Supplement (Standardized)4,320 4,355 (35)(1)
Total Community and Senior20,245 19,055 1,190 6 
Total UnitedHealthcare - Domestic Medical47,595 45,465 2,130 5 
Commercial - Global5,295 5,500 (205)(4)
Total UnitedHealthcare - Medical52,890 50,965 1,925 4 %
Supplemental Data:
Medicare Part D stand-alone3,380 3,360 20 1 %
UnitedHealthcare’s revenues and earnings from operations increased due to growth in the number of people served through individual and group Medicare Advantage plans; growth in existing Medicaid markets; including a greater mix of people with higher acuity needs; and an increase in the number of people served through risk-based and fee-based commercial offerings.
Optum
Total revenues and earnings from operations increased due to growth across the Optum businesses. The results by segment were as follows:
Optum Health
Revenues at Optum Health increased primarily due to organic growth in patients served under value-based care arrangements and business combinations. Earnings from operations increased due to organic growth in the number of people served under value-based care arrangements and cost management initiatives. Optum Health served approximately 103 million people as of March 31, 2023 compared to 100 million people as of March 31, 2022.
Optum Insight
Revenues and earnings from operations at Optum Insight increased due growth in business services as a result of business combinations and growth in technology services.
Optum Rx
Revenues and earnings from operations at Optum Rx increased due to higher script volumes from growth in people served and growth in specialty pharmacy offerings. Earnings from operations also increased as a result of continued supply chain management initiatives. Optum Rx fulfilled 378 million and 352 million adjusted scripts in the first quarters of 2023 and 2022, respectively.
18
LIQUIDITY, FINANCIAL CONDITION AND CAPITAL RESOURCES
Liquidity
Summary of our Major Sources and Uses of Cash and Cash Equivalents
 Three Months Ended March 31,Increase/(Decrease)
(in millions)202320222023 vs. 2022
Sources of cash:
Cash provided by operating activities$16,327 $5,319 $11,008 
Issuances of short-term borrowings and long-term debt, net of repayments12,375 2,048 10,327 
Proceeds from common stock issuances344 551 (207)
Customer funds administered5,012 5,120 (108)
Total sources of cash34,058 13,038 
Uses of cash:
Common stock repurchases(2,000)(2,500)500 
Cash paid for acquisitions, net of cash assumed(7,826)(1,231)(6,595)
Purchases of investments, net of sales and maturities (2,319)(1,632)(687)
Purchases of property, equipment and capitalized software(760)(555)(205)
Cash dividends paid(1,537)(1,363)(174)
Other(1,119)(1,807)688 
Total uses of cash(15,561)(9,088)
Effect of exchange rate changes on cash and cash equivalents51 157 (106)
Net increase in cash and cash equivalents$18,548 $4,107 $14,441 
2023 Cash Flows Compared to 2022 Cash Flows
Increased cash flows provided by operating activities were primarily driven by an increase in unearned revenue due to the March receipt of our April CMS premium payment of $11.2 billion and increased net earnings, partially offset by changes in working capital accounts. Other significant changes in sources or uses of cash year-over-year included increased net issuances of short-term borrowings and long-term debt, partially offset by increased cash paid for acquisitions and net purchases of investments.
Financial Condition
As of March 31, 2023, our cash, cash equivalent, available-for-sale debt securities and equity securities balances of $91.2 billion included approximately $41.9 billion of cash and cash equivalents (of which $7.0 billion was available for general corporate use), $45.4 billion of debt securities and $3.9 billion of investments in equity securities. Given the significant portion of our portfolio held in cash and cash equivalents, we do not anticipate fluctuations in the aggregate fair value of our financial assets to have a material impact on our liquidity or capital position. Our available-for-sale debt securities portfolio had a weighted-average duration of 4.0 years and a weighted-average credit rating of “Double A” as of March 31, 2023. When multiple credit ratings are available for an individual security, the average of the available ratings is used to determine the weighted-average credit rating.
Capital Resources and Uses of Liquidity
In addition to cash flows from operations and cash and cash equivalent balances available for general corporate use, our capital resources and uses of liquidity are as follows:
Cash Requirements. A summary of our cash requirements as of December 31, 2022 was disclosed in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2022 10-K. During the three months ended March 31, 2023, there were no material changes to this previously disclosed information outside the ordinary course of business. We believe our capital resources are sufficient to meet future, short-term and long-term, liquidity needs. We continually evaluate opportunities to expand our operations, including through internal development of new products, programs and technology applications and business combinations.

19
Short-Term Borrowings. Our revolving bank credit facilities provide liquidity support for our commercial paper borrowing program, which facilitates the private placement of unsecured debt through independent broker-dealers, and are available for general corporate purposes. For more information on our commercial paper and bank credit facilities, see Note 5 of Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this report and Note 8 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in our 2022 10-K.
Our revolving bank credit facilities contain various covenants, including covenants requiring us to maintain a defined debt to debt-plus-shareholders’ equity ratio of not more than 60%. As of March 31, 2023, our debt to debt-plus-shareholders’ equity ratio, as defined and calculated under the credit facilities, was approximately 42%.
Long-Term Debt. Periodically, we access capital markets and issue long-term debt for general corporate purposes, such as, to meet our working capital requirements, to refinance debt, to finance acquisitions or for share repurchases. For more information on our long-term debt, see Note 5 of Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this report and Note 8 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in our 2022 10-K.
Credit Ratings. Our credit ratings as of March 31, 2023 were as follows:
  
Moody’sS&P GlobalFitchA.M. Best
 RatingsOutlookRatingsOutlookRatingsOutlookRatingsOutlook
Senior unsecured debtA3PositiveA+StableAStableAStable
Commercial paperP-2n/aA-1n/aF1n/aAMB-1+n/a
The availability of financing in the form of debt or equity is influenced by many factors, including our profitability, operating cash flows, debt levels, credit ratings, debt covenants and other contractual restrictions, regulatory requirements and economic and market conditions. A significant downgrade in our credit ratings or adverse conditions in the capital markets may increase the cost of borrowing for us or limit our access to capital.
Share Repurchase Program. During the three months ended March 31, 2023, we repurchased approximately 4 million shares at an average price of $484.83 per share. As of March 31, 2023, we had Board of Directors’ authorization to purchase up to 27 million shares of our common stock.
Dividends. Our quarterly cash dividend to shareholders reflects an annual dividend rate of $6.60 per share.
For additional liquidity discussion, see Note 10 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Part II, Item 7 in our 2022 10-K.
RECENTLY ISSUED ACCOUNTING STANDARDS
There are no recently issued accounting standards that are expected to have a material impact on our Condensed Consolidated Financial Statements.
CRITICAL ACCOUNTING ESTIMATES
In preparing our Condensed Consolidated Financial Statements, we are required to make judgments, assumptions and estimates, which we believe are reasonable and prudent based on the available facts and circumstances. These judgments, assumptions and estimates affect certain of our revenues and expenses and their related balance sheet accounts and disclosure of our contingent liabilities. We base our assumptions and estimates primarily on historical experience and consider known and projected trends. On an ongoing basis, we re-evaluate our selection of assumptions and the method of calculating our estimates. Actual results, however, may materially differ from our calculated estimates, and this difference would be reported in our current operations.
Our critical accounting estimates include medical costs payable and goodwill. For a detailed description of our critical accounting estimates, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Part II, Item 7 in our 2022 10-K. For a detailed discussion of our significant accounting policies, see Note 2 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in our 2022 10-K.

20
FORWARD-LOOKING STATEMENTS

The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking” statements which are intended to take advantage of the “safe harbor” provisions of the federal securities law. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; the DOJ’s legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations (including any increase in the U.S. income tax rate applicable to corporations); increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to manage successfully our strategic alliances or complete, manage or integrate strategic transactions; risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events; fluctuations in foreign currency exchange rates; failure to attract, develop, retain, and manage the succession of key employees and executives; our investment portfolio performance; impairment of our goodwill and intangible assets; failure to protect proprietary rights to our databases, software and related products; downgrades in our credit ratings; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock.
This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations, more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We manage exposure to market interest rates by diversifying investments across different fixed-income market sectors and debt across maturities, as well as by matching a portion of our floating-rate assets and liabilities, either directly or through the use of interest rate swap contracts. Unrealized gains and losses on investments in available-for-sale debt securities are reported in comprehensive income.
The following table summarizes the impact of hypothetical changes in market interest rates across the entire yield curve by 1% point or 2% points as of March 31, 2023 on our investment income and interest expense per annum, and the fair value of our investments and debt (in millions, except percentages):
March 31, 2023
Increase (Decrease) in Market Interest RateInvestment
Income Per
Annum		Interest
Expense Per
Annum		Fair Value of
Financial Assets		Fair Value of
Financial Liabilities
2 %$1,027 $487 $(3,684)$(8,701)
1513 244 (1,894)(4,741)
(1)(513)(216)1,979 5,729 
(2)(1,027)(428)4,008 12,724 
Note: The impact of hypothetical changes in interest rates may not reflect the full 100 or 200 basis point change on interest income and interest expense or on the fair value of financial assets and liabilities as the rates are assumed to not fall below zero.
21
ITEM 4.    CONTROLS AND PROCEDURES
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act) that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
In connection with the filing of this quarterly report on Form 10-Q, management evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2023. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2023.
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
There have been no changes in our internal control over financial reporting during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1.    LEGAL PROCEEDINGS
A description of our legal proceedings is included in and incorporated by reference to Note 6 of Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.
ITEM 1A.    RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, “Risk Factors” of our 2022 10-K, which could materially affect our business, financial condition or future results. The risks described in our 2022 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.
There have been no material changes to the risk factors as disclosed in our 2022 10-K.
ITEM 2.    UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities (a)
First Quarter 2023
For the Month EndedTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Number of Shares That May Yet Be Purchased Under The Plans or Programs
(in millions)(in millions)(in millions)
January 31, 20231.3 $495.21 1.3 29.8
February 28, 20231.5 485.22 1.5 28.3
March 31, 20231.3 473.89 1.3 27.0
Total4.1 $484.83 4.1 
(a)    In November 1997, our Board of Directors adopted a share repurchase program, which the Board of Directors evaluates periodically. In June 2018, the Board of Directors renewed our share repurchase program with an authorization to repurchase up to 100 million shares of our common stock in open market purchases or other types of transactions (including prepaid or structured repurchase programs). There is no established expiration date for the program.
22
ITEM 6.    EXHIBITS*
The following exhibits are filed or incorporated by reference herein in response to Item 601 of Regulation S-K. The Company files Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K pursuant to the Securities Exchange Act of 1934 under Commission File No. 1-10864.
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
104 Cover Page Interactive Data File (formatted as Inline XBRL and embedded within Exhibit 101).
 ________________
*Pursuant to Item 601(b)(4)(iii) of Regulation S-K, copies of instruments defining the rights of certain holders of long-term debt are not filed. The Company will furnish copies thereof to the SEC upon request.
23
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
UNITEDHEALTH GROUP INCORPORATED
 
/s/ ANDREW WITTY
Chief Executive Officer
(principal executive officer)		Dated:May 3, 2023
Andrew Witty  
/s/ JOHN REX
Executive Vice President and
Chief Financial Officer
(principal financial officer)		Dated:May 3, 2023
John Rex  
/s/ THOMAS ROOS
Senior Vice President and
Chief Accounting Officer
(principal accounting officer)		Dated:May 3, 2023
Thomas Roos  
24
 EX-31.1 2 ex311unh2023331.htm EX-31.1 Document

EXHIBIT 31.1
CERTIFICATIONS PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
Certification of Principal Executive Officer

 I, Andrew P. Witty, certify that:

1.I have reviewed this report on Form 10-Q of UnitedHealth Group Incorporated (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 
May 3, 2023
/s/ ANDREW P. WITTY
 Andrew P. Witty
Chief Executive Officer



Certification of Principal Financial Officer

I, John F. Rex, certify that:

1.I have reviewed this report on Form 10-Q of UnitedHealth Group Incorporated (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


 
May 3, 2023
/s/ JOHN F. REX
 John F. Rex
Executive Vice President and Chief Financial Officer


 EX-32.1 3 ex321unh2023331.htm EX-32.1 Document

EXHIBIT 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Certification of Principal Executive Officer
In connection with the report of UnitedHealth Group Incorporated (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Andrew P. Witty, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
May 3, 2023
/s/ ANDREW P. WITTY
 Andrew P. Witty
Chief Executive Officer
Certification of Principal Financial Officer
In connection with the report of UnitedHealth Group Incorporated (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John F. Rex, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


 
May 3, 2023
/s/ JOHN F. REX
 John F. Rex
Executive Vice President and Chief Financial Officer

 EX-101.SCH 4 unh-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statements of Changes in Equity link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statement of Changes in Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Basis of Presentation (Notes) link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Investments (Notes) link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Fair Value (Notes) link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Medical Costs Payable (Notes) link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes) link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Commitments and Contingencies (Notes) link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Business Combinations (Notes) link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Segment Financial Information (Notes) link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Investments (Policies) link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Fair Value (Tables) link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Medical Costs Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Segment Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Investments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Fair Value (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Fair Value (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Medical Costs Payable (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Medical Costs Payable (Details) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Business Combinations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Business Combinations (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Business Combinations Acquired Finite-Lived Intangible Asets (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Segment Financial Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Segment Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 unh-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 unh-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 unh-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Variable Rate [Domain] Variable Rate [Domain] Earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Sales of investments Proceeds from Sale of Debt Securities, Available-for-Sale Total debt securities, Gross Unrealized Gains Investments, Gross Unrealized Gains Gross unrealized gains of investments. Statistical Measurement [Domain] Statistical Measurement [Domain] Total current assets Assets, Current Nonredeemable noncontrolling interests Business Combinations, Nonredeemable noncontrolling interests Nonredeemable noncontrolling interests acquired through business combinations Net change in other operating items, net of effects from acquisitions and changes in AARP balances: Increase (Decrease) in Operating Capital [Abstract] Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents U.S. Agency Mortgage-Backed Securities [Member] Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Debt Disclosure Debt Disclosure [Text Block] Entity Filer Category Entity Filer Category Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Debt Securities, Held-to-maturity, Fair Value Debt Securities, Held-to-Maturity, Fair Value Deferred income taxes Deferred Income Tax Liabilities, Net Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable and other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Transfers out of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 Mortgage-backed securities, Fair Value Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Corporate Obligations [Member] Corporate Debt Securities [Member] Purchases of investments Payments to Acquire Investments Preferred stock, shares authorized Preferred Stock, Shares Authorized Commitments and contingencies (Note 6) Commitments and Contingencies 4.500% notes due April 2033 4.500% notes due April 2033 [Member] 4.500% notes due April 2033 U.S. Government and Agency Obligations [Member] US Treasury and Government [Member] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Unearned revenues Deferred Revenue, Current Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities Proceeds from common stock issuances Proceeds from Issuance of Common Stock Class of Stock [Axis] Class of Stock [Axis] Fair Value, Nonrecurring [Member] Fair Value, Nonrecurring [Member] Medical costs payable Medical costs payable, beginning of period Medical costs payable, end of period Liability for Claims and Claims Adjustment Expense Corporate and Eliminations Corporate, Non-Segment [Member] Nature of Operations Nature of Operations [Text Block] Basis of presentation [Abstract] Basis of presentation [Abstract] Basis of presentation [Abstract] Property, equipment and other long-term assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Revenue [Policy Text Block] Revenue [Policy Text Block] Customer [Axis] Customer [Axis] Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Current liabilities: Liabilities, Current [Abstract] Held-to-maturity securities, Amortized Cost Debt Securities, Held-to-maturity Debt Securities, Held-to-maturity Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Business Combination and Asset Acquisition [Abstract] Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding Preferred Stock, Value, Issued Optum Eliminations Intersegment Eliminations [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Consolidation Items [Axis] Consolidation Items [Axis] Commercial Paper [Member] Commercial Paper [Member] Cash dividends paid on common shares Dividends, Cash Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Cash dividends paid Payments of Ordinary Dividends, Common Stock Diluted Earnings Per Share, Diluted Schedule of Investments [Table] Schedule of Investments [Table] Unearned revenues Increase (Decrease) in Deferred Revenue Premiums Premiums, revenues - unaffiliated customers Premiums Earned, Net Assets under management AARP Assets Under Management The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program. UnitedHealthcare Unitedhealthcare [Member] UnitedHealthcare [Member] Held-to-maturity Securities, Debt Maturities, within One Year, Fair Value Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Accounts Receivable, after Allowance for Credit Loss, Current Unaffiliated Customers External Customers [Member] External Customers [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Unobservable Inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] Earnings before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Affiliated Customers Intersegment [Member] Intersegment [Member] Due after five years through ten years, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Redeemable noncontrolling interests Redeemable Noncontrolling Interest, Equity, Carrying Amount Trading Symbol Trading Symbol Total debt securities, Gross Unrealized Losses Investments, Gross Unrealized Losses Gross unrealized losses of investments. State and Municipal Obligations [Member] US States and Political Subdivisions Debt Securities [Member] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Investment and other income Investment Income, Interest and Dividend Preferred stock, shares issued Preferred Stock, Shares Issued Total identifiable liabilities acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Debt securities, Fair Value Disclosure Investments, Fair Value Disclosure Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Current year Current Year Claims and Claims Adjustment Expense Debt Securities [Member] Debt Securities [Member] Net earnings attributable to UnitedHealth Group common shareholders Net earnings attributable to UnitedHealth Group common shareholders Net Income (Loss) Attributable to Parent Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Due after one year through five years, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Commercial Paper Commercial Paper Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Medical costs payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Liabilities, redeemable noncontrolling interests and equity Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Short-term Debt, Weighted Average Interest Rate, at Point in Time Debt Instrument, Interest Rate, Effective Percentage Total net tangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Investments [Text Block] Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Equity: Equity, Attributable to Parent [Abstract] Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10 Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Document Fiscal Period Focus Document Fiscal Period Focus Other Intangible Assets [Member] Other Intangible Assets [Member] Cost of products sold Cost of Goods and Services Sold Share-based compensation Share-Based Payment Arrangement, Noncash Expense Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life 5.200% notes due April 2063 5.200% notes due April 2063 [Member] 5.200% notes due April 2063 Common Stock [Member] Common Stock [Member] Quoted Prices in Active Markets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Goodwill Goodwill Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Payments for current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Document Fiscal Year Focus Document Fiscal Year Focus Total equity Balance Balance Equity, Including Portion Attributable to Noncontrolling Interest Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 5 through 10 Distribution to nonredeemable noncontrolling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Entity Small Business Entity Small Business Net earnings attributable to nonredeemable noncontrolling interest Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest Investments [Abstract] Investments [Abstract] Payments for prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Property, equipment and capitalized software, net Property, Plant and Equipment, Net Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Common Stock, Dividends, Per Share, Cash Paid Common Stock, Dividends, Per Share, Cash Paid Other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Total unrealized gains (losses), net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Measurement Frequency [Axis] Measurement Frequency [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Total reported medical costs Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Reported medical costs: Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract] Due after ten years, Fair Value Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Investments by Contractual Maturity [Table Text Block] Investments Classified by Contractual Maturity Date [Table Text Block] Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Net earnings Net earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities Short-Duration Insurance and Deposit Contracts Short-Duration Insurance and Deposit Contracts [Text Block] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Total foreign currency translation gains Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Other, net Payments for (Proceeds from) Other Investing Activities Long-Term Debt [Table Text Block] Schedule of Long-Term Debt Instruments [Table Text Block] Acquisition and other adjustments of nonredeemable noncontrolling interests Noncontrolling Interest, Period Increase (Decrease) Retained Earnings [Member] Retained Earnings [Member] Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Total liabilities, redeemable noncontrolling interests and equity Liabilities and Equity Debt Securities, Available-for-sale, Amortized Cost Total debt securities - available-for-sale, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other assets Other Assets, Noncurrent Dilutive effect of common share equivalents Weighted Average Number of Shares Outstanding, Diluted, Adjustment Basic Earnings Per Share, Basic Equity Securities, FV-NI and without Readily Determinable Fair Value Equity Securities, FV-NI and without Readily Determinable Fair Value Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Optum Rx Optum Rx [Member] Optum Rx [Member] Due after ten years, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 Total revenues Revenues Product and Service [Domain] Product and Service [Domain] Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Entity Address, City or Town Entity Address, City or Town Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Mortgage-backed securities, Amortized Cost Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Medical costs Policyholder Benefits and Claims Incurred, Net, Health Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Quarterly Report Document Quarterly Report Interest expense Interest Expense Total medical payments Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Document Transition Report Document Transition Report Optum Total Optum [Member] total [Member] Finite-lived Intangible Assets Acquired Finite-Lived Intangible Assets Acquired Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Customer funds administered Increase (Decrease) in Deposits Use of Estimates, Policy [Policy Text Block] Use of Estimates, Policy [Policy Text Block] Common stock, shares authorized Common Stock, Shares Authorized Medical costs payable Increase (Decrease) in Health Care Insurance Liabilities Debt Securities, Available-for-sale Debt Securities, Available-for-Sale Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Medical payments: Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract] Entity File Number Entity File Number Securities, Available for sale Debt Securities, Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Total debt securities, Amortized Cost Investments, Amortized Cost Investments at amortized cost. Net Unrealized Gains (Losses) on Investments [Member] AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Entity Shell Company Entity Shell Company Long-term investments Long-Term Investments Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] 4.250% notes due January 2029 4.250% notes due January 2029 [Member] 4.250% notes due January 2029 Noncash items: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items] Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items] Due in one year or less, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Assets under management [Axis] Assets under management [Axis] Assets under management [Axis] Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 5.050% notes due April 2053 5.050% notes due April 2053 [Member] 5.050% notes due April 2053 Total identifiable assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Insurance [Abstract] Insurance [Abstract] Debt and other financing obligations Debt Instrument, Fair Value Disclosure Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Greater Than 12 Months, Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Common stock, shares issued Common Stock, Shares, Issued Business Combination, Consideration Transferred Business Combination, Consideration Transferred Due after five years through ten years, Fair Value Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Short-Term and Long-Term Investments [Table Text Block] Unrealized Gain (Loss) on Investments [Table Text Block] Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss Security Exchange Name Security Exchange Name Deferred income taxes Deferred Income Tax Expense (Benefit) Assets, Fair Value Disclosure Assets, Fair Value Disclosure Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Operating costs Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Foreign Currency Translation Losses [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Acquisitions Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions Investment, Policy [Policy Text Block] Investment, Policy [Policy Text Block] Short-term borrowings and current maturities of long-term debt Debt, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Total operating costs Costs and Expenses Other, net Proceeds from (Payments for) Other Financing Activities Comprehensive income attributable to UnitedHealth Group common shareholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Optum Health Optum Health Optum Health [Member] Optum Health Member Document Type Document Type Goodwill Goodwill, Acquired During Period Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Redeemable noncontrolling interests Business Combinations, Redeemable noncontrolling interests Redeemable noncontrolling interests acquired through business combinations Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entitiy Registrant Name Entity Registrant Name Other assets Increase (Decrease) in Other Operating Assets Securities, Held to maturity, Unrecognized Holding Gain Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain Nonredeemable noncontrolling interests Equity, Attributable to Noncontrolling Interest Basis of Accounting, Policy [Policy Text Block] Basis of Accounting, Policy [Policy Text Block] Other, net Other Noncash Income (Expense) Document Period End Date Document Period End Date Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount Business Acquisition [Axis] Business Acquisition [Axis] Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Fair Value [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Repayments of long-term debt Repayments of Long-Term Debt Revenue, Remaining Performance Obligation, Percentage Revenue, Remaining Performance Obligation, Percentage Entitiy Central Index Key Entity Central Index Key Statement [Line Items] Segment Reporting Information [Line Items] Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Significant Accounting Policies [Text Block] Long-term debt and other financing obligations Long-Term Debt [Member] Other current liabilities Other Liabilities, Current Variable Rate [Axis] Variable Rate [Axis] Accounts payable and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Provision for income taxes Income Tax Expense (Benefit) Income Statement [Abstract] Income Statement [Abstract] Accounts receivable and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Schedule of Investments [Line Items] Schedule of Investments [Line Items] Issuances of common stock, and related tax effects (in shares) Stock Issued During Period, Shares, New Issues Operating costs: Costs and Expenses [Abstract] Title of 12(b) Security Title of 12(b) Security Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Fair Value [Text Block] Fair Value Disclosures [Text Block] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Optum Insight Optum Insight Optum Insight [Member] Optum Insight [Member] Business Combination Disclosure Business Combination Disclosure [Text Block] Greater Than 12 Months, Gross Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Issuances of common stock, and related tax effects Stock Issued During Period, Value, New Issues Operating Segments Operating Segments [Member] Equity: Equity [Abstract] Total reclassification adjustment, net of tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Share-based compensation Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Revenue from Products and Services Revenue from Products and Services - unaffiliated customers Revenue from Contract with Customer, Excluding Assessed Tax Other current receivables, net Other Receivables, Net, Current Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Customer-Related Intangible Assets [Member] Customer-Related Intangible Assets [Member] Schedule of Liability for Unpaid Claims and Claims Adjustment Expense Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Income tax effect OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Gross reclassification adjustment for net realized losses (gains) included in net earnings Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax Entity Tax Identification Number Entity Tax Identification Number Equity Method Investments Equity Method Investments Debt and other financing obligations, carrying value Debt, Long-Term and Short-Term, Combined Amount Less Than 12 Months, Gross Unrealized Losses Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash paid for acquisitions, net of cash assumed Payments to Acquire Businesses, Net of Cash Acquired Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Statistical Measurement [Axis] Statistical Measurement [Axis] Due in one year or less, Fair Value Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Major Types of Debt Securities [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Common share repurchases (in shares) Stock Repurchased and Retired During Period, Shares Entity Interactive Data Current Entity Interactive Data Current Net Assets Acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table] Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table] Total number of security positions Investment Owned, Balance, Contracts Long-term debt, less current maturities Long-Term Debt, Excluding Current Maturities Common share repurchases Payments for Repurchase of Common Stock Products Product [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Non-U.S. Agency Mortgage-Backed Securities [Member] Mortgage-Backed Securities, Issued by Private Enterprises [Member] Diluted weighted-average number of common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Assets under management [Domain] Assets under management [Domain] [Domain] for Assets under management [Axis] Segments [Domain] Segments [Domain] Other Intangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Indefinite-Lived Intangible Assets Acquired Indefinite-Lived Intangible Assets Acquired Transfers Into Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 Purchases of property, equipment and capitalized software Payments to Acquire Property, Plant, and Equipment Par Value Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Additional Paid-In Capital [Member] Additional Paid-in Capital [Member] Current assets: Assets, Current [Abstract] Prior year Prior Year Claims and Claims Adjustment Expense Equity Securities, FV-NI Equity Securities, FV-NI unh:ProductsandservicesMember Products and Services [Member] Products and services Total assets Assets Assets Entity Address, State or Province Entity Address, State or Province Trademarks and Technology [Member] Trademarks and Technology [Member] Trademarks and Technology [Member] Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Cover [Abstract] Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities Non Recurring Basis Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Common stock, shares outstanding Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Maturities of investments Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Redeemable noncontrolling interests fair value and other adjustments Noncontrolling Interest, Change in Redemption Value Other liabilities Other Liabilities, Noncurrent Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Amount Short-term investments Short-Term Investments Segment Reporting Disclosure Segment Reporting Disclosure [Text Block] Increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Common stock, par value Common Stock, Par or Stated Value Per Share Equity Component [Domain] Equity Component [Domain] Income tax effect Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax Cash flows used for investing activities Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] Customer [Domain] Customer [Domain] Debt Instrument [Axis] Debt Instrument [Axis] Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Debt Instrument [Line Items] Debt Instrument [Line Items] Basic weighted-average number of common shares outstanding Weighted Average Number of Shares Outstanding, Basic Scenario [Axis] Scenario [Axis] Common share repurchases Stock Repurchased and Retired During Period, Value Entity Current Reporting Status Entity Current Reporting Status Earnings from operations Earnings from operations Operating Income (Loss) Gross unrealized gains (losses) on investment securities during the period OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Total liabilities Liabilities Services Service [Member] Revenues: Revenues [Abstract] Proceeds from short-term borrowings, net Proceeds from (Repayments of) Commercial Paper Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Total, Fair Value Debt Securities, Available-for-Sale, Unrealized Loss Position Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Scenario [Domain] Scenario [Domain] Number of Reportable Segments Number of Reportable Segments Earnings per share attributable to UnitedHealth Group common shareholders: Earnings Per Share [Abstract] Common stock, $0.01 par value - 3,000 shares authorized; 932 and 934 issued and outstanding Common Stock, Value, Issued Less Than 12 Months, Fair Value Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Due after one year through five years, Fair Value Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Fair Value Measurements, Nonrecurring [Table Text Block] Fair Value Measurements, Nonrecurring [Table Text Block] Nonredeemable Noncontrolling Interests [Member] Noncontrolling Interest [Member] EX-101.PRE 8 unh-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 9 unh-20230331_g1.jpg begin 644 unh-20230331_g1.jpg M_]C_X 02D9)1@ ! @$ 2 !( #_[0 L4&AO=&]S:&]P(#,N, X0DE- ^T M ! 2 $ 0!( 0 !_^(,6$E#0U]04D]&24Q% $! ,2$QI M;F\"$ ;6YT ", * M #( -P [ $ 10!* $\ M5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! M ,8 RP#0 -4 VP#@ .4 ZP#P /8 ^P$! 0&!YD'K >_!](' MY0?X" L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$ DE"3H)3PED"7D)CPFD M";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W KS"PL+(@LY"U$+:0N "Y@+ ML O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U #5H-= V.#:D-PPW> M#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1 F$$,0 M81!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,# M$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%> 6 M Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA &&48BABO&-48^AD@ M&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:' (<*AQ2''L< MHQS,'/4='AU''7 =F1W#'>P>%AY 'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!! M(&P@F"#$(/ A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D M321\)*LDVB4))3@E:"67)< ^(#Y@/J ^X#\A/V$_HC_B0"- 9$"F0.=!*4%J0:Q! M[D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T? M2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,%W)7AI>;%Z]7P]?85^S8 5@5V"J8/QA3V&B8?5B26*< M8O!C0V.78^MD0&249.EE/6629>=F/6:29NAG/6>39^EH/VB6:.QI0VF::?%J M2&J?:O=K3VNG:_]L5VRO;0AM8&VY;A)N:V[$;QYO>&_1<"MPAG#@<3IQE7'P M,QY*GF)>>=Z M1GJE>P1[8WO"?"%\@7SA?4%]H7X!?F)^PG\C?X1_Y8!'@*B!"H%K@%JX8.AG*&UX<[AY^(!(AIB,Z),XF9B?Z*9(K*BS"+ MEHO\C&.,RHTQC9B-_XYFCLZ/-H^>D :0;I#6D3^1J)(1DGJ2XY--D[:4()2* ME/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP M0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@ MJ%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[ L'6PZK%@L=:R M2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R; MO16]C[X*OH2^_[]ZO_7 <,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q MHM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFENV<[BCNM.] [\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV M^_>*^!GXJ/DX^$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5& MI+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7 MY_(B8J+C(V.CX*3E)66EYB9FINGM\?7 MY_(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H M# ,! (1 Q$ /P#[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%4/=W,=E:75Y*&:*TA>9PE"Q6 M-2Q J0*T'CAB+-(D:%OD#_G%/_G+W3?^5S_M'#M0S AP\-=;L& M_P!3WW\X?S*L/R>_++SC^9>I:;/K%IY2L?K1LK=UCDN)'D2&*,.U0H,DBAFH M:"IXM2APM!I):K41Q U9=AVCK8Z333RD6(BZ81_SC1^?5K_SD;^64/YB6WEJ M7RE(-2NM+N-.DNEO526V]-N4=P(K?FK)*IWC4@U%" &-W;'9AT&I.(RO:[Y- M'8G:P[1THRB-;D5SY/0[3\UORNO_ #-)Y*L?S)\K7OG**>2V?08-8LI-36:& MOJQ-9K.9@R<3R7C44WRB6AU$^C7S-BKJL]N\B$JPH0#L18_.6A/YWBB]=_+RZC;'55BX"3U#9"7U@O AJ\*4WZ9+\MF\ M/Q.$\/?6WS1^:P^+X?$.+NL7\DG\S_F[^4_DG4_T+YS_ #/\I>4=9]%+CZAK M6M6%A<^E(2$D]&XGC?BW$T-*&F2PZ#4YH\4,XD#[ MV._]#&?\X]_^7W_+S_PJ-)_[*\L_DC7?ZC/_ $I_4U?RUV=_JT/],/UO0/+_ M )S\G^;=&D\Q^5?->C>9O+T32(^J:5?6][9JT(K*#<0221@H#\7Q;=\HRZ?+ MBGPSB0>XBBY.'4X=0DTCR5^9?E3SAJL,+7,EEHF MLV.H7"PJ55I&BMIY7"@L 32E2,KSZ'4X8WDA(#S!#;I^T-+GE6/)&1\B#]RC MYE_.'\I/)>J/H?G'\TO*/E/6HXTF;3]9UNPL+I8Y!5',-Q<1N%8=#3?#A[/U M6:/%#'(CO )1G[2TF"7#DR1B>XD#[T#I7YZ?DEKM[%INA_G%Y'UG49S2*UL? M,.FW$[FH'PQQ7+,=SV&')V;K,8N6.0'F"C%VKHLDJAEB3Y2!_2]4S&> M?^>_P#G(WS+_P X\:?Y2U2UOO+]UJVG+K0K2M*C-?@TF?/?AP,J[@ M3]SLM1K-/IP#DF(WWD#[V%?]#&?\X]_^7W_+S_PJ-)_[*\N_DC7?ZC/_ $I_ M4T?RUV=_JT/],/UO4=%US1?,FEV6N>7=7LM?T34H_5M-0TZXCNK6XCJ1SBFA M9T<5!%03F-DQSQR,9"B.A8_+WFO2[?7/*VO:=YET6\KZ&H:5=17EK+Q-#PF@=T:A%#0XY<4\O>9];L/+FAZ>%:ZU'5+F*SM( S!%,D\SHB M@LP J>II@Q8IY)",02>X+ES0Q0,ID #J=@OT77-%\R:79:YY=U>RU_1-2C]6 MTU#3KB.ZM;B.I'.*:%G1Q4$5!..3'/'(QD*(Z%.++#)$2B00>1#$/,_YN_E/ MY)U/]"^<_P S_*7E'6?12X^H:UK5A87/I2$A)/1N)XWXMQ-#2AIEN'0:G-'B MACD1W@$M.?M'28)<.3)&)[B0/O8[_P!#&?\ ./?_ )??\O/_ J-)_[*\L_D MC7?ZC/\ TI_4U?RUV=_JT/\ 3#];._*GGKR1Y\M+F_\ (WG+0_.=C93?5[BY MT+4;;48H92H?TY'MI955N)!H36F4Y]-FP&LD3$^8K[W(T^KP:B-XYB0\B#]S M7EKSYY'\Z2:I#Y.\Y:%YLET240:BFC:C;7[6]'>9/-/ECR;I4NN^;_ #'I?E71+=TCEU#6 M+R&QM$>1@J*T]P\: LQH 3N301^FZGINM M:?9:OH^H6VK:5J4*7-I>V;((0%D\F&?/CPXS.9H#F7YFW_P#S\LO?-'F6Y\O_ )&?\X^^8_S/2UY- MZPDF6ZEC4D>HMA8V5^ZH>H9G!IU4'8=#'V.&/'Q:C,(_CO)#S4_;5O\ GXSK-OY]T'R#^;W_ #CWYA_+B_\ ,=[:V5LSS3?6D:[F6"-W ML;ZQL7*!VW97)\%)R.?V2@<$LF',) "_EY@EEI_;.?YB.+/@E D@#X^1 ?I' MYF\V^5?)6F'6_.7F;2?*6C+*D!O]9O8+"U$LE>"&:XDC3DU#05J?48L,.+)( =Y-!YV/\ G(O_ )Q\8A5_/;\O&9C0 >9])))/_1WF M1_).N_U*7^E/ZG'';79Y_P M#_3#];U;3-4TS6K&WU/1]1M=6TV[7G!=V'OK;YM M0U6 Y3C$QQ=UB_DGNI:GINBZ?>ZOK&H6VDZ5IL+W-W>WDJ06]O#&"SR2RR,J M(J@5)) RN$)3D !9;)SC"),C0"#T#S)Y=\UZ1;>8/*VOZ;YET&\Y_5]2TJZ MAO+27TV9'].>!WC;BRD&AV((R67#DQ2X9@@]QV8X3_G(C M_G'^&1XI?SS_ "^BEB8HZ/YGTI65E-""#=U!!S('9.N(_NI?Z4_J<8]L]G@T M2/.V@><8;7::30]2M=06/M\9MI90/IRG/I,_P"!W]>;_-_2^_O^ MJ^2_,NJ^9?SU_,3RO/)%>?E+YG_2\ M_H*3+%#<:M/"MU&17>&81D[?9)8T"YU>/4XXXL.*?*<:^P;/&Y=)EGFSYH'> M$K_V1W^#]VKK\V;+\[?^<'/S!_,:U*)=:U^5WF:/5($V%OJ=MI5Y!>Q4ZA1* MC%*]4*MWSC8Z&6C[9AB/2<:]UBGN9]H1UW8>3*.N.5^^C;QO_GU;_P"L]^C_4'WEPO^!__P 9T_ZY^Z+Y6T/_ .2H3_\ @6ZC_P!T M6XS8Y/\ G&O@/]TZS'_SE?Q/^Y?I-^:W_.%/Y"_G)YUU'\P/.>AZD_F;5XK> M*]GL=1FMDG-K$D$3M&"5Y"*-$J*;*.]2=!H?:+7:3",<)"AY/2:_V8[/UF8Y M?G9^>_GKR!Y[M+VZ\NZ!Y>U34;2.TNGMI1/:ZII] MK$6D3H>2O->I71NKF2ZFFN7T:>+DSR$T M 2)0 !MXDG.6P=I9];VEAGE-GBB/M>NU'9>GT'96>&(4.&1_P!B_.3_ )P! M_P"<8OR<_/CR7Y^UG\S/+MQK6H:%K=O96:,'XNY&;[V MI[:U>BS0CBE0(OD#U\WG?8_L'1:_3SEFC9!KF1T\GZB?E7_SB%^0GY,^:X_. MWD'R?-IOF6"VFM(;NYU&]O/2CN %EX)<3R(&913E2M"1W.7Y,_FAY.\N?F'_P _*-3\F><-._3'EKS#YETZ MUU"S,TT'K0_H:V;CZMO)%(NZC=6!SI]%J,F#V>$X&B :_P!,\GK]+BU/M,<> M07$D6/\ -'<^[OS3_P"?;WY >8/)FL6OY:>7+CR'YTBMY)=+O8M3U"]@DN56 ML<-S%?W=ROIN1Q)7BRUY5-*'2Z+VOUT,H.67%'J* ^X.]UWL3V=DPD8H\,NA MLG[R7F/_ #[-_//S3YHLO.7Y*>==1N=4O/(]M'J6A27KM)=0V(E^K75F[N2Q M2&1XO3!^R'*_950,CVQ[-Q8Y1SXQ0EL:[^A<;V'[5S98ST^4V8[B^==1\'SG M_P Y2:KINA?\_&O)FMZS?0:7I&C^9?(=]?7ERXCAM[:W?3Y)II78@*J(I9B> M@&9_8<)3[!G&(LD3 ^UUOM#DC#VBQRD: ,"3\0_6_P#Z&F_YQO\ _+X^2O\ MN,6O_53.8_D77_ZE+Y%ZW^7NS?\ 5H_,/R0_YQ;U73==_P"?C7G/6]&OH-4T MC6/,OGR^L;RV<20W%MSV2 M,_:+)*)L$S(/Q+*/^?L/_*>?E'_VP-0_ZBH\K]A?[G+[PV_\$/\ OL7N/Z'V MEI/_ #[R_P"<5;K2M,NI_(E\TUS:0RR$:WJ8JSHK,:"ZIU.:B?M9VF)$QO9)B#X?VG];ZV_+?\ +?R?^4OD_2_(?D/2SH_EG1S,UM;--+<,&N)7 MGE9I9WD=BSR$[GV&V:S5ZO+JLIR9#9+MM%HL.DPC'C%1#\M?^?GU_P Y M+_D?_P XR:%?&W2U5KW59X_C]"34AZLKO'W:WL;(RK7M)G1^S-:+L_+JI#R' MP_:7E_:L'7]I8='$^9^/Z@$!_P ^NO.M[Y>\R_F]^16O.MM>6LOZ=M;5C0I= MV4@T_4U%=B2/0VZT0G<=)>VNGCDQXM1'ER^>X_2Q]@]3+%DRZ:7,&_B-I?H? M3?\ S\G_ /67=;_[;^C_ /)\YKO9#_C2C[C]SL_;;_C*E[Q]Z67?FM_SA3^0OYR>==1_,#SGH M>I/YFU>*WBO9['49K9)S:Q)!$[1@E>0BC1*BFRCO4FK0^T6NTF$8X2%#R;M? M[,=GZS,>[7\M=*NK%O--MZNI3WEW+=RRBTAG6!*N:!4]> M0@ =6-:[4X_6]K:G79('*;KD]MV?V-I>S\Q M'^/2_J'[P['_ (('_&=#^N/ND^@_^<'_ /UE7\G/^V7=?]1]WF![1_\ &EE] M_P"AV7LQ_P 9>'W/C_\ Y^M^>M0T[RC^5OY=V3Z?8Q1:SY[TJU\T:Q>@*9KJ74XQ<6X=Q^S%!*B*O:A/V MF8G6>TFMGJ-?.SM$\(^&SM_9;0X]-V;CX1O("1/OW?17FOR#Y,\\OY?E\W>6 M['7YO*FJ6^M:/+=1\I+*^M762*:%Q1E(9!45HP%&!&V8;<-\$B+%'S#L< M^DPYN'CB#1L>1#\__P#GZE_ZSWY._P#-AZ?_ -TG6\WGL1_CTOZA^\//?\$# M_C.A_7'W20'_ #CK_P X3_\ .-/YB?D'^6OFWS3^7DEWYH\S:#'=7VI1:QJT M+M<2%P95B2^$"D4% (^/MA[6]I.T,&MR0A/8'84/U([']ENS-1H,66!X0]"4'$ M4V-9=GQCV7V,=0!ZY"_GR_6Q[3G+M?MT:8GT1-4/(>K]3[X_,/\ YP._YQX\ MT?E_J7E;RU^7UAY0UV&R==&UJP:5;N"[1#Z+SRO(S3J6H'$A:H)H0U&&DTGM M-K\6<3E,D=0>3OM9[*=G9=.81QB)K8CF^7_^?8'YP^8]3B\\?D9YHOY;Q/)] MLNKZ#%(S9>VG9^.)AJ(#ZMC]X+J_83M+ M+(3TV0_3N/(&ZMN7+ZM']JM*;4J:[CVM[5 MU6B\/P95=WL#RKO![W1>Q?8^CU_B^-&ZX:W(YWW$=SO^22"XCH.,C,:\OB^SQ'8VJEVO MH,D,]$C:_N/P9=N:.'8G:.+)I[ /3GUW'Q?OSG$O>NQ5V*NQ5V*I3K__ !PM M:_Y@+G_DTV2Q_6&.3Z"_&?\ Y],2QCS%^=D!=1-)IVANJ5W*I-?AB!X N*_/ M.L]NQZ,7O/Z'C/\ @=GUYO=']+] O^_\ 0]#[3_\ &7F]SQK_ )]B?^LUW'_@7ZK_ ,F;+,OVR_XT?\T.'[#?\98_ MK%\U?\X'^7=)\W?G%_SEUY5UZU6]T3S';7VF7\#=)+>ZU*\BE7O2JL:',_VF MRRQ:333B=Q1'R#K?9/##+K=7"0L&P?F7GOY/^8]6_(FR_P"@C]SF1K\,=;+2ZR _BB#\_T%QNS MLTM!'5Z'(?X9&/\ I3]XW?7/_/JW_P!9[\X_^;#U#_NDZ)FL]M_\>C_4'WEV MO_ __P",Z?\ 7/W1?*VA_P#R5"?_ ,"W4?\ NBW&;')_SC7P'^Z=9C_YROXG M_%]B_^-C+ M_5E_N@_7;_G(S_UGO\]__->>:/\ NDW>Y^L?\ SCG_ ,XQ:A^0FJ^9 M=5OOSA\S?F2?,%I!:)::NS+:V_I.SF41O<7),AK0$$4!84-=N9[6[8CK8Q Q MQC7<]9V/V)+0RD3EE.^]^:VN?_)4(/\ P+=._P"Z+;YT&/\ YQKX'_=/-9/^ M8$B/A;5[2X(9O:"&.7(F /N)?H%_P!$V/\ G%W_ *LF MO_\ <8G_ *9H_P#1?VE_.'R#O_\ 03V5_-/S+\_?^<1O+6E^3/\ GX-YA\GZ M&DD6B^5-;\[:-IZ2N9)%M;'Z];PAW.[$)&*D]S6 M"&'V@GCCR!F![@6*^8KWS%_A?2X+.?6M8E#W5R+:, M*T]Q(>YI4DDT'4GKFBU&7QLTI"(%GD'H=-A\##&!D30JSS/O?AQ^1/\ SDA^ M4]M_SEM^;G_.0?YNZ_+I=OJBWMOY76.PN;U_3GECMK=OW$4I4Q6%N(R32O,T M\,['M/L?5'LO%I\,;JN+<#S^\O#]D]MZ,=KYM5GE5[1V)\NGD?YT>0/*G M_.>-M^;_ .6NMM=?EWYG\T13WUQ+!-:<;?7HUAUE MTNSL^7L0X31#M33XNWQGPR]$COT^K:7/SW?IO\ \_)__67=;_[; M^C_\GSG.^R'_ !I1]Q^YZ;VV_P",J7O'WIQ_S[K_ /64/(?_ #'ZW_W4[K(^ MUO\ QIS^'W!G[&?\9./X_>7W!FG=V_"?_G#_ /\ D@GYG?\ ;0\[?]1[YV7; M_P#QAX_='[GAO9O_ )R'+[Y_>_<+7_\ CA:U_P P%S_R:;./Q_6'M\GT%_.- M_P X4_D%?_GWYD\\:58_F7K/Y:MY?TRUNWN-&5F>Z$TS((Y.-Q;[+2HW.=[[ M2=J#18X$XQ*R>;YS[*=DRUV28&0PH#EU>L_\YF_\XGZI^1/Y7Z#YNOOSJ\Q_ MF/%J/FFUT@:;K"NL$3366H7 N%Y7EP.:BV*CX>C'?QQO9SMR.LU)@,48^F[' MO#E^U/8$M#I(S.:4KD!1]QW^Q^I7_.#_ /ZRK^3G_;+NO^H^[SF_:/\ XTLO MO_0]3[,?\9>'W/A7_G[/H]^S?DEY@2$OID8UW3Y91TCG?]'RQJW^NJ.1_JG- MU["9(_O8]=C][H?^")BE6&?3M:;;W=_:):VS796EU6DRRR1LCES[G3>U/;&KTFMPPQ3H'GL._P V3?\ /U+_ -9[ M\G?^;#T__NDZWD/8C_'I?U#]X9?\$#_C.A_7'W2>)?FE;?F]IO\ S@7^07GS M\KO.VO>6;#RIHB0^9[+1+N6T:XT^_=8TN7> K(1!*@4@'[,C,=@;;W495FNK6\MF626SA"I&L<#\DF4 %F5DYLS**87M;J=6=5X63Z1O$# MN[W8>Q>ET8T8RX_J.TB>=]SY&_YQ[/Z$_P"?F7YC6.J6ZPW6K>://0M!*1R' MUA[V]B=*5W>!21['Z,VG:WK]GL9CT$?T!U'8O[OVFRB7,F=?'?[G[G,RHK,S M!54$DDT ZDG.->X?AE_S[8;],_\Y1?G!YETZU$>B7'EC6&1HZ>G%]>UO39K M>,"BG=(FI\(V7MG8^U_H[-Q0/.Q]D2\/[%?O.ULTX\J/VR%(+\K/_DI^J?\ M@7^F]I_^,O-[G@O_.#'_K$.M_\ @U?\0DS-]IO^-@?YK@^R M7_&)_IOTODG_ )]SV?YJ7WDW_G(V#\FM8\OZ)YY,WDYK:X\RP3SV!A#:[ZR- MZ =D8CHW!QVX[\EVGM=+3#+@\8$Q]7+G_"Z;V)CJCAU'@$"7IKBY?Q=SZ5\O M?\X/?G!^8OYQ:/\ FW_SE1^9^B^<'\NRVTEKI/EU)3#<16;F:"U9I;/3TAA$ MC%G5(V+U:K!F+#7Y?:32X-(<.DQD7S)\_B7:8?9?6:C6#/K,@E7(1\N70/U' MSG'IW8J[%78J[%6B 0014'8@XJ_'G4?^<6_^,T9)?H]^17Y1:-^1?Y6^5ORTT6X-]'H4#->7SH$>\OKAVF MNK@K5J!I'/%23Q0*M32N:'M/7SUFIEEEU^P='HNRNSH:'2QPQZ=>\]2^0_\ MG#G_ )QU_-/\G_SB_/WS7Y[T>UTW0?-EVR:)LSSR"A([;\]R6)_\ .>O_ M #B5^8/YL^9/*WYF?DOHJZKYL^HS:!YALX[RUT^2>S*2"&X$EW/;1M\$LD,@ MYI)0UB"[$ M\J4KF3[:TA[#\"_7557G?/DX,.P=8/:#\S7HN[L=UT/;>DU>@QX\9L@@G;E0(_2\M[-=@ZS1]I9R#^A^AWYQ>6M4\Y_E'^:?D_0XXY=;\U^4-8KV._NCJ^IZ-<2"6./TE"&+7H !Q'0@YU':FL["U\Q+)E-@ M5L#_ ,2\CV1HO:+LW&88L(HF]R/^*#[1_)/S;_SGKJOYB:19?G7^5WE+RY^7 M,L5P=2O[.[M#-:L-LU':6G[%C@)P9)&70;_I M=UV5J>WIZ@#48HB'4@B_LD7R[^<7_..7_.3^F?\ .8FK?G]^5WY;6'G?2H-2 MLM6TMI]7TZUAD:+3X;5XIXKF^LY@59&K04Z48YLNS^UNSI=DC3Y9F)H@[$]; MZ NL[2[&[3AVR=5AQB0L$;@=*ZD,]_,*\_Y^4?FWH=_Y%_Y59Y6_*S0O,%N] MGJ&IV6K6$ER;>8%)HS,-6OW1'5J$QP\Z5HV4:2/L_I9C)XDID9L7]Y^Y].?\XB_P#.+>G_ /.,ODO4K&ZU.'S#YX\US0W.NZG; MH4MP(%806EL' HYY, SLQ8A1Q5==V]VU+M',#51'(?I=G[.]@Q[,P&-W M(\S^@/F7\XO^<5_SB\Z?\YQ^1?SAT31;.3\N--U?ROK%[J\E_;Q_5TT-X)+B M!K9I!<-(_P!5HG"-D^)>3+\7'8]G=MZ7#V//#(^LB0 K^=YNM[3[ U>?MS'G MB!P Q)-_S?+F_5#.;>H?E?\ D[_SBO\ G%Y+_P"._MY/K":X\\EO MLLAN%D3ZU1^<:I\+<6;X>72=H]MZ7-V/##$^L"(( MK^;YO+]F=@:O!VYDSR X"9$&_P"=Y/F7\N=:_*WRK'Y MHMM"TR\LKY/TA8V4D,DLR2(U+ZXME92 ?LDFO48^RG;&DT<)QRRJR*V)^Y?; M+L/6:Z>.6&-T#>X'WTMM/.O_ #]'L[6VM(OR2\F&*UB2%.5WI1/%%"BI_P 2 MC>@Q.F]G";\67R/_ !*!J_:D"O!C\Q_Q3Z&OV_YRD\X_\XI>?-/\U>2=,TG\ M^]>L;_2+/2=)OK2.)K6\E6W$PG:]FMXY!;RR,/WYW5356/$8$1V=B[3@82)Q M @V0?U.RD>U,W94Q. &4@B@1^LCEYL?_ .<1?^<3=$_*O\G[+2/S5\C^7-;\ M_:SJ%QJNI_7;6TU1K,2B.*&T6X>.12$CA4L$)3FS<2P^(S[?[1-G?[7$] MK?9R>KQPEIX#B!W H;'Y/2?SY_*3\Z/S<_YPT\M^0I=#@N?S@MK+0)M6TR2_ MM@9KJPX)=!;II1;F1J%S^\XUJ QVKC]EZ[2:7M8Y+]%FC70\MG)[7[/UFL[& M&.OWE1L6.8Y[\GRC^4_E;_GY9^3'D?3/R^\D_E?HD7EW2);F6W6]OO+]Q,&N MIGGDY2'6%K\8Y)Y#9[A+]3J>SL/M+HL Q8\0H=YCUW_ )S] M-?\ G'W4/SRU+\O(;C_G(30=+\N_F NH7,?U;2IH9E>Q' P23?5YKB%9"2XX MI(PXA2:,64<]VK#1QSUIR3&NO>]-V1/73T]ZJ($[Z=WVOAS_ )QT_P"<6_SD M_+W_ )S#_,;\T_-6@6ECY#U"Y\QW&GZI'J%K-]<&JW?JVZQV\4C3J>+U;U(T M H=SM7<=K]M:3/V5CPP/J'#8KE0='V+V#K-/VQES3'I/%1L;V;?J)J=M)>Z; MJ%G$566[MI84+U"AI$9030$TJ?#.<@:D"]1,7$A^9/\ S[]_YQD_.'\B/-7Y MFZM^9WE^VT&SU>QM-.TXQ7]K>-=M#/+(\J"UEFXI2G]YP;9]C^PM9H,F0YHU= ;@W\GM/_ #GO^2_Y@_GE^3&C>6/RTTF' M7?,.C>;;+6GL9+J"S:6VCL]0M9/2DN9(8N2M>*U&=?A#4JU%.)[+]HX-'JS/ M*:!B1?/J#^AS/:[LO4:[1"&$61(&KKH1U][V+_G&'R%YC_+#\A/RT\B>;[>* MS\RZ!ICI?V\,JSI#+-<33^EZL9*,5$H#%25J#Q)%"Q M-)DTVAQXY\P-T5_SD+^1GES_ )R$_+35/R_\P2FPG>1;[2-31!))I^HPJZPW M"H2O):.R.M1R1F (-"'LKM+)H=0,D?<1WA/;'96+M#3'%/W@]Q[WYC?EAY+_ M .<^?^<1)]4\H^3O(6G_ )J>0KR[>XAA29;RR$K"C36H6ZM+N OQ'-73@3VY M'EG0ZW4]B=J 3G,PE^.>Q!>9[/TO;_9!./' 3A[_ +MP0D/Y@_E%_P YB_\ M.5_YL>1_-/GK\G[#\N+'RLMK8O=-.MO!%:)=&XDD=)KVXFE>LC4$:=*#WR>E MU_979NEG#'E,B?U>YCK.SNV.U=9CGDQ" C77SOO?='_.?/Y-?F'^>'Y,Z%Y7 M_+/1(_,'F#2?-]EK$MD]W;69:UBL=2MG9)+N6"*H>[0T+C:M*G;-/[+=HX-' MJS/*:!B1W]0>GN=S[7]F:C7:(0PBR) U==".OO>O?DE^5]UHG_..'DC\IOS' MTB![A/*@T37],,B3Q<;F-TN+=I(F9&^&0J2I(KT)ZYB=HZT3U\\V,_Q6"YO9 MFA,.SH8FS6MUJ. MC32QVS75U9J(DN8))6CA;U(5$E^L2M3&MWMOJ_P"8/G&2&?6[FUJ;:WCMPX@L M[=W5694]1F9R!R8]**N8/M#VV>T,PX141R_6Y_LUV .S,!$C7[F6."6.\D@:UO."RR6Z2P7$ M3,9 )5D#.W&NQ&P[+[;TF70?E-38'('[1\G6]K]@:W%VB-9I0">9B?=1[N:! M_-O5/^7]IJFH1:-J,-Q?NOHK=ZEJ*S-+*1\15/4EXJ-R$"UJQW[R7RW_ ,^[_P#G'G\VOR'A_-V3\T_+4?EI_-DF MA)ID2WUG>O*NG#4S-(39SW"JO^F(!R()WV\=E[6=K:76G'X4KJ[V(YUW^YU/ ML9V+J] ,OC1JZK<'E?=[WZ4YS[TKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK__ !V0$! end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information Document - shares
 3 Months Ended
Mar. 31, 2023
Apr. 28, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 1-10864  
Entitiy Registrant Name UnitedHealth Group Incorporated  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 41-1321939  
Entity Address, Address Line One UnitedHealth Group Center  
Entity Address, Address Line Two 9900 Bren Road East  
Entity Address, City or Town Minnetonka,  
Entity Address, State or Province MN  
Entity Address, Postal Zip Code 55343  
City Area Code 952  
Local Phone Number 936-1300  
Title of 12(b) Security Common Stock, $.01 par value  
Trading Symbol UNH  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entitiy Central Index Key 0000731766  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Common Stock, Shares Outstanding   931,032,030
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 41,913 $ 23,365
Short-term investments 4,584 4,546
Accounts receivable, net 22,414 17,681
Other current receivables, net 14,696 12,769
Assets under management 3,837 4,087
Prepaid expenses and other current assets 6,451 6,621
Total current assets 93,895 69,069
Long-term investments 46,884 43,728
Property, equipment and capitalized software, net 10,637 10,128
Goodwill 100,406 93,352
Other intangible assets, net 16,165 14,401
Other assets 15,692 15,027
Total assets 283,679 245,705
Current liabilities:    
Medical costs payable 31,809 29,056
Accounts payable and accrued liabilities 29,856 27,715
Short-term borrowings and current maturities of long-term debt 9,931 3,110
Unearned revenues 14,487 3,075
Other current liabilities 30,399 26,281
Total current liabilities 116,482 89,237
Long-term debt, less current maturities 60,657 54,513
Deferred income taxes 2,834 2,769
Other liabilities 13,084 12,839
Total liabilities 193,057 159,358
Commitments and contingencies (Note 6)
Redeemable noncontrolling interests 4,801 4,897
Equity:    
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0
Common stock, $0.01 par value - 3,000 shares authorized; 932 and 934 issued and outstanding 9 9
Retained earnings 88,852 86,156
Accumulated other comprehensive loss (7,549) (8,393)
Nonredeemable noncontrolling interests 4,509 3,678
Total equity 85,821 81,450
Total liabilities, redeemable noncontrolling interests and equity $ 283,679 $ 245,705
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10 10
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 3,000 3,000
Common stock, shares issued 932 934
Common stock, shares outstanding 932 934
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Premiums $ 72,786 $ 64,070
Investment and other income 798 367
Total revenues 91,931 80,149
Operating costs:    
Medical costs 59,845 52,523
Operating costs 13,625 11,401
Cost of products sold 9,405 8,487
Depreciation and amortization 970 788
Total operating costs 83,845 73,199
Earnings from operations 8,086 6,950
Interest expense (754) (433)
Earnings before income taxes 7,332 6,517
Provision for income taxes (1,558) (1,369)
Net earnings 5,774 5,148
Earnings attributable to noncontrolling interests (163) (121)
Net earnings attributable to UnitedHealth Group common shareholders $ 5,611 $ 5,027
Earnings per share attributable to UnitedHealth Group common shareholders:    
Basic $ 6.01 $ 5.34
Diluted $ 5.95 $ 5.27
Basic weighted-average number of common shares outstanding 933 941
Dilutive effect of common share equivalents 10 13
Diluted weighted-average number of common shares outstanding 943 954
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 5 2
Products    
Revenue from Products and Services $ 10,267 $ 9,340
Services    
Revenue from Products and Services $ 8,080 $ 6,372
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Net earnings $ 5,774 $ 5,148
Other comprehensive income (loss):    
Gross unrealized gains (losses) on investment securities during the period 640 (2,023)
Income tax effect (147) 465
Total unrealized gains (losses), net of tax 493 (1,558)
Gross reclassification adjustment for net realized losses (gains) included in net earnings 13 (3)
Income tax effect (3) 1
Total reclassification adjustment, net of tax 10 (2)
Total foreign currency translation gains 341 918
Other comprehensive income (loss) 844 (642)
Comprehensive income 6,618 4,506
Comprehensive income attributable to noncontrolling interests (163) (121)
Comprehensive income attributable to UnitedHealth Group common shareholders $ 6,455 $ 4,385
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Net Unrealized Gains (Losses) on Investments [Member]
Foreign Currency Translation Losses [Member]
Nonredeemable Noncontrolling Interests [Member]
Balance at Dec. 31, 2021 $ 75,045 $ 10 $ 0 $ 77,134 $ 423 $ (5,807) $ 3,285
Balance (in shares) at Dec. 31, 2021   941          
Net earnings attributable to UnitedHealth Group common shareholders 5,027     5,027      
Net earnings attributable to nonredeemable noncontrolling interest             88
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,115            
Other comprehensive income (loss) (642)       (1,560) 918  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 333 $ 0 333        
Share-based compensation 282   282        
Common share repurchases (in shares)   (5)          
Common share repurchases (2,500) $ 0 (484) (2,016)      
Cash dividends paid on common shares (1,363)     (1,363)      
Redeemable noncontrolling interests fair value and other adjustments (131)   (131)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 91           91
Distribution to nonredeemable noncontrolling interests (102)           (102)
Balance at Mar. 31, 2022 76,128 $ 10 0 78,782 (1,137) (4,889) 3,362
Balance (in shares) at Mar. 31, 2022   939          
Balance at Dec. 31, 2022 $ 81,450 $ 9 0 86,156 (2,778) (5,615) 3,678
Balance (in shares) at Dec. 31, 2022 934 934          
Net earnings attributable to UnitedHealth Group common shareholders $ 5,611     5,611      
Net earnings attributable to nonredeemable noncontrolling interest             113
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,724            
Other comprehensive income (loss) 844       503 341  
Issuances of common stock, and related tax effects (in shares)   2          
Issuances of common stock, and related tax effects 350 $ 0 350        
Share-based compensation 366   366        
Common share repurchases (in shares)   (4)          
Common share repurchases (2,011) $ 0 (633) (1,378)      
Cash dividends paid on common shares (1,537)     (1,537)      
Redeemable noncontrolling interests fair value and other adjustments (83)   (83)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 819           819
Distribution to nonredeemable noncontrolling interests (101)           (101)
Balance at Mar. 31, 2023 $ 85,821 $ 9 $ 0 $ 88,852 $ (2,275) $ (5,274) $ 4,509
Balance (in shares) at Mar. 31, 2023 932 932          
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statement of Changes in Equity (Parenthetical) - $ / shares
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]    
Common Stock, Dividends, Per Share, Cash Paid $ 1.65 $ 1.45
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net earnings $ 5,774 $ 5,148
Noncash items:    
Depreciation and amortization 970 788
Deferred income taxes (332) 161
Share-based compensation 362 299
Other, net 69 17
Net change in other operating items, net of effects from acquisitions and changes in AARP balances:    
Accounts receivable (4,306) (4,521)
Other assets (1,875) (1,089)
Medical costs payable 2,467 3,849
Accounts payable and other liabilities 1,796 589
Unearned revenues 11,402 78
Cash flows from operating activities 16,327 5,319
Investing activities    
Purchases of investments (4,894) (4,982)
Sales of investments 456 1,591
Maturities of investments 2,119 1,759
Cash paid for acquisitions, net of cash assumed (7,826) (1,231)
Purchases of property, equipment and capitalized software (760) (555)
Other, net (115) (255)
Cash flows used for investing activities (11,020) (3,673)
Financing activities    
Common share repurchases (2,000) (2,500)
Cash dividends paid (1,537) (1,363)
Proceeds from common stock issuances 344 551
Repayments of long-term debt (1,375) (1,100)
Proceeds from short-term borrowings, net 7,349 3,148
Proceeds from issuance of long-term debt 6,401 0
Customer funds administered 5,012 5,120
Other, net (1,004) (1,552)
Cash flows from financing activities 13,190 2,304
Effect of exchange rate changes on cash and cash equivalents 51 157
Increase in cash and cash equivalents 18,548 4,107
Cash and cash equivalents, beginning of period 23,365 21,375
Cash and cash equivalents, end of period $ 41,913 $ 25,482
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation (Notes)
 3 Months Ended
Mar. 31, 2023
Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation
UnitedHealth Group Incorporated (individually and together with its subsidiaries, “UnitedHealth Group” and the “Company”) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations the Company is privileged to serve.
The Company has prepared the Condensed Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries. The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC), the Company has omitted certain footnote disclosures that would substantially duplicate the disclosures contained in its annual audited Consolidated Financial Statements. Therefore, these Condensed Consolidated Financial Statements should be read together with the Consolidated Financial Statements and the Notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC (2022 10-K). The accompanying Condensed Consolidated Financial Statements include all normal recurring adjustments necessary to present the interim financial statements fairly.
Use of Estimates
These Condensed Consolidated Financial Statements include certain amounts based on the Company’s best estimates and judgments. The Company’s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters that are inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.
Revenues - Products and Services
As of March 31, 2023 and December 31, 2022, accounts receivable related to products and services were $8.1 billion and $7.1 billion, respectively. Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracting having an original expected duration of one year or less, contracts where revenue recognized as invoiced and contracts with variable consideration related undelivered performance obligations, was $12.3 billion, of which approximately half is expected to be recognized in the next three years.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Notes)
 3 Months Ended
Mar. 31, 2023
Investments [Abstract]  
Investments [Text Block] Investments
A summary of debt securities by major security type is as follows:
(in millions)Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Fair
Value
March 31, 2023
Debt securities - available-for-sale:
U.S. government and agency obligations$4,760 $5 $(236)$4,529 
State and municipal obligations8,055 65 (365)7,755 
Corporate obligations24,149 59 (1,525)22,683 
U.S. agency mortgage-backed securities8,213 35 (708)7,540 
Non-U.S. agency mortgage-backed securities3,156 1 (283)2,874 
Total debt securities - available-for-sale48,333 165 (3,117)45,381 
Debt securities - held-to-maturity:
U.S. government and agency obligations594 — (10)584 
State and municipal obligations28 — (3)25 
Corporate obligations60 — — 60 
Total debt securities - held-to-maturity682 — (13)669 
Total debt securities$49,015 $165 $(3,130)$46,050 
December 31, 2022
Debt securities - available-for-sale:
U.S. government and agency obligations$4,093 $1 $(285)$3,809 
State and municipal obligations7,702 25 (479)7,248 
Corporate obligations23,675 17 (1,798)21,894 
U.S. agency mortgage-backed securities7,379 15 (808)6,586 
Non-U.S. agency mortgage-backed securities3,077 1 (294)2,784 
Total debt securities - available-for-sale45,926 59 (3,664)42,321 
Debt securities - held-to-maturity:
U.S. government and agency obligations578 — (14)564 
State and municipal obligations29 — (3)26 
Corporate obligations89 — — 89 
Total debt securities - held-to-maturity696 — (17)679 
Total debt securities$46,622 $59 $(3,681)$43,000 
The Company held $3.9 billion and $3.7 billion of equity securities as of March 31, 2023 and December 31, 2022, respectively. The Company’s investments in equity securities primarily consist of employee savings plan related investments, venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company’s investments included $1.5 billion of equity method investments in operating businesses in the health care sector as of March 31, 2023 and December 31, 2022. The allowance for credit losses on held-to-maturity securities at March 31, 2023 and December 31, 2022 was not material.
The amortized cost and fair value of debt securities as of March 31, 2023, by contractual maturity, were as follows:
Available-for-SaleHeld-to-Maturity
(in millions)Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value
Due in one year or less$4,722 $4,691 $377 $376 
Due after one year through five years14,356 13,708 261 254 
Due after five years through ten years12,240 11,217 24 22 
Due after ten years5,646 5,351 20 17 
U.S. agency mortgage-backed securities8,213 7,540 — — 
Non-U.S. agency mortgage-backed securities3,156 2,874 — — 
Total debt securities$48,333 $45,381 $682 $669 
The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:
 Less Than 12 Months12 Months or Greater Total
(in millions)Fair
Value		Gross
Unrealized
Losses		Fair
Value		Gross
Unrealized
Losses		Fair
Value		Gross
Unrealized
Losses
March 31, 2023
Debt securities - available-for-sale:
U.S. government and agency obligations
$1,279 $(12)$1,825 $(224)$3,104 $(236)
State and municipal obligations1,898 (30)3,110 (335)5,008 (365)
Corporate obligations6,337 (178)12,443 (1,347)18,780 (1,525)
U.S. agency mortgage-backed securities1,589 (55)4,274 (653)5,863 (708)
Non-U.S. agency mortgage-backed securities
783 (26)1,989 (257)2,772 (283)
Total debt securities - available-for-sale$11,886 $(301)$23,641 $(2,816)$35,527 $(3,117)
December 31, 2022
Debt securities - available-for-sale:
U.S. government and agency obligations
$2,007 $(96)$1,290 $(189)$3,297 $(285)
State and municipal obligations4,630 (288)1,178 (191)5,808 (479)
Corporate obligations13,003 (893)6,637 (905)19,640 (1,798)
U.S. agency mortgage-backed securities3,561 (345)2,239 (463)5,800 (808)
Non-U.S. agency mortgage-backed securities
1,698 (128)976 (166)2,674 (294)
Total debt securities - available-for-sale$24,899 $(1,750)$12,320 $(1,914)$37,219 $(3,664)
The Company’s unrealized losses from debt securities as of March 31, 2023 were generated from approximately 32,000 positions out of a total of 42,000 positions. The Company believes that it will collect the timely principal and interest due on its debt securities that have an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company’s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of March 31, 2023, the Company did not have the intent to sell any of the available-for-sale debt securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities at March 31, 2023 and December 31, 2022 was not material.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value (Notes)
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value [Text Block] Fair Value
Certain assets and liabilities are measured at fair value in the Condensed Consolidated Financial Statements or have fair values disclosed in the Notes to the Condensed Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP.
For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K.
The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:
(in millions)Quoted Prices
in Active
Markets
(Level 1)		Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
Fair and Carrying
Value
March 31, 2023
Cash and cash equivalents$41,851 $62 $— $41,913 
Debt securities - available-for-sale:
U.S. government and agency obligations4,122 407 — 4,529 
State and municipal obligations— 7,755 — 7,755 
Corporate obligations16 22,486 181 22,683 
U.S. agency mortgage-backed securities— 7,540 — 7,540 
Non-U.S. agency mortgage-backed securities— 2,874 — 2,874 
Total debt securities - available-for-sale4,138 41,062 181 45,381 
Equity securities2,128 35 70 2,233 
Assets under management 1,491 2,245 101 3,837 
Total assets at fair value$49,608 $43,404 $352 $93,364 
Percentage of total assets at fair value53 %46 %1 %100 %
December 31, 2022
Cash and cash equivalents$23,202 $163 $— $23,365 
Debt securities - available-for-sale:
U.S. government and agency obligations3,505 304 — 3,809 
State and municipal obligations— 7,248 — 7,248 
Corporate obligations7 21,695 192 21,894 
U.S. agency mortgage-backed securities— 6,586 — 6,586 
Non-U.S. agency mortgage-backed securities— 2,784 — 2,784 
Total debt securities - available-for-sale3,512 38,617 192 42,321 
Equity securities2,043 35 70 2,148 
Assets under management 1,788 2,203 96 4,087 
Total assets at fair value$30,545 $41,018 $358 $71,921 
Percentage of total assets at fair value42 %57 %1 %100 %
There were no transfers in or out of Level 3 financial assets or liabilities during the three months ended March 31, 2023 or 2022.
The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:
(in millions)Quoted Prices
in Active
Markets
(Level 1)		Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
Fair
Value		Total Carrying Value
March 31, 2023
Debt securities - held-to-maturity$595 $74 $— $669 $682 
Long-term debt and other financing obligations$— $60,307 $— $60,307 $62,360 
December 31, 2022
Debt securities - held-to-maturity$577 $102 $— $679 $696 
Long-term debt and other financing obligations$— $53,626 $— $53,626 $56,823 
Nonfinancial assets and liabilities or financial assets and liabilities that are measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. There were no significant fair value adjustments for these assets and liabilities recorded during the three months ended March 31, 2023 or 2022.
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Costs Payable (Notes)
 3 Months Ended
Mar. 31, 2023
Insurance [Abstract]  
Short-Duration Insurance and Deposit Contracts Medical Costs Payable
The following table shows the components of the change in medical costs payable for the three months ended March 31:
(in millions)20232022
Medical costs payable, beginning of period$29,056 $24,483 
Acquisitions1 8 
Reported medical costs:
Current year60,315 52,813 
Prior years(470)(290)
Total reported medical costs59,845 52,523 
Medical payments:
Payments for current year
(35,087)(29,589)
Payments for prior years(22,006)(18,749)
Total medical payments(57,093)(48,338)
Medical costs payable, end of period$31,809 $28,676 
For the three months ended March 31, 2023 and 2022, prior years’ medical cost reserve development included no individual factors that were significant. Medical costs payable included reserves for claims incurred by insured customers but not yet reported to the Company of $21.7 billion and $20.0 billion at March 31, 2023 and December 31, 2022, respectively.
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Short-Term Borrowings and Long-Term Debt (Notes)
 3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt Disclosure Short-Term Borrowings and Long-Term Debt
In March 2023, the Company issued $6.5 billion of senior unsecured notes consisting of the following:
(in millions, except percentages)Par Value
4.250% notes due January 2029
$1,250 
4.500% notes due April 2033
1,500 
5.050% notes due April 2053
2,000 
5.200% notes due April 2063
1,750 
As of March 31, 2023, the Company had $8.2 billion of commercial paper outstanding, with a weighted-average annual interest rate of 5.2%.
For more information on the Company’s short-term borrowings, debt covenants and long-term debt, see Note 8 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Notes)
 3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies
Legal Matters
The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company’s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.
The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.
Government Investigations, Audits and Reviews
The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by the Centers for Medicare and Medicaid Services (CMS), state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the Internal Revenue Service, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the Federal Deposit Insurance Corporation, the Consumer Financial Protection Bureau (CFPB), the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company’s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company’s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company’s health plans.
On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower’s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company’s motion to dismiss. In May 2018, the DOJ moved to dismiss the Company’s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government’s motion for partial summary judgment and dismissed the Company’s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combinations (Notes)
 3 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Combination Disclosure Business Combinations
During the three months ended March 31, 2023, the Company completed several business combinations for total consideration of $8.0 billion.
Acquired assets (liabilities) at acquisition date were:
(in millions)
Cash and cash equivalents$142 
Accounts receivable and other current assets530 
Property, equipment and other long-term assets659 
Other intangible assets2,141 
Total identifiable assets acquired3,472 
Medical costs payable(1)
Accounts payable and other current liabilities(467)
Other long-term liabilities(698)
Total identifiable liabilities acquired(1,166)
Total net identifiable assets2,306 
Goodwill6,646 
Redeemable noncontrolling interests(130)
Nonredeemable noncontrolling interests(819)
Net assets acquired$8,003 
The majority of goodwill is not deductible for income tax purposes. The preliminary purchase price allocations for the various business combinations are subject to adjustment as valuation analyses, primarily related to intangible assets and contingent liabilities, are finalized.
The acquisition date fair values and weighted-average useful lives assigned to intangible assets were:
(in millions, except years)Fair ValueWeighted-Average Useful Life
Acquired finite-lived intangible assets:
Customer-related$234 13 years
Trademarks and technology2205 years
Other1011 years
Total acquired finite-lived intangible assets464 9 years
Total acquired indefinite-lived intangible assets - operating licenses and certificates1,677 
Total acquired intangible assets$2,141 
The results of operations and financial condition of acquired entities have been included in the Company’s consolidated results and the results of the corresponding operating segment as of the date of acquisition. Through March 31, 2023, acquired entities impact on revenues and net earnings was not material.
Unaudited pro forma revenues and net earnings for the three months ended March 31, 2023 and 2022, as if the business combinations had occurred on January 1, 2022, were immaterial for both periods.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Financial Information (Notes)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Reporting Disclosure Segment Financial Information
The Company’s four reportable segments are UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. For more information on the Company’s segments, see Part I, Item I, “Business” and Note 14 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K. Total assets at Optum Health increased to $80.4 billion as of March 31, 2023 compared to $69.0 billion as of December 31, 2022, primarily due to goodwill from business combinations of $5.9 billion.
The following tables present reportable segment financial information:
  Optum  
(in millions)UnitedHealthcareOptum HealthOptum InsightOptum RxOptum EliminationsOptumCorporate and
Eliminations		Consolidated
Three Months Ended March 31, 2023
Revenues - unaffiliated customers:
Premiums$67,458 $5,328 $— $— $— $5,328 $— $72,786 
Products— 44 40 10,183 — 10,267 — 10,267 
Services2,555 3,089 1,926 510 — 5,525 — 8,080 
Total revenues - unaffiliated customers
70,013 8,461 1,966 10,693 — 21,120 — 91,133 
Total revenues - affiliated customers
— 14,266 2,510 16,679 (859)32,596 (32,596)— 
Investment and other income
455 277 20 46 — 343 — 798 
Total revenues$70,468 $23,004 $4,496 $27,418 $(859)$54,059 $(32,596)$91,931 
Earnings from operations$4,343 $1,776 $907 $1,060 $— $3,743 $— $8,086 
Interest expense— — — — — — (754)(754)
Earnings before income taxes
$4,343 $1,776 $907 $1,060 $— $3,743 $(754)$7,332 
Three Months Ended March 31, 2022
Revenues - unaffiliated customers:
Premiums$59,937 $4,133 $— $— $— $4,133 $— $64,070 
Products— 6 40 9,294 — 9,340 — 9,340 
Services2,515 2,558 974 325 — 3,857 — 6,372 
Total revenues - unaffiliated customers
62,452 6,697 1,014 9,619 — 17,330 — 79,782 
Total revenues - affiliated customers
— 9,829 2,138 14,291 (553)25,705 (25,705)— 
Investment and other income
143 156 67 1 — 224 — 367 
Total revenues$62,595 $16,682 $3,219 $23,911 $(553)$43,259 $(25,705)$80,149 
Earnings from operations$3,798 $1,366 $847 $939 $— $3,152 $— $6,950 
Interest expense— — — — — — (433)(433)
Earnings before income taxes
$3,798 $1,366 $847 $939 $— $3,152 $(433)$6,517 
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation (Policies)
 3 Months Ended
Mar. 31, 2023
Basis of presentation [Abstract]  
Basis of Accounting, Policy [Policy Text Block] The Company has prepared the Condensed Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries. The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC), the Company has omitted certain footnote disclosures that would substantially duplicate the disclosures contained in its annual audited Consolidated Financial Statements. Therefore, these Condensed Consolidated Financial Statements should be read together with the Consolidated Financial Statements and the Notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC (2022 10-K). The accompanying Condensed Consolidated Financial Statements include all normal recurring adjustments necessary to present the interim financial statements fairly.
Use of Estimates, Policy [Policy Text Block] These Condensed Consolidated Financial Statements include certain amounts based on the Company’s best estimates and judgments. The Company’s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters that are inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.
Revenue [Policy Text Block] As of March 31, 2023 and December 31, 2022, accounts receivable related to products and services were $8.1 billion and $7.1 billion, respectively. Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracting having an original expected duration of one year or less, contracts where revenue recognized as invoiced and contracts with variable consideration related undelivered performance obligations, was $12.3 billion, of which approximately half is expected to be recognized in the next three years.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Policies)
 3 Months Ended
Mar. 31, 2023
Investments [Abstract]  
Investment, Policy [Policy Text Block] At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of March 31, 2023, the Company did not have the intent to sell any of the available-for-sale debt securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary.
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Tables)
 3 Months Ended
Mar. 31, 2023
Short-Term and Long-Term Investments [Table Text Block]
A summary of debt securities by major security type is as follows:
(in millions)Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Fair
Value
March 31, 2023
Debt securities - available-for-sale:
U.S. government and agency obligations$4,760 $5 $(236)$4,529 
State and municipal obligations8,055 65 (365)7,755 
Corporate obligations24,149 59 (1,525)22,683 
U.S. agency mortgage-backed securities8,213 35 (708)7,540 
Non-U.S. agency mortgage-backed securities3,156 1 (283)2,874 
Total debt securities - available-for-sale48,333 165 (3,117)45,381 
Debt securities - held-to-maturity:
U.S. government and agency obligations594 — (10)584 
State and municipal obligations28 — (3)25 
Corporate obligations60 — — 60 
Total debt securities - held-to-maturity682 — (13)669 
Total debt securities$49,015 $165 $(3,130)$46,050 
December 31, 2022
Debt securities - available-for-sale:
U.S. government and agency obligations$4,093 $1 $(285)$3,809 
State and municipal obligations7,702 25 (479)7,248 
Corporate obligations23,675 17 (1,798)21,894 
U.S. agency mortgage-backed securities7,379 15 (808)6,586 
Non-U.S. agency mortgage-backed securities3,077 1 (294)2,784 
Total debt securities - available-for-sale45,926 59 (3,664)42,321 
Debt securities - held-to-maturity:
U.S. government and agency obligations578 — (14)564 
State and municipal obligations29 — (3)26 
Corporate obligations89 — — 89 
Total debt securities - held-to-maturity696 — (17)679 
Total debt securities$46,622 $59 $(3,681)$43,000 
Investments by Contractual Maturity [Table Text Block]
The amortized cost and fair value of debt securities as of March 31, 2023, by contractual maturity, were as follows:
Available-for-SaleHeld-to-Maturity
(in millions)Amortized
Cost		Fair
Value		Amortized
Cost		Fair
Value
Due in one year or less$4,722 $4,691 $377 $376 
Due after one year through five years14,356 13,708 261 254 
Due after five years through ten years12,240 11,217 24 22 
Due after ten years5,646 5,351 20 17 
U.S. agency mortgage-backed securities8,213 7,540 — — 
Non-U.S. agency mortgage-backed securities3,156 2,874 — — 
Total debt securities$48,333 $45,381 $682 $669 
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value
The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:
 Less Than 12 Months12 Months or Greater Total
(in millions)Fair
Value		Gross
Unrealized
Losses		Fair
Value		Gross
Unrealized
Losses		Fair
Value		Gross
Unrealized
Losses
March 31, 2023
Debt securities - available-for-sale:
U.S. government and agency obligations
$1,279 $(12)$1,825 $(224)$3,104 $(236)
State and municipal obligations1,898 (30)3,110 (335)5,008 (365)
Corporate obligations6,337 (178)12,443 (1,347)18,780 (1,525)
U.S. agency mortgage-backed securities1,589 (55)4,274 (653)5,863 (708)
Non-U.S. agency mortgage-backed securities
783 (26)1,989 (257)2,772 (283)
Total debt securities - available-for-sale$11,886 $(301)$23,641 $(2,816)$35,527 $(3,117)
December 31, 2022
Debt securities - available-for-sale:
U.S. government and agency obligations
$2,007 $(96)$1,290 $(189)$3,297 $(285)
State and municipal obligations4,630 (288)1,178 (191)5,808 (479)
Corporate obligations13,003 (893)6,637 (905)19,640 (1,798)
U.S. agency mortgage-backed securities3,561 (345)2,239 (463)5,800 (808)
Non-U.S. agency mortgage-backed securities
1,698 (128)976 (166)2,674 (294)
Total debt securities - available-for-sale$24,899 $(1,750)$12,320 $(1,914)$37,219 $(3,664)
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value (Tables)
 3 Months Ended
Mar. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]
The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:
(in millions)Quoted Prices
in Active
Markets
(Level 1)		Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
Fair and Carrying
Value
March 31, 2023
Cash and cash equivalents$41,851 $62 $— $41,913 
Debt securities - available-for-sale:
U.S. government and agency obligations4,122 407 — 4,529 
State and municipal obligations— 7,755 — 7,755 
Corporate obligations16 22,486 181 22,683 
U.S. agency mortgage-backed securities— 7,540 — 7,540 
Non-U.S. agency mortgage-backed securities— 2,874 — 2,874 
Total debt securities - available-for-sale4,138 41,062 181 45,381 
Equity securities2,128 35 70 2,233 
Assets under management 1,491 2,245 101 3,837 
Total assets at fair value$49,608 $43,404 $352 $93,364 
Percentage of total assets at fair value53 %46 %1 %100 %
December 31, 2022
Cash and cash equivalents$23,202 $163 $— $23,365 
Debt securities - available-for-sale:
U.S. government and agency obligations3,505 304 — 3,809 
State and municipal obligations— 7,248 — 7,248 
Corporate obligations7 21,695 192 21,894 
U.S. agency mortgage-backed securities— 6,586 — 6,586 
Non-U.S. agency mortgage-backed securities— 2,784 — 2,784 
Total debt securities - available-for-sale3,512 38,617 192 42,321 
Equity securities2,043 35 70 2,148 
Assets under management 1,788 2,203 96 4,087 
Total assets at fair value$30,545 $41,018 $358 $71,921 
Percentage of total assets at fair value42 %57 %1 %100 %
Fair Value Measurements, Nonrecurring [Table Text Block]
The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:
(in millions)Quoted Prices
in Active
Markets
(Level 1)		Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
Fair
Value		Total Carrying Value
March 31, 2023
Debt securities - held-to-maturity$595 $74 $— $669 $682 
Long-term debt and other financing obligations$— $60,307 $— $60,307 $62,360 
December 31, 2022
Debt securities - held-to-maturity$577 $102 $— $679 $696 
Long-term debt and other financing obligations$— $53,626 $— $53,626 $56,823 
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Costs Payable (Tables)
 3 Months Ended
Mar. 31, 2023
Insurance [Abstract]  
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense
The following table shows the components of the change in medical costs payable for the three months ended March 31:
(in millions)20232022
Medical costs payable, beginning of period$29,056 $24,483 
Acquisitions1 8 
Reported medical costs:
Current year60,315 52,813 
Prior years(470)(290)
Total reported medical costs59,845 52,523 
Medical payments:
Payments for current year
(35,087)(29,589)
Payments for prior years(22,006)(18,749)
Total medical payments(57,093)(48,338)
Medical costs payable, end of period$31,809 $28,676 
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Short-Term Borrowings and Long-Term Debt (Tables)
 3 Months Ended
Mar. 31, 2023
Debt Instrument [Line Items]  
Long-Term Debt [Table Text Block]
In March 2023, the Company issued $6.5 billion of senior unsecured notes consisting of the following:
(in millions, except percentages)Par Value
4.250% notes due January 2029
$1,250 
4.500% notes due April 2033
1,500 
5.050% notes due April 2053
2,000 
5.200% notes due April 2063
1,750 
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combinations (Tables)
 3 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Acquired assets (liabilities) at acquisition date were:
(in millions)
Cash and cash equivalents$142 
Accounts receivable and other current assets530 
Property, equipment and other long-term assets659 
Other intangible assets2,141 
Total identifiable assets acquired3,472 
Medical costs payable(1)
Accounts payable and other current liabilities(467)
Other long-term liabilities(698)
Total identifiable liabilities acquired(1,166)
Total net identifiable assets2,306 
Goodwill6,646 
Redeemable noncontrolling interests(130)
Nonredeemable noncontrolling interests(819)
Net assets acquired$8,003 
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] The acquisition date fair values and weighted-average useful lives assigned to intangible assets were:
(in millions, except years)Fair ValueWeighted-Average Useful Life
Acquired finite-lived intangible assets:
Customer-related$234 13 years
Trademarks and technology2205 years
Other1011 years
Total acquired finite-lived intangible assets464 9 years
Total acquired indefinite-lived intangible assets - operating licenses and certificates1,677 
Total acquired intangible assets$2,141 
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Financial Information (Tables)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following tables present reportable segment financial information:
  Optum  
(in millions)UnitedHealthcareOptum HealthOptum InsightOptum RxOptum EliminationsOptumCorporate and
Eliminations		Consolidated
Three Months Ended March 31, 2023
Revenues - unaffiliated customers:
Premiums$67,458 $5,328 $— $— $— $5,328 $— $72,786 
Products— 44 40 10,183 — 10,267 — 10,267 
Services2,555 3,089 1,926 510 — 5,525 — 8,080 
Total revenues - unaffiliated customers
70,013 8,461 1,966 10,693 — 21,120 — 91,133 
Total revenues - affiliated customers
— 14,266 2,510 16,679 (859)32,596 (32,596)— 
Investment and other income
455 277 20 46 — 343 — 798 
Total revenues$70,468 $23,004 $4,496 $27,418 $(859)$54,059 $(32,596)$91,931 
Earnings from operations$4,343 $1,776 $907 $1,060 $— $3,743 $— $8,086 
Interest expense— — — — — — (754)(754)
Earnings before income taxes
$4,343 $1,776 $907 $1,060 $— $3,743 $(754)$7,332 
Three Months Ended March 31, 2022
Revenues - unaffiliated customers:
Premiums$59,937 $4,133 $— $— $— $4,133 $— $64,070 
Products— 6 40 9,294 — 9,340 — 9,340 
Services2,515 2,558 974 325 — 3,857 — 6,372 
Total revenues - unaffiliated customers
62,452 6,697 1,014 9,619 — 17,330 — 79,782 
Total revenues - affiliated customers
— 9,829 2,138 14,291 (553)25,705 (25,705)— 
Investment and other income
143 156 67 1 — 224 — 367 
Total revenues$62,595 $16,682 $3,219 $23,911 $(553)$43,259 $(25,705)$80,149 
Earnings from operations$3,798 $1,366 $847 $939 $— $3,152 $— $6,950 
Interest expense— — — — — — (433)(433)
Earnings before income taxes
$3,798 $1,366 $847 $939 $— $3,152 $(433)$6,517 
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Nature of Operations UnitedHealth Group Incorporated (individually and together with its subsidiaries, “UnitedHealth Group” and the “Company”) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations the Company is privileged to serve.  
Accounts Receivable, after Allowance for Credit Loss, Current $ 22,414 $ 17,681
Revenue, Remaining Performance Obligation, Amount $ 12,300  
Revenue, Remaining Performance Obligation, Percentage 50.00%  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 3 years  
unh:ProductsandservicesMember    
Accounts Receivable, after Allowance for Credit Loss, Current $ 8,100 $ 7,100
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Narrative) (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Investments [Abstract]    
Equity Securities, FV-NI and without Readily Determinable Fair Value $ 3,900 $ 3,700
Equity Method Investments $ 1,500  
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions 32,000  
Total number of security positions 42,000  
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Short-Term and Long-Term Investments) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost $ 48,333 $ 45,926
Securities, Available for sale Debt Securities, Gross Unrealized Gains 165 59
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (3,117) (3,664)
Debt Securities, Available-for-sale 45,381 42,321
Held-to-maturity securities, Amortized Cost 682 696
Securities, Held to maturity, Unrecognized Holding Gain 0 0
Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss (13) (17)
Debt Securities, Held-to-maturity, Fair Value 669 679
Total debt securities, Amortized Cost 49,015 46,622
Total debt securities, Gross Unrealized Gains 165 59
Total debt securities, Gross Unrealized Losses (3,130) (3,681)
Debt securities, Fair Value Disclosure 46,050 43,000
Debt Securities [Member]    
Schedule of Investments [Line Items]    
Debt Securities, Available-for-sale 45,381 42,321
U.S. Government and Agency Obligations [Member]    
Schedule of Investments [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 4,760 4,093
Securities, Available for sale Debt Securities, Gross Unrealized Gains 5 1
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (236) (285)
Debt Securities, Available-for-sale 4,529 3,809
Held-to-maturity securities, Amortized Cost 594 578
Securities, Held to maturity, Unrecognized Holding Gain 0 0
Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss (10) (14)
Debt Securities, Held-to-maturity, Fair Value 584 564
State and Municipal Obligations [Member]    
Schedule of Investments [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 8,055 7,702
Securities, Available for sale Debt Securities, Gross Unrealized Gains 65 25
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (365) (479)
Debt Securities, Available-for-sale 7,755 7,248
Held-to-maturity securities, Amortized Cost 28 29
Securities, Held to maturity, Unrecognized Holding Gain 0 0
Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss (3) (3)
Debt Securities, Held-to-maturity, Fair Value 25 26
Corporate Obligations [Member]    
Schedule of Investments [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 24,149 23,675
Securities, Available for sale Debt Securities, Gross Unrealized Gains 59 17
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (1,525) (1,798)
Debt Securities, Available-for-sale 22,683 21,894
Held-to-maturity securities, Amortized Cost 60 89
Securities, Held to maturity, Unrecognized Holding Gain 0 0
Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss 0 0
Debt Securities, Held-to-maturity, Fair Value 60 89
U.S. Agency Mortgage-Backed Securities [Member]    
Schedule of Investments [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 8,213 7,379
Securities, Available for sale Debt Securities, Gross Unrealized Gains 35 15
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (708) (808)
Debt Securities, Available-for-sale 7,540 6,586
Non-U.S. Agency Mortgage-Backed Securities [Member]    
Schedule of Investments [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 3,156 3,077
Securities, Available for sale Debt Securities, Gross Unrealized Gains 1 1
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (283) (294)
Debt Securities, Available-for-sale $ 2,874 $ 2,784
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Due in one year or less, Amortized Cost $ 4,722  
Due after one year through five years, Amortized Cost 14,356  
Due after five years through ten years, Amortized Cost 12,240  
Due after ten years, Amortized Cost 5,646  
Total debt securities - available-for-sale, Amortized Cost 48,333 $ 45,926
Due in one year or less, Fair Value 4,691  
Due after one year through five years, Fair Value 13,708  
Due after five years through ten years, Fair Value 11,217  
Due after ten years, Fair Value 5,351  
Debt Securities, Available-for-sale 45,381 42,321
Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One 377  
Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five 261  
Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 24  
Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 20  
Debt Securities, Held-to-maturity 682 696
Held-to-maturity Securities, Debt Maturities, within One Year, Fair Value 376  
Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five 254  
Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 22  
Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 17  
Debt Securities, Held-to-maturity, Fair Value 669 679
U.S. Agency Mortgage-Backed Securities [Member]    
Schedule of Investments [Line Items]    
Mortgage-backed securities, Amortized Cost 8,213  
Total debt securities - available-for-sale, Amortized Cost 8,213 7,379
Mortgage-backed securities, Fair Value 7,540  
Debt Securities, Available-for-sale 7,540 6,586
Non-U.S. Agency Mortgage-Backed Securities [Member]    
Schedule of Investments [Line Items]    
Mortgage-backed securities, Amortized Cost 3,156  
Total debt securities - available-for-sale, Amortized Cost 3,156 3,077
Mortgage-backed securities, Fair Value 2,874  
Debt Securities, Available-for-sale $ 2,874 $ 2,784
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Debt Securities [Member]    
Schedule of Investments [Line Items]    
Less Than 12 Months, Fair Value $ 11,886 $ 24,899
Less Than 12 Months, Gross Unrealized Losses (301) (1,750)
Greater Than 12 Months, Fair Value 23,641 12,320
Greater Than 12 Months, Gross Unrealized Losses (2,816) (1,914)
Total, Fair Value 35,527 37,219
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss (3,117) (3,664)
U.S. Government and Agency Obligations [Member]    
Schedule of Investments [Line Items]    
Less Than 12 Months, Fair Value 1,279 2,007
Less Than 12 Months, Gross Unrealized Losses (12) (96)
Greater Than 12 Months, Fair Value 1,825 1,290
Greater Than 12 Months, Gross Unrealized Losses (224) (189)
Total, Fair Value 3,104 3,297
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss (236) (285)
State and Municipal Obligations [Member]    
Schedule of Investments [Line Items]    
Less Than 12 Months, Fair Value 1,898 4,630
Less Than 12 Months, Gross Unrealized Losses (30) (288)
Greater Than 12 Months, Fair Value 3,110 1,178
Greater Than 12 Months, Gross Unrealized Losses (335) (191)
Total, Fair Value 5,008 5,808
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss (365) (479)
Corporate Obligations [Member]    
Schedule of Investments [Line Items]    
Less Than 12 Months, Fair Value 6,337 13,003
Less Than 12 Months, Gross Unrealized Losses (178) (893)
Greater Than 12 Months, Fair Value 12,443 6,637
Greater Than 12 Months, Gross Unrealized Losses (1,347) (905)
Total, Fair Value 18,780 19,640
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss (1,525) (1,798)
U.S. Agency Mortgage-Backed Securities [Member]    
Schedule of Investments [Line Items]    
Less Than 12 Months, Fair Value 1,589 3,561
Less Than 12 Months, Gross Unrealized Losses (55) (345)
Greater Than 12 Months, Fair Value 4,274 2,239
Greater Than 12 Months, Gross Unrealized Losses (653) (463)
Total, Fair Value 5,863 5,800
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss (708) (808)
Non-U.S. Agency Mortgage-Backed Securities [Member]    
Schedule of Investments [Line Items]    
Less Than 12 Months, Fair Value 783 1,698
Less Than 12 Months, Gross Unrealized Losses (26) (128)
Greater Than 12 Months, Fair Value 1,989 976
Greater Than 12 Months, Gross Unrealized Losses (257) (166)
Total, Fair Value 2,772 2,674
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $ (283) $ (294)
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Fair Value [Line Items]    
Transfers Into Level 3 $ 0 $ 0
Transfers out of Level 3 0 0
Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis $ 0 $ 0
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents $ 41,913 $ 23,365
Debt Securities, Available-for-sale 45,381 42,321
Equity Securities, FV-NI 2,233 2,148
Assets under management 3,837 4,087
Assets, Fair Value Disclosure 93,364 71,921
Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 45,381 42,321
U.S. Government and Agency Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 4,529 3,809
State and Municipal Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 7,755 7,248
Corporate Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 22,683 21,894
U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 7,540 6,586
Non-U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 2,874 2,784
Quoted Prices in Active Markets (Level 1) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 41,851 23,202
Equity Securities, FV-NI 2,128 2,043
Assets under management 1,491 1,788
Assets, Fair Value Disclosure 49,608 30,545
Quoted Prices in Active Markets (Level 1) [Member] | Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 4,138 3,512
Quoted Prices in Active Markets (Level 1) [Member] | U.S. Government and Agency Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 4,122 3,505
Quoted Prices in Active Markets (Level 1) [Member] | State and Municipal Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 0 0
Quoted Prices in Active Markets (Level 1) [Member] | Corporate Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 16 7
Quoted Prices in Active Markets (Level 1) [Member] | U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 0 0
Quoted Prices in Active Markets (Level 1) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 0 0
Other Observable Inputs (Level 2) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 62 163
Equity Securities, FV-NI 35 35
Assets under management 2,245 2,203
Assets, Fair Value Disclosure 43,404 41,018
Other Observable Inputs (Level 2) [Member] | Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 41,062 38,617
Other Observable Inputs (Level 2) [Member] | U.S. Government and Agency Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 407 304
Other Observable Inputs (Level 2) [Member] | State and Municipal Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 7,755 7,248
Other Observable Inputs (Level 2) [Member] | Corporate Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 22,486 21,695
Other Observable Inputs (Level 2) [Member] | U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 7,540 6,586
Other Observable Inputs (Level 2) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 2,874 2,784
Unobservable Inputs (Level 3) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Equity Securities, FV-NI 70 70
Assets under management 101 96
Assets, Fair Value Disclosure 352 358
Unobservable Inputs (Level 3) [Member] | Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 181 192
Unobservable Inputs (Level 3) [Member] | U.S. Government and Agency Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 0 0
Unobservable Inputs (Level 3) [Member] | State and Municipal Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 0 0
Unobservable Inputs (Level 3) [Member] | Corporate Obligations [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 181 192
Unobservable Inputs (Level 3) [Member] | U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 0 0
Unobservable Inputs (Level 3) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale $ 0 $ 0
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Held-to-maturity, Fair Value $ 669 $ 679
Debt Securities, Held-to-maturity 682 696
Fair Value, Nonrecurring [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Held-to-maturity, Fair Value 669 679
Debt and other financing obligations 60,307 53,626
Fair Value, Nonrecurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Held-to-maturity, Fair Value 595 577
Debt and other financing obligations 0 0
Fair Value, Nonrecurring [Member] | Other Observable Inputs (Level 2) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Held-to-maturity, Fair Value 74 102
Debt and other financing obligations 60,307 53,626
Fair Value, Nonrecurring [Member] | Unobservable Inputs (Level 3) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Held-to-maturity, Fair Value 0 0
Debt and other financing obligations 0 0
Long-term debt and other financing obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt and other financing obligations, carrying value $ 62,360 $ 56,823
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Costs Payable (Narrative) (Details) - USD ($)
$ in Billions
Mar. 31, 2023
Dec. 31, 2022
Insurance [Abstract]    
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount $ 21.7 $ 20.0
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Costs Payable (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]    
Medical costs payable, beginning of period $ 29,056 $ 24,483
Acquisitions 1 8
Reported medical costs:    
Current year 60,315 52,813
Prior year (470) (290)
Total reported medical costs 59,845 52,523
Medical payments:    
Payments for current year (35,087) (29,589)
Payments for prior years (22,006) (18,749)
Total medical payments (57,093) (48,338)
Medical costs payable, end of period $ 31,809 $ 28,676
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Short-Term Borrowings and Long-Term Debt (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Debt Instrument [Line Items]  
Par Value $ 6,500
Commercial Paper $ 8,200
4.250% notes due January 2029  
Debt Instrument [Line Items]  
Debt Instrument, Interest Rate, Stated Percentage 4.25%
Par Value $ 1,250
4.500% notes due April 2033  
Debt Instrument [Line Items]  
Debt Instrument, Interest Rate, Stated Percentage 4.50%
Par Value $ 1,500
5.050% notes due April 2053  
Debt Instrument [Line Items]  
Debt Instrument, Interest Rate, Stated Percentage 5.05%
Par Value $ 2,000
5.200% notes due April 2063  
Debt Instrument [Line Items]  
Debt Instrument, Interest Rate, Stated Percentage 5.20%
Par Value $ 1,750
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Short-Term Borrowings and Long-Term Debt (Narrative) (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Rate
Debt Instrument [Line Items]  
Commercial Paper | $ $ 8,200
Commercial Paper [Member]  
Debt Instrument [Line Items]  
Short-term Debt, Weighted Average Interest Rate, at Point in Time | Rate 5.20%
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combinations (Narrative) (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Business Combination, Consideration Transferred $ 8,000
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combinations (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
Business Acquisition [Line Items]  
Cash and cash equivalents $ 142
Accounts receivable and other current assets 530
Property, equipment and other long-term assets 659
Other Intangible Assets 2,141
Total identifiable assets acquired 3,472
Medical costs payable (1)
Accounts payable and other current liabilities (467)
Other long-term liabilities (698)
Total identifiable liabilities acquired (1,166)
Total net tangible assets 2,306
Goodwill 6,646
Redeemable noncontrolling interests (130)
Nonredeemable noncontrolling interests (819)
Net Assets Acquired $ 8,003
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combinations Acquired Finite-Lived Intangible Asets (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Finite-lived Intangible Assets Acquired $ 464
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life 9 years
Indefinite-Lived Intangible Assets Acquired $ 1,677
Other Intangible Assets 2,141
Customer-Related Intangible Assets [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived Intangible Assets Acquired $ 234
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life 13 years
Trademarks and Technology [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived Intangible Assets Acquired $ 220
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life 5 years
Other Intangible Assets [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived Intangible Assets Acquired $ 10
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life 11 years
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Financial Information (Narrative) (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
reportableSegments
Dec. 31, 2022
USD ($)
Statement [Line Items]    
Number of Reportable Segments | reportableSegments 4  
Assets $ 283,679 $ 245,705
Goodwill 6,646  
Optum Health    
Statement [Line Items]    
Assets 80,400 $ 69,000
Goodwill $ 5,900  
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Financial Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement [Line Items]    
Premiums, revenues - unaffiliated customers $ 72,786 $ 64,070
Investment and other income 798 367
Total revenues 91,931 80,149
Earnings from operations 8,086 6,950
Interest expense (754) (433)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7,332 6,517
Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 10,267 9,340
Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 8,080 6,372
Optum    
Statement [Line Items]    
Investment and other income 343 224
Total revenues 54,059 43,259
Earnings from operations 3,743 3,152
Interest expense 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3,743 3,152
Unaffiliated Customers    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 72,786 64,070
Total revenues 91,133 79,782
Unaffiliated Customers | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 10,267 9,340
Unaffiliated Customers | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 8,080 6,372
Unaffiliated Customers | Optum    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 5,328 4,133
Total revenues 21,120 17,330
Unaffiliated Customers | Optum | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 10,267 9,340
Unaffiliated Customers | Optum | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 5,525 3,857
Affiliated Customers    
Statement [Line Items]    
Total revenues 0 0
Affiliated Customers | Optum    
Statement [Line Items]    
Total revenues 32,596 25,705
Operating Segments | UnitedHealthcare    
Statement [Line Items]    
Investment and other income 455 143
Total revenues 70,468 62,595
Earnings from operations 4,343 3,798
Interest expense 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4,343 3,798
Operating Segments | Optum Health    
Statement [Line Items]    
Investment and other income 277 156
Total revenues 23,004 16,682
Earnings from operations 1,776 1,366
Interest expense 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1,776 1,366
Operating Segments | Optum Insight    
Statement [Line Items]    
Investment and other income 20 67
Total revenues 4,496 3,219
Earnings from operations 907 847
Interest expense 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 907 847
Operating Segments | Optum Rx    
Statement [Line Items]    
Investment and other income 46 1
Total revenues 27,418 23,911
Earnings from operations 1,060 939
Interest expense 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1,060 939
Operating Segments | Unaffiliated Customers | UnitedHealthcare    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 67,458 59,937
Total revenues 70,013 62,452
Operating Segments | Unaffiliated Customers | UnitedHealthcare | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 0 0
Operating Segments | Unaffiliated Customers | UnitedHealthcare | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 2,555 2,515
Operating Segments | Unaffiliated Customers | Optum Health    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 5,328 4,133
Total revenues 8,461 6,697
Operating Segments | Unaffiliated Customers | Optum Health | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 44 6
Operating Segments | Unaffiliated Customers | Optum Health | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 3,089 2,558
Operating Segments | Unaffiliated Customers | Optum Insight    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 0 0
Total revenues 1,966 1,014
Operating Segments | Unaffiliated Customers | Optum Insight | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 40 40
Operating Segments | Unaffiliated Customers | Optum Insight | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 1,926 974
Operating Segments | Unaffiliated Customers | Optum Rx    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 0 0
Total revenues 10,693 9,619
Operating Segments | Unaffiliated Customers | Optum Rx | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 10,183 9,294
Operating Segments | Unaffiliated Customers | Optum Rx | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 510 325
Operating Segments | Affiliated Customers | UnitedHealthcare    
Statement [Line Items]    
Total revenues 0 0
Operating Segments | Affiliated Customers | Optum Health    
Statement [Line Items]    
Total revenues 14,266 9,829
Operating Segments | Affiliated Customers | Optum Insight    
Statement [Line Items]    
Total revenues 2,510 2,138
Operating Segments | Affiliated Customers | Optum Rx    
Statement [Line Items]    
Total revenues 16,679 14,291
Optum Eliminations    
Statement [Line Items]    
Investment and other income 0 0
Total revenues (859) (553)
Earnings from operations 0 0
Interest expense 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 0 0
Optum Eliminations | Unaffiliated Customers    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 0 0
Total revenues 0 0
Optum Eliminations | Unaffiliated Customers | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 0 0
Optum Eliminations | Unaffiliated Customers | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 0 0
Optum Eliminations | Affiliated Customers    
Statement [Line Items]    
Total revenues (859) (553)
Corporate and Eliminations    
Statement [Line Items]    
Investment and other income 0 0
Total revenues (32,596) (25,705)
Earnings from operations 0 0
Interest expense (754) (433)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (754) (433)
Corporate and Eliminations | Unaffiliated Customers    
Statement [Line Items]    
Premiums, revenues - unaffiliated customers 0 0
Total revenues 0 0
Corporate and Eliminations | Unaffiliated Customers | Products    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 0 0
Corporate and Eliminations | Unaffiliated Customers | Services    
Statement [Line Items]    
Revenue from Products and Services - unaffiliated customers 0 0
Corporate and Eliminations | Affiliated Customers    
Statement [Line Items]    
Total revenues $ (32,596) $ (25,705)
XML 50 unh-20230331_htm.xml IDEA: XBRL DOCUMENT 0000731766 2023-01-01 2023-03-31 0000731766 2023-04-28 0000731766 2023-03-31 0000731766 2022-12-31 0000731766 2022-01-01 2022-03-31 0000731766 us-gaap:ProductMember 2023-01-01 2023-03-31 0000731766 us-gaap:ProductMember 2022-01-01 2022-03-31 0000731766 us-gaap:ServiceMember 2023-01-01 2023-03-31 0000731766 us-gaap:ServiceMember 2022-01-01 2022-03-31 0000731766 us-gaap:CommonStockMember 2022-12-31 0000731766 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000731766 us-gaap:RetainedEarningsMember 2022-12-31 0000731766 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0000731766 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000731766 us-gaap:NoncontrollingInterestMember 2022-12-31 0000731766 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000731766 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000731766 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-03-31 0000731766 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0000731766 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000731766 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000731766 us-gaap:CommonStockMember 2023-03-31 0000731766 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000731766 us-gaap:RetainedEarningsMember 2023-03-31 0000731766 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-03-31 0000731766 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0000731766 us-gaap:NoncontrollingInterestMember 2023-03-31 0000731766 us-gaap:CommonStockMember 2021-12-31 0000731766 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000731766 us-gaap:RetainedEarningsMember 2021-12-31 0000731766 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0000731766 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000731766 us-gaap:NoncontrollingInterestMember 2021-12-31 0000731766 2021-12-31 0000731766 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000731766 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000731766 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-03-31 0000731766 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0000731766 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000731766 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000731766 us-gaap:CommonStockMember 2022-03-31 0000731766 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000731766 us-gaap:RetainedEarningsMember 2022-03-31 0000731766 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-03-31 0000731766 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0000731766 us-gaap:NoncontrollingInterestMember 2022-03-31 0000731766 2022-03-31 0000731766 unh:ProductsAndServicesMember 2023-03-31 0000731766 unh:ProductsAndServicesMember 2022-12-31 0000731766 2023-04-01 2023-03-31 0000731766 us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0000731766 us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-03-31 0000731766 us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0000731766 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2023-03-31 0000731766 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2023-03-31 0000731766 us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0000731766 us-gaap:USStatesAndPoliticalSubdivisionsMember 2022-12-31 0000731766 us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000731766 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2022-12-31 0000731766 us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2022-12-31 0000731766 us-gaap:DebtSecuritiesMember 2023-03-31 0000731766 us-gaap:DebtSecuritiesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:DebtSecuritiesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:DebtSecuritiesMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:DebtSecuritiesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:DebtSecuritiesMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000731766 us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000731766 us-gaap:LongTermDebtMember 2023-03-31 0000731766 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000731766 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000731766 us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000731766 us-gaap:LongTermDebtMember 2022-12-31 0000731766 unh:A4250NotesDueJanuary2029Member 2023-03-31 0000731766 unh:A4500NotesDueApril2033Member 2023-03-31 0000731766 unh:A5050NotesDueApril2053Member 2023-03-31 0000731766 unh:A5200NotesDueApril2063Member 2023-03-31 0000731766 us-gaap:CommercialPaperMember 2023-03-31 0000731766 us-gaap:CustomerRelatedIntangibleAssetsMember 2023-01-01 2023-03-31 0000731766 unh:TrademarksAndTechnologyMember 2023-01-01 2023-03-31 0000731766 us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-03-31 0000731766 unh:OptumHealthMember 2023-03-31 0000731766 unh:OptumHealthMember 2022-12-31 0000731766 unh:OptumHealthMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:UnitedhealthcareMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:OptumHealthMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:OptumInsightMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:OptumRxMember 2023-01-01 2023-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:ExternalCustomersMember 2023-01-01 2023-03-31 0000731766 unh:ExternalCustomersMember unh:TotalOptumMember 2023-01-01 2023-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:ExternalCustomersMember 2023-01-01 2023-03-31 0000731766 unh:ExternalCustomersMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:UnitedhealthcareMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:OptumHealthMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:OptumInsightMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:OptumRxMember 2023-01-01 2023-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:ExternalCustomersMember us-gaap:ProductMember 2023-01-01 2023-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ProductMember unh:TotalOptumMember 2023-01-01 2023-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:ExternalCustomersMember us-gaap:ProductMember 2023-01-01 2023-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ProductMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:UnitedhealthcareMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:OptumHealthMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:OptumInsightMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:OptumRxMember 2023-01-01 2023-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:ExternalCustomersMember us-gaap:ServiceMember 2023-01-01 2023-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ServiceMember unh:TotalOptumMember 2023-01-01 2023-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:ExternalCustomersMember us-gaap:ServiceMember 2023-01-01 2023-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ServiceMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:UnitedhealthcareMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:OptumHealthMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:OptumInsightMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:OptumRxMember 2023-01-01 2023-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:IntersegmentMember 2023-01-01 2023-03-31 0000731766 unh:IntersegmentMember unh:TotalOptumMember 2023-01-01 2023-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:IntersegmentMember 2023-01-01 2023-03-31 0000731766 unh:IntersegmentMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:UnitedhealthcareMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:OptumHealthMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:OptumInsightMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:OptumRxMember 2023-01-01 2023-03-31 0000731766 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-03-31 0000731766 unh:TotalOptumMember 2023-01-01 2023-03-31 0000731766 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:UnitedhealthcareMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:OptumHealthMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:OptumInsightMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember unh:OptumRxMember 2022-01-01 2022-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:ExternalCustomersMember 2022-01-01 2022-03-31 0000731766 unh:ExternalCustomersMember unh:TotalOptumMember 2022-01-01 2022-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:ExternalCustomersMember 2022-01-01 2022-03-31 0000731766 unh:ExternalCustomersMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:UnitedhealthcareMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:OptumHealthMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:OptumInsightMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ProductMember unh:OptumRxMember 2022-01-01 2022-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:ExternalCustomersMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ProductMember unh:TotalOptumMember 2022-01-01 2022-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:ExternalCustomersMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ProductMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:UnitedhealthcareMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:OptumHealthMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:OptumInsightMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:ExternalCustomersMember us-gaap:ServiceMember unh:OptumRxMember 2022-01-01 2022-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:ExternalCustomersMember us-gaap:ServiceMember 2022-01-01 2022-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ServiceMember unh:TotalOptumMember 2022-01-01 2022-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:ExternalCustomersMember us-gaap:ServiceMember 2022-01-01 2022-03-31 0000731766 unh:ExternalCustomersMember us-gaap:ServiceMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:UnitedhealthcareMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:OptumHealthMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:OptumInsightMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:IntersegmentMember unh:OptumRxMember 2022-01-01 2022-03-31 0000731766 us-gaap:IntersegmentEliminationMember unh:IntersegmentMember 2022-01-01 2022-03-31 0000731766 unh:IntersegmentMember unh:TotalOptumMember 2022-01-01 2022-03-31 0000731766 us-gaap:CorporateNonSegmentMember unh:IntersegmentMember 2022-01-01 2022-03-31 0000731766 unh:IntersegmentMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:UnitedhealthcareMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:OptumHealthMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:OptumInsightMember 2022-01-01 2022-03-31 0000731766 us-gaap:OperatingSegmentsMember unh:OptumRxMember 2022-01-01 2022-03-31 0000731766 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-03-31 0000731766 unh:TotalOptumMember 2022-01-01 2022-03-31 0000731766 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-03-31 shares iso4217:USD iso4217:USD shares utr:Rate pure unh:reportableSegments false 2023 Q1 0000731766 --12-31 0.50 10-Q true 2023-03-31 false 1-10864 UnitedHealth Group Incorporated DE 41-1321939 UnitedHealth Group Center 55343 9900 Bren Road East Minnetonka, MN 952 936-1300 Common Stock, $.01 par value UNH NYSE Yes Yes Large Accelerated Filer false false false 931032030 41913000000 23365000000 4584000000 4546000000 22414000000 17681000000 14696000000 12769000000 3837000000 4087000000 6451000000 6621000000 93895000000 69069000000 46884000000 43728000000 10637000000 10128000000 100406000000 93352000000 16165000000 14401000000 15692000000 15027000000 283679000000 245705000000 31809000000 29056000000 29856000000 27715000000 9931000000 3110000000 14487000000 3075000000 30399000000 26281000000 116482000000 89237000000 60657000000 54513000000 2834000000 2769000000 13084000000 12839000000 193057000000 159358000000 4801000000 4897000000 0.001 0.001 10000000 10000000 0 0 0 0 0 0 0.01 0.01 3000000000 3000000000 932000000 932000000 934000000 934000000 9000000 9000000 88852000000 86156000000 -7549000000 -8393000000 4509000000 3678000000 85821000000 81450000000 283679000000 245705000000 72786000000 64070000000 10267000000 9340000000 8080000000 6372000000 798000000 367000000 91931000000 80149000000 59845000000 52523000000 13625000000 11401000000 9405000000 8487000000 970000000 788000000 83845000000 73199000000 8086000000 6950000000 754000000 433000000 7332000000 6517000000 1558000000 1369000000 5774000000 5148000000 163000000 121000000 5611000000 5027000000 6.01 5.34 5.95 5.27 933000000 941000000 10000000 13000000 943000000 954000000 5000000 2000000 5774000000 5148000000 640000000 -2023000000 147000000 -465000000 493000000 -1558000000 -13000000 3000000 -3000000 1000000 -10000000 2000000 341000000 918000000 844000000 -642000000 6618000000 4506000000 163000000 121000000 6455000000 4385000000 934000000 9000000 0 86156000000 -2778000000 -5615000000 3678000000 81450000000 5611000000 113000000 5724000000 503000000 341000000 844000000 2000000 0 350000000 350000000 366000000 366000000 4000000 0 633000000 1378000000 2011000000 1.65 1537000000 1537000000 -83000000 -83000000 819000000 819000000 101000000 101000000 932000000 9000000 0 88852000000 -2275000000 -5274000000 4509000000 85821000000 941000000 10000000 0 77134000000 423000000 -5807000000 3285000000 75045000000 5027000000 88000000 5115000000 -1560000000 918000000 -642000000 3000000 0 333000000 333000000 282000000 282000000 5000000 0 484000000 2016000000 2500000000 1.45 1363000000 1363000000 -131000000 -131000000 91000000 91000000 102000000 102000000 939000000 10000000 0 78782000000 -1137000000 -4889000000 3362000000 76128000000 5774000000 5148000000 970000000 788000000 -332000000 161000000 362000000 299000000 -69000000 -17000000 4306000000 4521000000 1875000000 1089000000 2467000000 3849000000 1796000000 589000000 11402000000 78000000 16327000000 5319000000 4894000000 4982000000 456000000 1591000000 2119000000 1759000000 7826000000 1231000000 760000000 555000000 115000000 255000000 -11020000000 -3673000000 2000000000 2500000000 1537000000 1363000000 344000000 551000000 1375000000 1100000000 7349000000 3148000000 6401000000 0 5012000000 5120000000 -1004000000 -1552000000 13190000000 2304000000 51000000 157000000 18548000000 4107000000 23365000000 21375000000 41913000000 25482000000 Basis of Presentation <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group Incorporated (individually and together with its subsidiaries, “UnitedHealth Group” and the “Company”) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations the Company is privileged to serve.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Condensed Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries. The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC), the Company has omitted certain footnote disclosures that would substantially duplicate the disclosures contained in its annual audited Consolidated Financial Statements. Therefore, these Condensed Consolidated Financial Statements should be read together with the Consolidated Financial Statements and the Notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC (2022 10-K). The accompanying Condensed Consolidated Financial Statements include all normal recurring adjustments necessary to present the interim financial statements fairly. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Condensed Consolidated Financial Statements include certain amounts based on the Company’s best estimates and judgments. The Company’s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters that are inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues - Products and Services</span></div>As of March 31, 2023 and December 31, 2022, accounts receivable related to products and services were $8.1 billion and $7.1 billion, respectively. Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracting having an original expected duration of one year or less, contracts where revenue recognized as invoiced and contracts with variable consideration related undelivered performance obligations, was $12.3 billion, of which approximately half is expected to be recognized in the next three years. UnitedHealth Group Incorporated (individually and together with its subsidiaries, “UnitedHealth Group” and the “Company”) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations the Company is privileged to serve. The Company has prepared the Condensed Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries. The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC), the Company has omitted certain footnote disclosures that would substantially duplicate the disclosures contained in its annual audited Consolidated Financial Statements. Therefore, these Condensed Consolidated Financial Statements should be read together with the Consolidated Financial Statements and the Notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC (2022 10-K). The accompanying Condensed Consolidated Financial Statements include all normal recurring adjustments necessary to present the interim financial statements fairly. These Condensed Consolidated Financial Statements include certain amounts based on the Company’s best estimates and judgments. The Company’s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters that are inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted. As of March 31, 2023 and December 31, 2022, accounts receivable related to products and services were $8.1 billion and $7.1 billion, respectively. Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracting having an original expected duration of one year or less, contracts where revenue recognized as invoiced and contracts with variable consideration related undelivered performance obligations, was $12.3 billion, of which approximately half is expected to be recognized in the next three years. 8100000000 7100000000 12300000000 P3Y Investments<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,333 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,381 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,015 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,130)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,050 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,702 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,926 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,681)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held $3.9 billion and $3.7 billion of equity securities as of March 31, 2023 and December 31, 2022, respectively. The Company’s investments in equity securities primarily consist of employee savings plan related investments, venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company’s investments included $1.5 billion of equity method investments in operating businesses in the health care sector as of March 31, 2023 and December 31, 2022. The allowance for credit losses on held-to-maturity securities at March 31, 2023 and December 31, 2022 was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of March 31, 2023, by contractual maturity, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,691 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,333 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,381 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:37.044%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,008 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,780 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,886 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,816)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,527 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,007 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,808 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,899 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,750)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,914)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unrealized losses from debt securities as of March 31, 2023 were generated from approximately 32,000 positions out of a total of 42,000 positions. The Company believes that it will collect the timely principal and interest due on its debt securities that have an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company’s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of March 31, 2023, the Company did not have the intent to sell any of the available-for-sale debt securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities at March 31, 2023 and December 31, 2022 was not material.</span></div> <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,333 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,381 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,015 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,130)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,050 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,702 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,926 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,681)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4760000000 5000000 236000000 4529000000 8055000000 65000000 365000000 7755000000 24149000000 59000000 1525000000 22683000000 8213000000 35000000 708000000 7540000000 3156000000 1000000 283000000 2874000000 48333000000 165000000 3117000000 45381000000 594000000 0 10000000 584000000 28000000 0 3000000 25000000 60000000 0 0 60000000 682000000 0 13000000 669000000 49015000000 165000000 3130000000 46050000000 4093000000 1000000 285000000 3809000000 7702000000 25000000 479000000 7248000000 23675000000 17000000 1798000000 21894000000 7379000000 15000000 808000000 6586000000 3077000000 1000000 294000000 2784000000 45926000000 59000000 3664000000 42321000000 578000000 0 14000000 564000000 29000000 0 3000000 26000000 89000000 0 0 89000000 696000000 0 17000000 679000000 46622000000 59000000 3681000000 43000000000 3900000000 3700000000 1500000000 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of March 31, 2023, by contractual maturity, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,691 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,333 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,381 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4722000000 4691000000 377000000 376000000 14356000000 13708000000 261000000 254000000 12240000000 11217000000 24000000 22000000 5646000000 5351000000 20000000 17000000 8213000000 7540000000 3156000000 2874000000 48333000000 45381000000 682000000 669000000 <div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:37.044%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,008 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,780 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,886 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,816)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,527 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,007 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,808 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,899 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,750)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,320 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,914)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1279000000 12000000 1825000000 224000000 3104000000 236000000 1898000000 30000000 3110000000 335000000 5008000000 365000000 6337000000 178000000 12443000000 1347000000 18780000000 1525000000 1589000000 55000000 4274000000 653000000 5863000000 708000000 783000000 26000000 1989000000 257000000 2772000000 283000000 11886000000 301000000 23641000000 2816000000 35527000000 3117000000 2007000000 96000000 1290000000 189000000 3297000000 285000000 4630000000 288000000 1178000000 191000000 5808000000 479000000 13003000000 893000000 6637000000 905000000 19640000000 1798000000 3561000000 345000000 2239000000 463000000 5800000000 808000000 1698000000 128000000 976000000 166000000 2674000000 294000000 24899000000 1750000000 12320000000 1914000000 37219000000 3664000000 32000 42000 At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of March 31, 2023, the Company did not have the intent to sell any of the available-for-sale debt securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. Fair Value<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value in the Condensed Consolidated Financial Statements or have fair values disclosed in the Notes to the Condensed Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,851 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,138 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,062 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,381 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,505 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,695 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,617 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,043 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,545 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,018 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 financial assets or liabilities during the three months ended March 31, 2023 or 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:41.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonfinancial assets and liabilities or financial assets and liabilities that are measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. There were no significant fair value adjustments for these assets and liabilities recorded during the three months ended March 31, 2023 or 2022.</span></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,851 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,138 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,062 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,381 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,128 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,505 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,809 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,695 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,617 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,321 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,043 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,545 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,018 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 41851000000 62000000 0 41913000000 4122000000 407000000 0 4529000000 0 7755000000 0 7755000000 16000000 22486000000 181000000 22683000000 0 7540000000 0 7540000000 0 2874000000 0 2874000000 4138000000 41062000000 181000000 45381000000 2128000000 35000000 70000000 2233000000 1491000000 2245000000 101000000 3837000000 49608000000 43404000000 352000000 93364000000 23202000000 163000000 0 23365000000 3505000000 304000000 0 3809000000 0 7248000000 0 7248000000 7000000 21695000000 192000000 21894000000 0 6586000000 0 6586000000 0 2784000000 0 2784000000 3512000000 38617000000 192000000 42321000000 2043000000 35000000 70000000 2148000000 1788000000 2203000000 96000000 4087000000 30545000000 41018000000 358000000 71921000000 0 0 0 0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Condensed Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:41.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 595000000 74000000 0 669000000 682000000 0 60307000000 0 60307000000 62360000000 577000000 102000000 0 679000000 696000000 0 53626000000 0 53626000000 56823000000 0 0 Medical Costs Payable<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the three months ended March 31: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,056 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,523 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,087)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,093)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,338)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,676 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>For the three months ended March 31, 2023 and 2022, prior years’ medical cost reserve development included no individual factors that were significant. Medical costs payable included reserves for claims incurred by insured customers but not yet reported to the Company of $21.7 billion and $20.0 billion at March 31, 2023 and December 31, 2022, respectively. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the three months ended March 31: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,056 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,523 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,087)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,093)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,338)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,809 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,676 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 29056000000 24483000000 1000000 8000000 60315000000 52813000000 -470000000 -290000000 59845000000 52523000000 35087000000 29589000000 22006000000 18749000000 57093000000 48338000000 31809000000 28676000000 21700000000 20000000000 Short-Term Borrowings and Long-Term Debt <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company issued $6.5 billion of senior unsecured notes consisting of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Par Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.250% notes due January 2029</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500% notes due April 2033</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.050% notes due April 2053</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.200% notes due April 2063</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company had $8.2 billion of commercial paper outstanding, with a weighted-average annual interest rate of 5.2%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the Company’s short-term borrowings, debt covenants and long-term debt, see Note 8 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K.</span></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company issued $6.5 billion of senior unsecured notes consisting of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Par Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.250% notes due January 2029</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500% notes due April 2033</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.050% notes due April 2053</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.200% notes due April 2063</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6500000000 0.04250 1250000000 0.04500 1500000000 0.05050 2000000000 0.05200 1750000000 8200000000 0.052 Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company’s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Investigations, Audits and Reviews</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by the Centers for Medicare and Medicaid Services (CMS), state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the Internal Revenue Service, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the Federal Deposit Insurance Corporation, the Consumer Financial Protection Bureau (CFPB), the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company’s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company’s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company’s health plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower’s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company’s motion to dismiss. In May 2018, the DOJ moved to dismiss the Company’s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government’s motion for partial summary judgment and dismissed the Company’s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.</span></div> Business Combinations<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the Company completed several business combinations for total consideration of $8.0 billion.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired assets (liabilities) at acquisition date were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,472 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable liabilities acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net identifiable assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,003 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of goodwill is not deductible for income tax purposes. The preliminary purchase price allocations for the various business combinations are subject to adjustment as valuation analyses, primarily related to intangible assets and contingent liabilities, are finalized.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to intangible assets were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired finite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired indefinite-lived intangible assets - operating licenses and certificates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations and financial condition of acquired entities have been included in the Company’s consolidated results and the results of the corresponding operating segment as of the date of acquisition. Through March 31, 2023, acquired entities impact on revenues and net earnings was not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaudited pro forma revenues and net earnings for the three months ended March 31, 2023 and 2022, as if the business combinations had occurred on January 1, 2022, were immaterial for both periods.</span></div> 8000000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired assets (liabilities) at acquisition date were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,472 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable liabilities acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net identifiable assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,003 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 142000000 530000000 659000000 2141000000 3472000000 1000000 467000000 698000000 1166000000 2306000000 6646000000 130000000 819000000 8003000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to intangible assets were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired finite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired indefinite-lived intangible assets - operating licenses and certificates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table> 234000000 P13Y 220000000 P5Y 10000000 P11Y 464000000 P9Y 1677000000 2141000000 Segment Financial Information<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s four reportable segments are UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. For more information on the Company’s segments, see Part I, Item I, “Business” and Note 14 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in the 2022 10-K. Total assets at Optum Health increased to $80.4 billion as of March 31, 2023 compared to $69.0 billion as of December 31, 2022, primarily due to goodwill from business combinations of $5.9 billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reportable segment financial information:</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,555 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,089 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,525 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,461 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,966 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,693 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,120 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,133 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,679 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,468 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,004 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,496 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,059 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,931 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,343 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,086 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,343 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,332 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">974 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,452 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,697 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,014 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,619 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,330 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,782 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,705)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,798 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">847 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,152 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,950 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">847 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,152 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,517 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4 80400000000 69000000000 5900000000 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reportable segment financial information:</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,555 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,089 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,525 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,461 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,966 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,693 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,120 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,133 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,679 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,468 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,004 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,496 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,059 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,931 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,343 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,086 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,343 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,332 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">974 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,452 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,697 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,014 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,619 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,330 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,782 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,705)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,798 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">847 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,152 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,950 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">847 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,152 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,517 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 67458000000 5328000000 0 0 0 5328000000 0 72786000000 0 44000000 40000000 10183000000 0 10267000000 0 10267000000 2555000000 3089000000 1926000000 510000000 0 5525000000 0 8080000000 70013000000 8461000000 1966000000 10693000000 0 21120000000 0 91133000000 0 14266000000 2510000000 16679000000 -859000000 32596000000 -32596000000 0 455000000 277000000 20000000 46000000 0 343000000 0 798000000 70468000000 23004000000 4496000000 27418000000 -859000000 54059000000 -32596000000 91931000000 4343000000 1776000000 907000000 1060000000 0 3743000000 0 8086000000 0 0 0 0 0 0 754000000 754000000 4343000000 1776000000 907000000 1060000000 0 3743000000 -754000000 7332000000 59937000000 4133000000 0 0 0 4133000000 0 64070000000 0 6000000 40000000 9294000000 0 9340000000 0 9340000000 2515000000 2558000000 974000000 325000000 0 3857000000 0 6372000000 62452000000 6697000000 1014000000 9619000000 0 17330000000 0 79782000000 0 9829000000 2138000000 14291000000 -553000000 25705000000 -25705000000 0 143000000 156000000 67000000 1000000 0 224000000 0 367000000 62595000000 16682000000 3219000000 23911000000 -553000000 43259000000 -25705000000 80149000000 3798000000 1366000000 847000000 939000000 0 3152000000 0 6950000000 0 0 0 0 0 0 433000000 433000000 3798000000 1366000000 847000000 939000000 0 3152000000 -433000000 6517000000 EXCEL 51 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 203 248 1 false 39 0 false 6 false false R1.htm 0000001 - Document - Document and Entity Information Document Sheet http://www.uhg.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.uhg.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 0000004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 3 false false R4.htm 0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 4 false false R5.htm 0000006 - Statement - Condensed Consolidated Statements of Changes in Equity Sheet http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity Condensed Consolidated Statements of Changes in Equity Statements 5 false false R6.htm 0000007 - Statement - Condensed Consolidated Statement of Changes in Equity (Parenthetical) Sheet http://www.uhg.com/role/CondensedConsolidatedStatementofChangesinEquityParenthetical Condensed Consolidated Statement of Changes in Equity (Parenthetical) Statements 6 false false R7.htm 0000008 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000009 - Disclosure - Basis of Presentation (Notes) Notes http://www.uhg.com/role/BasisofPresentationNotes Basis of Presentation (Notes) Notes 8 false false R9.htm 0000010 - Disclosure - Investments (Notes) Notes http://www.uhg.com/role/InvestmentsNotes Investments (Notes) Notes 9 false false R10.htm 0000011 - Disclosure - Fair Value (Notes) Notes http://www.uhg.com/role/FairValueNotes Fair Value (Notes) Notes 10 false false R11.htm 0000012 - Disclosure - Medical Costs Payable (Notes) Notes http://www.uhg.com/role/MedicalCostsPayableNotes Medical Costs Payable (Notes) Notes 11 false false R12.htm 0000013 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes) Notes http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNotes Short-Term Borrowings and Long-Term Debt (Notes) Notes 12 false false R13.htm 0000014 - Disclosure - Commitments and Contingencies (Notes) Notes http://www.uhg.com/role/CommitmentsandContingenciesNotes Commitments and Contingencies (Notes) Notes 13 false false R14.htm 0000015 - Disclosure - Business Combinations (Notes) Notes http://www.uhg.com/role/BusinessCombinationsNotes Business Combinations (Notes) Notes 14 false false R15.htm 0000016 - Disclosure - Segment Financial Information (Notes) Notes http://www.uhg.com/role/SegmentFinancialInformationNotes Segment Financial Information (Notes) Notes 15 false false R16.htm 0000017 - Disclosure - Basis of Presentation (Policies) Sheet http://www.uhg.com/role/BasisofPresentationPolicies Basis of Presentation (Policies) Policies 16 false false R17.htm 0000018 - Disclosure - Investments (Policies) Sheet http://www.uhg.com/role/InvestmentsPolicies Investments (Policies) Policies 17 false false R18.htm 0000019 - Disclosure - Investments (Tables) Sheet http://www.uhg.com/role/InvestmentsTables Investments (Tables) Tables http://www.uhg.com/role/InvestmentsNotes 18 false false R19.htm 0000020 - Disclosure - Fair Value (Tables) Sheet http://www.uhg.com/role/FairValueTables Fair Value (Tables) Tables http://www.uhg.com/role/FairValueNotes 19 false false R20.htm 0000021 - Disclosure - Medical Costs Payable (Tables) Sheet http://www.uhg.com/role/MedicalCostsPayableTables Medical Costs Payable (Tables) Tables http://www.uhg.com/role/MedicalCostsPayableNotes 20 false false R21.htm 0000022 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables) Sheet http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables Short-Term Borrowings and Long-Term Debt (Tables) Tables http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNotes 21 false false R22.htm 0000023 - Disclosure - Business Combinations (Tables) Sheet http://www.uhg.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.uhg.com/role/BusinessCombinationsNotes 22 false false R23.htm 0000024 - Disclosure - Segment Financial Information (Tables) Sheet http://www.uhg.com/role/SegmentFinancialInformationTables Segment Financial Information (Tables) Tables http://www.uhg.com/role/SegmentFinancialInformationNotes 23 false false R24.htm 0000025 - Disclosure - Basis of Presentation (Details) Sheet http://www.uhg.com/role/BasisofPresentationDetails Basis of Presentation (Details) Details http://www.uhg.com/role/BasisofPresentationPolicies 24 false false R25.htm 0000026 - Disclosure - Investments (Narrative) (Details) Sheet http://www.uhg.com/role/InvestmentsNarrativeDetails Investments (Narrative) (Details) Details http://www.uhg.com/role/InvestmentsTables 25 false false R26.htm 0000027 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details) Sheet http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails Investments (Short-Term and Long-Term Investments) (Details) Details http://www.uhg.com/role/InvestmentsTables 26 false false R27.htm 0000028 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details) Sheet http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details) Details http://www.uhg.com/role/InvestmentsTables 27 false false R28.htm 0000029 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) Sheet http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) Details http://www.uhg.com/role/InvestmentsTables 28 false false R29.htm 0000030 - Disclosure - Fair Value (Narrative) (Details) Sheet http://www.uhg.com/role/FairValueNarrativeDetails Fair Value (Narrative) (Details) Details http://www.uhg.com/role/FairValueTables 29 false false R30.htm 0000031 - Disclosure - Fair Value (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Sheet http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Details http://www.uhg.com/role/FairValueTables 30 false false R31.htm 0000032 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details) Sheet http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details) Details http://www.uhg.com/role/FairValueTables 31 false false R32.htm 0000033 - Disclosure - Medical Costs Payable (Narrative) (Details) Sheet http://www.uhg.com/role/MedicalCostsPayableNarrativeDetails Medical Costs Payable (Narrative) (Details) Details http://www.uhg.com/role/MedicalCostsPayableTables 32 false false R33.htm 0000034 - Disclosure - Medical Costs Payable (Details) Sheet http://www.uhg.com/role/MedicalCostsPayableDetails Medical Costs Payable (Details) Details http://www.uhg.com/role/MedicalCostsPayableTables 33 false false R34.htm 0000035 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details) Sheet http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails Short-Term Borrowings and Long-Term Debt (Details) Details http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables 34 false false R35.htm 0000036 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details) Sheet http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails Short-Term Borrowings and Long-Term Debt (Narrative) (Details) Details http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables 35 false false R36.htm 0000037 - Disclosure - Business Combinations (Narrative) (Details) Sheet http://www.uhg.com/role/BusinessCombinationsNarrativeDetails Business Combinations (Narrative) (Details) Details http://www.uhg.com/role/BusinessCombinationsTables 36 false false R37.htm 0000038 - Disclosure - Business Combinations (Details) Sheet http://www.uhg.com/role/BusinessCombinationsDetails Business Combinations (Details) Details http://www.uhg.com/role/BusinessCombinationsTables 37 false false R38.htm 0000039 - Disclosure - Business Combinations Acquired Finite-Lived Intangible Asets (Details) Sheet http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails Business Combinations Acquired Finite-Lived Intangible Asets (Details) Details 38 false false R39.htm 0000040 - Disclosure - Segment Financial Information (Narrative) (Details) Sheet http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails Segment Financial Information (Narrative) (Details) Details http://www.uhg.com/role/SegmentFinancialInformationTables 39 false false R40.htm 0000041 - Disclosure - Segment Financial Information (Details) Sheet http://www.uhg.com/role/SegmentFinancialInformationDetails Segment Financial Information (Details) Details http://www.uhg.com/role/SegmentFinancialInformationTables 40 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationPercentage - unh-20230331.htm 4 unh-20230331.htm ex311unh2023331.htm ex321unh2023331.htm unh-20230331.xsd unh-20230331_cal.xml unh-20230331_def.xml unh-20230331_lab.xml unh-20230331_pre.xml unh-20230331_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 57 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "unh-20230331.htm": { "axisCustom": 0, "axisStandard": 11, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 819, "http://xbrl.sec.gov/dei/2023": 30 }, "contextCount": 203, "dts": { "calculationLink": { "local": [ "unh-20230331_cal.xml" ] }, "definitionLink": { "local": [ "unh-20230331_def.xml" ] }, "inline": { "local": [ "unh-20230331.htm" ] }, "labelLink": { "local": [ "unh-20230331_lab.xml" ] }, "presentationLink": { "local": [ "unh-20230331_pre.xml" ] }, "schema": { "local": [ "unh-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 373, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 1, "http://xbrl.sec.gov/dei/2023": 5, "total": 6 }, "keyCustom": 7, "keyStandard": 241, "memberCustom": 13, "memberStandard": 26, "nsprefix": "unh", "nsuri": "http://www.uhg.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document and Entity Information Document", "menuCat": "Cover", "order": "1", "role": "http://www.uhg.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Fair Value (Notes)", "menuCat": "Notes", "order": "10", "role": "http://www.uhg.com/role/FairValueNotes", "shortName": "Fair Value (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Medical Costs Payable (Notes)", "menuCat": "Notes", "order": "11", "role": "http://www.uhg.com/role/MedicalCostsPayableNotes", "shortName": "Medical Costs Payable (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes)", "menuCat": "Notes", "order": "12", "role": "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNotes", "shortName": "Short-Term Borrowings and Long-Term Debt (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Commitments and Contingencies (Notes)", "menuCat": "Notes", "order": "13", "role": "http://www.uhg.com/role/CommitmentsandContingenciesNotes", "shortName": "Commitments and Contingencies (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Business Combinations (Notes)", "menuCat": "Notes", "order": "14", "role": "http://www.uhg.com/role/BusinessCombinationsNotes", "shortName": "Business Combinations (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Segment Financial Information (Notes)", "menuCat": "Notes", "order": "15", "role": "http://www.uhg.com/role/SegmentFinancialInformationNotes", "shortName": "Segment Financial Information (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Basis of Presentation (Policies)", "menuCat": "Policies", "order": "16", "role": "http://www.uhg.com/role/BasisofPresentationPolicies", "shortName": "Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Investments (Policies)", "menuCat": "Policies", "order": "17", "role": "http://www.uhg.com/role/InvestmentsPolicies", "shortName": "Investments (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "18", "role": "http://www.uhg.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Fair Value (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.uhg.com/role/FairValueTables", "shortName": "Fair Value (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Medical Costs Payable (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.uhg.com/role/MedicalCostsPayableTables", "shortName": "Medical Costs Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables", "shortName": "Short-Term Borrowings and Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Business Combinations (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.uhg.com/role/BusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Segment Financial Information (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.uhg.com/role/SegmentFinancialInformationTables", "shortName": "Segment Financial Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Basis of Presentation (Details)", "menuCat": "Details", "order": "24", "role": "http://www.uhg.com/role/BasisofPresentationDetails", "shortName": "Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Investments (Narrative) (Details)", "menuCat": "Details", "order": "25", "role": "http://www.uhg.com/role/InvestmentsNarrativeDetails", "shortName": "Investments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details)", "menuCat": "Details", "order": "26", "role": "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails", "shortName": "Investments (Short-Term and Long-Term Investments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)", "menuCat": "Details", "order": "27", "role": "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "shortName": "Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i8293e70edc244d379ae49d28fb7b5961_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)", "menuCat": "Details", "order": "28", "role": "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "shortName": "Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i8293e70edc244d379ae49d28fb7b5961_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Fair Value (Narrative) (Details)", "menuCat": "Details", "order": "29", "role": "http://www.uhg.com/role/FairValueNarrativeDetails", "shortName": "Fair Value (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PremiumsEarnedNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations", "menuCat": "Statements", "order": "3", "role": "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Fair Value (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "menuCat": "Details", "order": "30", "role": "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Value (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)", "menuCat": "Details", "order": "31", "role": "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i78df53bf1bbb413788dffdc360285048_I20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Medical Costs Payable (Narrative) (Details)", "menuCat": "Details", "order": "32", "role": "http://www.uhg.com/role/MedicalCostsPayableNarrativeDetails", "shortName": "Medical Costs Payable (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "icf06bd6f0498405baddfc1fd477fb1d3_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Medical Costs Payable (Details)", "menuCat": "Details", "order": "33", "role": "http://www.uhg.com/role/MedicalCostsPayableDetails", "shortName": "Medical Costs Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i872a2b104c4840609500cb8749c5ca93_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details)", "menuCat": "Details", "order": "34", "role": "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "shortName": "Short-Term Borrowings and Long-Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CommercialPaper", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details)", "menuCat": "Details", "order": "35", "role": "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails", "shortName": "Short-Term Borrowings and Long-Term Debt (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice146414b847423cab0c9d1b1601ee0b_I20230331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "reportCount": 1, "unique": true, "unitRef": "rate", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Business Combinations (Narrative) (Details)", "menuCat": "Details", "order": "36", "role": "http://www.uhg.com/role/BusinessCombinationsNarrativeDetails", "shortName": "Business Combinations (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Business Combinations (Details)", "menuCat": "Details", "order": "37", "role": "http://www.uhg.com/role/BusinessCombinationsDetails", "shortName": "Business Combinations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "ice2bf95c701543d0853ca015848897ee_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Business Combinations Acquired Finite-Lived Intangible Asets (Details)", "menuCat": "Details", "order": "38", "role": "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails", "shortName": "Business Combinations Acquired Finite-Lived Intangible Asets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "reportablesegments", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Segment Financial Information (Narrative) (Details)", "menuCat": "Details", "order": "39", "role": "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails", "shortName": "Segment Financial Information (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "reportablesegments", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income", "menuCat": "Statements", "order": "4", "role": "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "shortName": "Condensed Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PremiumsEarnedNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Segment Financial Information (Details)", "menuCat": "Details", "order": "40", "role": "http://www.uhg.com/role/SegmentFinancialInformationDetails", "shortName": "Segment Financial Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "icd57dd9e4e8e498a9c44c9c6e8d0ee51_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:InvestmentIncomeInterestAndDividend", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i872a2b104c4840609500cb8749c5ca93_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Condensed Consolidated Statements of Changes in Equity", "menuCat": "Statements", "order": "5", "role": "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity", "shortName": "Condensed Consolidated Statements of Changes in Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i872a2b104c4840609500cb8749c5ca93_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Condensed Consolidated Statement of Changes in Equity (Parenthetical)", "menuCat": "Statements", "order": "6", "role": "http://www.uhg.com/role/CondensedConsolidatedStatementofChangesinEquityParenthetical", "shortName": "Condensed Consolidated Statement of Changes in Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - Condensed Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Basis of Presentation (Notes)", "menuCat": "Notes", "order": "8", "role": "http://www.uhg.com/role/BasisofPresentationNotes", "shortName": "Basis of Presentation (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Investments (Notes)", "menuCat": "Notes", "order": "9", "role": "http://www.uhg.com/role/InvestmentsNotes", "shortName": "Investments (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20230331.htm", "contextRef": "i71322a8944ed4df3b0936ea69f1d2620_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 39, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r784" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r785" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entitiy Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r786" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entitiy Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r781" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r783" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.uhg.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r226", "r260", "r271", "r272", "r273", "r274", "r275", "r277", "r281", "r365", "r366", "r367", "r368", "r370", "r371", "r373", "r375", "r376", "r852", "r853" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r226", "r260", "r271", "r272", "r273", "r274", "r275", "r277", "r281", "r365", "r366", "r367", "r368", "r370", "r371", "r373", "r375", "r376", "r852", "r853" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r286", "r758", "r855", "r868", "r869" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r286", "r758", "r855", "r868", "r869" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r283", "r516", "r573", "r574", "r575", "r576", "r577", "r578", "r742", "r757", "r768", "r793", "r850", "r851", "r855", "r868" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails", "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/MedicalCostsPayableDetails", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r283", "r516", "r573", "r574", "r575", "r576", "r577", "r578", "r742", "r757", "r768", "r793", "r850", "r851", "r855", "r868" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails", "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/MedicalCostsPayableDetails", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r361", "r362", "r363", "r364", "r415", "r422", "r424", "r425", "r426", "r491", "r515", "r580", "r611", "r612", "r666", "r687", "r691", "r692", "r721", "r738", "r739", "r748", "r756", "r764", "r769", "r772", "r848", "r854", "r861", "r862", "r863", "r864", "r865" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r361", "r362", "r363", "r364", "r415", "r422", "r424", "r425", "r426", "r491", "r515", "r580", "r611", "r612", "r666", "r687", "r691", "r692", "r721", "r738", "r739", "r748", "r756", "r764", "r769", "r772", "r848", "r854", "r861", "r862", "r863", "r864", "r865" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r240", "r423", "r788", "r821" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails", "http://www.uhg.com/role/BasisofPresentationNotes", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheetParenthetical", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r240", "r423", "r788", "r789", "r821" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails", "http://www.uhg.com/role/BasisofPresentationNotes", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheetParenthetical", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables" ], "xbrltype": "stringItemType" }, "unh_A4250NotesDueJanuary2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.250% notes due January 2029", "label": "4.250% notes due January 2029 [Member]", "terseLabel": "4.250% notes due January 2029" } } }, "localname": "A4250NotesDueJanuary2029Member", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "unh_A4500NotesDueApril2033Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.500% notes due April 2033", "label": "4.500% notes due April 2033 [Member]", "terseLabel": "4.500% notes due April 2033" } } }, "localname": "A4500NotesDueApril2033Member", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "unh_A5050NotesDueApril2053Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "5.050% notes due April 2053", "label": "5.050% notes due April 2053 [Member]", "terseLabel": "5.050% notes due April 2053" } } }, "localname": "A5050NotesDueApril2053Member", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "unh_A5200NotesDueApril2063Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "5.200% notes due April 2063", "label": "5.200% notes due April 2063 [Member]", "terseLabel": "5.200% notes due April 2063" } } }, "localname": "A5200NotesDueApril2063Member", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "unh_AarpAssetsUnderManagement": { "auth_ref": [], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.", "label": "AARP Assets Under Management", "terseLabel": "Assets under management" } } }, "localname": "AarpAssetsUnderManagement", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "unh_AssetsundermanagementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets under management [Axis]", "label": "Assets under management [Axis]", "terseLabel": "Assets under management [Axis]" } } }, "localname": "AssetsundermanagementAxis", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/FairValueTables" ], "xbrltype": "stringItemType" }, "unh_AssetsundermanagementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Assets under management [Axis]", "label": "Assets under management [Domain]", "terseLabel": "Assets under management [Domain]" } } }, "localname": "AssetsundermanagementDomain", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/FairValueTables" ], "xbrltype": "domainItemType" }, "unh_BasisofpresentationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis of presentation [Abstract]", "label": "Basis of presentation [Abstract]", "terseLabel": "Basis of presentation [Abstract]" } } }, "localname": "BasisofpresentationAbstract", "nsuri": "http://www.uhg.com/20230331", "xbrltype": "stringItemType" }, "unh_BusinessCombinationsNonredeemableNoncontrollingInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Nonredeemable noncontrolling interests acquired through business combinations", "label": "Business Combinations, Nonredeemable noncontrolling interests", "negatedTerseLabel": "Nonredeemable noncontrolling interests" } } }, "localname": "BusinessCombinationsNonredeemableNoncontrollingInterests", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "unh_BusinessCombinationsRedeemableNoncontrollingInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redeemable noncontrolling interests acquired through business combinations", "label": "Business Combinations, Redeemable noncontrolling interests", "negatedTerseLabel": "Redeemable noncontrolling interests" } } }, "localname": "BusinessCombinationsRedeemableNoncontrollingInterests", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "unh_ExternalCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "External Customers [Member]", "label": "External Customers [Member]", "terseLabel": "Unaffiliated Customers" } } }, "localname": "ExternalCustomersMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis", "label": "Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities Non Recurring Basis", "terseLabel": "Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis" } } }, "localname": "FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "unh_IntersegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intersegment [Member]", "label": "Intersegment [Member]", "terseLabel": "Affiliated Customers" } } }, "localname": "IntersegmentMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "unh_InvestmentsAmortizedCost": { "auth_ref": [], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments at amortized cost.", "label": "Investments, Amortized Cost", "totalLabel": "Total debt securities, Amortized Cost" } } }, "localname": "InvestmentsAmortizedCost", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "unh_InvestmentsGrossUnrealizedGains": { "auth_ref": [], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 1.0, "parentTag": "unh_InvestmentsAmortizedCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross unrealized gains of investments.", "label": "Investments, Gross Unrealized Gains", "terseLabel": "Total debt securities, Gross Unrealized Gains" } } }, "localname": "InvestmentsGrossUnrealizedGains", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "unh_InvestmentsGrossUnrealizedLosses": { "auth_ref": [], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 2.0, "parentTag": "unh_InvestmentsAmortizedCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross unrealized losses of investments.", "label": "Investments, Gross Unrealized Losses", "negatedTerseLabel": "Total debt securities, Gross Unrealized Losses" } } }, "localname": "InvestmentsGrossUnrealizedLosses", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "unh_OptumHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Optum Health Member", "label": "Optum Health [Member]", "terseLabel": "Optum Health", "verboseLabel": "Optum Health" } } }, "localname": "OptumHealthMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "unh_OptumInsightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Optum Insight [Member]", "label": "Optum Insight [Member]", "terseLabel": "Optum Insight", "verboseLabel": "Optum Insight" } } }, "localname": "OptumInsightMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "unh_OptumRxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Optum Rx [Member]", "label": "Optum Rx [Member]", "terseLabel": "Optum Rx" } } }, "localname": "OptumRxMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "unh_ProductsAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Products and services", "label": "Products and Services [Member]", "terseLabel": "unh:ProductsandservicesMember" } } }, "localname": "ProductsAndServicesMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "unh_TotalOptumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "total [Member]", "label": "Total Optum [Member]", "terseLabel": "Optum" } } }, "localname": "TotalOptumMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "unh_TrademarksAndTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trademarks and Technology [Member]", "label": "Trademarks and Technology [Member]", "terseLabel": "Trademarks and Technology [Member]" } } }, "localname": "TrademarksAndTechnologyMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "domainItemType" }, "unh_UnitedhealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "UnitedHealthcare [Member]", "label": "Unitedhealthcare [Member]", "terseLabel": "UnitedHealthcare" } } }, "localname": "UnitedhealthcareMember", "nsuri": "http://www.uhg.com/20230331", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r287", "r288" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r198", "r199", "r200", "r202", "r210", "r211", "r805" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "terseLabel": "Net Unrealized Gains (Losses) on Investments [Member]" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r37", "r38", "r99", "r196", "r545", "r585", "r586" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r4", "r16", "r38", "r210", "r211", "r477", "r478", "r479", "r480", "r481", "r805" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Losses [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r427", "r428", "r429", "r599", "r818", "r819", "r820", "r857", "r873" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Noncash items:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r129", "r189", "r225", "r258", "r273", "r279", "r325", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r441", "r445", "r470", "r540", "r633", "r767", "r780", "r852", "r853", "r859" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r183", "r197", "r225", "r325", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r441", "r445", "r470", "r767", "r852", "r853", "r859" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r80" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Assets, Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r296" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Securities, Available for sale Debt Securities, Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r297" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r293", "r333", "r539" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "terseLabel": "Total debt securities - available-for-sale, Amortized Cost", "totalLabel": "Debt Securities, Available-for-sale, Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": { "auth_ref": [ "r833" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "verboseLabel": "Due after five years through ten years, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": { "auth_ref": [ "r302", "r535" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "verboseLabel": "Due after five years through ten years, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "auth_ref": [ "r832" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "terseLabel": "Due after one year through five years, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "auth_ref": [ "r301", "r534" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "verboseLabel": "Due after one year through five years, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": { "auth_ref": [ "r834" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10", "verboseLabel": "Due after ten years, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": { "auth_ref": [ "r303", "r536" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10", "verboseLabel": "Due after ten years, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "auth_ref": [ "r831" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One", "verboseLabel": "Due in one year or less, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r300", "r533" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "verboseLabel": "Due in one year or less, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "auth_ref": [ "r829", "r830" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "terseLabel": "Mortgage-backed securities, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r299", "r532", "r829" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Mortgage-backed securities, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r294", "r333", "r520", "r826" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale", "terseLabel": "Debt Securities, Available-for-sale" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]", "terseLabel": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Accounting, Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Significant Accounting Policies [Text Block]" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r438", "r762", "r763" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r70", "r71", "r438", "r762", "r763" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r1", "r2", "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Business Combination, Consideration Transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r122", "r439" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combination Disclosure" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total identifiable assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedTerseLabel": "Accounts payable and other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedTerseLabel": "Medical costs payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Other Intangible Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails", "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTotalLabel": "Total identifiable liabilities acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r72", "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Total net tangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedTerseLabel": "Other long-term liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r72", "r73" ], "calculation": { "http://www.uhg.com/role/BusinessCombinationsDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, equipment and other long-term assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "terseLabel": "Net Assets Acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r45", "r185", "r743" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r45", "r110", "r223" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r3", "r110" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]", "terseLabel": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]" } } }, "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable": { "auth_ref": [ "r142", "r145" ], "lang": { "en-us": { "role": { "documentation": "Description of the reasons for the change in incurred claims and claim adjustment expenses recognized in the income statement attributable to insured events of prior fiscal years. Also includes disclosures of additional premiums or return premiums accrued as a result of changes in incurred claims and claim adjustment expenses.", "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]", "terseLabel": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]" } } }, "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r177", "r193", "r194", "r195", "r225", "r243", "r244", "r246", "r248", "r252", "r253", "r325", "r365", "r368", "r369", "r370", "r376", "r377", "r406", "r407", "r408", "r409", "r411", "r470", "r592", "r593", "r594", "r595", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r621", "r642", "r660", "r731", "r732", "r733", "r734", "r735", "r787", "r813", "r822" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaper": { "auth_ref": [ "r92", "r130", "r866" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.", "label": "Commercial Paper", "terseLabel": "Commercial Paper" } } }, "localname": "CommercialPaper", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r117", "r774", "r775", "r776", "r777" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial Paper [Member]" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r34", "r87", "r542", "r620" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "Commitments and contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r115", "r359", "r360", "r737", "r849" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CommitmentsandContingenciesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Cash Paid", "terseLabel": "Common Stock, Dividends, Per Share, Cash Paid" } } }, "localname": "CommonStockDividendsPerShareCashPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementofChangesinEquityParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r770", "r771", "r772", "r774", "r775", "r776", "r777", "r818", "r819", "r857", "r871", "r873" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r96", "r621" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r17", "r96", "r621", "r639", "r873", "r874" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r96", "r544", "r767" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.01 par value - 3,000 shares authorized; 932 and 934 issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r39", "r206", "r208", "r217", "r524", "r558" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to UnitedHealth Group common shareholders" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r10", "r76", "r79", "r206", "r208", "r216", "r523", "r557" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive income attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r79", "r124", "r206", "r208", "r215", "r522", "r556" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r759", "r761", "r870" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate Obligations [Member]" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r21", "r272", "r273", "r274", "r275", "r281", "r825" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate and Eliminations" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r105", "r516" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of products sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r103" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating costs" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Operating costs:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerRelatedIntangibleAssetsMember": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.", "label": "Customer-Related Intangible Assets [Member]", "terseLabel": "Customer-Related Intangible Assets [Member]" } } }, "localname": "CustomerRelatedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r191" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt, Current", "terseLabel": "Short-term borrowings and current maturities of long-term debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r116", "r224", "r378", "r384", "r385", "r386", "r387", "r388", "r389", "r394", "r401", "r402", "r404" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt Disclosure" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r24", "r93", "r94", "r131", "r132", "r226", "r379", "r380", "r381", "r382", "r383", "r385", "r390", "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r483", "r751", "r752", "r753", "r754", "r755", "r814" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r84", "r86", "r379", "r483", "r752", "r753" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Par Value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r392", "r469", "r752", "r753" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Debt and other financing obligations" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r31", "r84", "r405", "r483" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Short-term Debt, Weighted Average Interest Rate, at Point in Time" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r31", "r380" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [ "r226", "r379", "r380", "r381", "r382", "r383", "r385", "r390", "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r403", "r483", "r751", "r752", "r753", "r754", "r755", "r814" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r32", "r226", "r379", "r380", "r381", "r382", "r383", "r385", "r390", "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r483", "r751", "r752", "r753", "r754", "r755", "r814" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r32", "r66", "r67", "r83", "r84", "r86", "r89", "r118", "r119", "r226", "r379", "r380", "r381", "r382", "r383", "r385", "r390", "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r403", "r483", "r751", "r752", "r753", "r754", "r755", "r814" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt, Long-Term and Short-Term, Combined Amount", "verboseLabel": "Debt and other financing obligations, carrying value" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "auth_ref": [ "r158", "r338", "r749" ], "calculation": { "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "terseLabel": "Greater Than 12 Months, Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r158", "r338" ], "calculation": { "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "negatedTerseLabel": "Greater Than 12 Months, Gross Unrealized Losses" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "auth_ref": [ "r158", "r338", "r749" ], "calculation": { "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "terseLabel": "Less Than 12 Months, Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [ "r158", "r338" ], "calculation": { "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "negatedTerseLabel": "Less Than 12 Months, Gross Unrealized Losses" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": { "auth_ref": [ "r155", "r335", "r749" ], "calculation": { "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position", "totalLabel": "Total, Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": { "auth_ref": [ "r156", "r336" ], "calculation": { "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss", "negatedTotalLabel": "Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r154", "r749", "r845" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "auth_ref": [ "r157", "r337" ], "lang": { "en-us": { "role": { "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions", "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtSecuritiesMember": { "auth_ref": [ "r54", "r772", "r875" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.", "label": "Debt Securities [Member]", "terseLabel": "Debt Securities [Member]" } } }, "localname": "DebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r13", "r121", "r172", "r436", "r437", "r816" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r430", "r431", "r541" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r802" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Unearned revenues" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r13", "r60" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r9", "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Cash", "negatedTerseLabel": "Cash dividends paid on common shares" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share attributable to UnitedHealth Group common shareholders:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r218", "r232", "r233", "r234", "r235", "r236", "r241", "r243", "r246", "r247", "r248", "r250", "r455", "r456", "r525", "r559", "r745" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r218", "r232", "r233", "r234", "r235", "r236", "r243", "r246", "r247", "r248", "r250", "r455", "r456", "r525", "r559", "r745" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r473" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity:" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r17", "r179", "r209", "r210", "r211", "r227", "r228", "r229", "r231", "r237", "r239", "r251", "r326", "r327", "r412", "r427", "r428", "r429", "r433", "r434", "r447", "r448", "r449", "r450", "r451", "r452", "r454", "r475", "r477", "r478", "r479", "r480", "r481", "r484", "r581", "r582", "r583", "r599", "r660" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r268", "r324", "r801", "r842" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": { "auth_ref": [ "r468" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.", "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value", "terseLabel": "Equity Securities, FV-NI and without Readily Determinable Fair Value" } } }, "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": { "auth_ref": [ "r190", "r468", "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI", "terseLabel": "Equity Securities, FV-NI" } } }, "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r458", "r459", "r464" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueTables" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r458", "r459", "r464" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueTables" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": { "auth_ref": [ "r18", "r80", "r127" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).", "label": "Fair Value Measurements, Nonrecurring [Table Text Block]", "terseLabel": "Fair Value Measurements, Nonrecurring [Table Text Block]" } } }, "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r80", "r81", "r82" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r392", "r416", "r417", "r418", "r419", "r420", "r421", "r459", "r488", "r489", "r490", "r752", "r753", "r759", "r760", "r761" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "verboseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r458", "r459", "r460", "r461", "r465" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "Fair Value [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r392", "r416", "r421", "r459", "r488", "r759", "r760", "r761" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets (Level 1) [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r392", "r416", "r421", "r459", "r489", "r752", "r753", "r759", "r760", "r761" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Other Observable Inputs (Level 2) [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r392", "r416", "r417", "r418", "r419", "r420", "r421", "r459", "r490", "r752", "r753", "r759", "r760", "r761" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Unobservable Inputs (Level 3) [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "auth_ref": [ "r462" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3", "terseLabel": "Transfers Into Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "auth_ref": [ "r462" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3", "terseLabel": "Transfers out of Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r392", "r416", "r417", "r418", "r419", "r420", "r421", "r488", "r489", "r490", "r752", "r753", "r759", "r760", "r761" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "verboseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r458", "r459", "r460", "r461", "r463", "r465" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Nonrecurring [Member]", "terseLabel": "Fair Value, Nonrecurring [Member]" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/FairValueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r328", "r329", "r330", "r331", "r332", "r334", "r339", "r340", "r403", "r410", "r453", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r555", "r749", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r838", "r839", "r840", "r841" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]", "verboseLabel": "Major Types of Debt Securities [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails", "http://www.uhg.com/role/InvestmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.", "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r351", "r353", "r354", "r355", "r517", "r518" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r57", "r59" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r352" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-Lived Intangible Assets Acquired", "terseLabel": "Finite-lived Intangible Assets Acquired" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r187", "r341", "r519", "r750", "r767", "r846", "r847" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r344", "r750" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecurities": { "auth_ref": [ "r171", "r305", "r330", "r844" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss", "terseLabel": "Debt Securities, Held-to-maturity", "totalLabel": "Held-to-maturity securities, Amortized Cost", "verboseLabel": "Debt Securities, Held-to-maturity" } } }, "localname": "HeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "auth_ref": [ "r148", "r315" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain", "terseLabel": "Securities, Held to maturity, Unrecognized Holding Gain" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "auth_ref": [ "r149", "r316" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss", "negatedLabel": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": { "auth_ref": [ "r152", "r161", "r320", "r535" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "terseLabel": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount": { "auth_ref": [ "r312", "r530" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 5 through 10", "terseLabel": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "auth_ref": [ "r151", "r160", "r319", "r534" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "terseLabel": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": { "auth_ref": [ "r311", "r529" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five", "terseLabel": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue": { "auth_ref": [ "r153", "r162", "r321", "r536" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10", "terseLabel": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount": { "auth_ref": [ "r313", "r531" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10", "terseLabel": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r150", "r159", "r318", "r533" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "terseLabel": "Held-to-maturity Securities, Debt Maturities, within One Year, Fair Value" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": { "auth_ref": [ "r310", "r528" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One", "terseLabel": "Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "auth_ref": [ "r147", "r314", "r520", "r539" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Fair Value", "terseLabel": "Debt Securities, Held-to-maturity, Fair Value" } } }, "localname": "HeldToMaturitySecuritiesFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r101", "r137", "r258", "r272", "r278", "r281", "r526", "r550", "r747" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r163", "r173", "r238", "r239", "r266", "r432", "r435", "r561" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTerseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r12" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and other liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r12" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r740" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Unearned revenues" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeposits": { "auth_ref": [ "r46", "r88" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.", "label": "Increase (Decrease) in Deposits", "terseLabel": "Customer funds administered" } } }, "localname": "IncreaseDecreaseInDeposits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": { "auth_ref": [ "r12" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in health care insurance liability balances during the period.", "label": "Increase (Decrease) in Health Care Insurance Liabilities", "verboseLabel": "Medical costs payable" } } }, "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Net change in other operating items, net of effects from acquisitions and changes in AARP balances:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r12" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.", "label": "Indefinite-Lived Intangible Assets Acquired", "terseLabel": "Indefinite-Lived Intangible Assets Acquired" } } }, "localname": "IndefinitelivedIntangibleAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InsuranceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Insurance [Abstract]", "terseLabel": "Insurance [Abstract]" } } }, "localname": "InsuranceAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r56", "r58" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "verboseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r85", "r139", "r212", "r262", "r482", "r645", "r778", "r872" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r260", "r271", "r272", "r273", "r274", "r275", "r277", "r281" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Optum Eliminations" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentIncomeInterestAndDividend": { "auth_ref": [ "r107" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Interest and Dividend", "terseLabel": "Investment and other income" } } }, "localname": "InvestmentIncomeInterestAndDividend", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceContracts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of contracts.", "label": "Investment Owned, Balance, Contracts", "terseLabel": "Total number of security positions" } } }, "localname": "InvestmentOwnedBalanceContracts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r560", "r588", "r589", "r590", "r591", "r683", "r685" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investment, Policy [Policy Text Block]" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments [Abstract]", "terseLabel": "Investments [Abstract]" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Investments by Contractual Maturity [Table Text Block]" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r458" ], "calculation": { "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": { "order": 3.0, "parentTag": "unh_InvestmentsAmortizedCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Debt securities, Fair Value Disclosure" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r128", "r140", "r146", "r178", "r289", "r291", "r466", "r467" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "Investments [Text Block]" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r28", "r225", "r325", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r442", "r445", "r446", "r470", "r619", "r746", "r780", "r852", "r859", "r860" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r98", "r134", "r548", "r767", "r815", "r843", "r858" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, redeemable noncontrolling interests and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, redeemable noncontrolling interests and equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r30", "r184", "r225", "r325", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r442", "r445", "r446", "r470", "r767", "r852", "r859", "r860" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r90", "r144" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense", "periodEndLabel": "Medical costs payable, end of period", "periodStartLabel": "Medical costs payable, beginning of period", "verboseLabel": "Medical costs payable" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions", "terseLabel": "Acquisitions" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]", "terseLabel": "Medical payments:" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "auth_ref": [ "r19" ], "calculation": { "http://www.uhg.com/role/MedicalCostsPayableDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "negatedTerseLabel": "Payments for current year" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "auth_ref": [ "r19" ], "calculation": { "http://www.uhg.com/role/MedicalCostsPayableDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "negatedTerseLabel": "Payments for prior years" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount", "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "auth_ref": [ "r143" ], "calculation": { "http://www.uhg.com/role/MedicalCostsPayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.uhg.com/role/MedicalCostsPayableNarrativeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "totalLabel": "Total reported medical costs" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]", "terseLabel": "Reported medical costs:" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-Term Debt [Member]", "terseLabel": "Long-term debt and other financing obligations" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r192" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, less current maturities" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r186" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-Term Investments", "terseLabel": "Long-term investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r32", "r61" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtDetails", "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r36", "r133", "r225", "r325", "r365", "r368", "r369", "r370", "r376", "r377", "r470", "r547", "r623" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Nonredeemable noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestChangeInRedemptionValue": { "auth_ref": [ "r26", "r64", "r65", "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.", "label": "Noncontrolling Interest, Change in Redemption Value", "terseLabel": "Redeemable noncontrolling interests fair value and other adjustments" } } }, "localname": "MinorityInterestChangeInRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distribution to nonredeemable noncontrolling interests" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Acquisition and other adjustments of nonredeemable noncontrolling interests" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember": { "auth_ref": [ "r828", "r830", "r835", "r836", "r837", "r856" ], "lang": { "en-us": { "role": { "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by non-governmental sponsored enterprises.", "label": "Mortgage-Backed Securities, Issued by Private Enterprises [Member]", "terseLabel": "Non-U.S. Agency Mortgage-Backed Securities [Member]" } } }, "localname": "MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember": { "auth_ref": [ "r830", "r836", "r837", "r856" ], "lang": { "en-us": { "role": { "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by US Government Sponsored Enterprises, such as Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac).", "label": "Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]", "terseLabel": "U.S. Agency Mortgage-Backed Securities [Member]" } } }, "localname": "MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r164", "r176" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Nature of Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r222" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r222" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash flows used for investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r110", "r111", "r112" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r102", "r112", "r138", "r182", "r204", "r207", "r211", "r225", "r230", "r232", "r233", "r234", "r235", "r238", "r239", "r245", "r258", "r272", "r278", "r281", "r325", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r456", "r470", "r553", "r641", "r658", "r659", "r747", "r778", "r852" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net earnings attributable to UnitedHealth Group common shareholders", "totalLabel": "Net earnings attributable to UnitedHealth Group common shareholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r78", "r125", "r204", "r207", "r238", "r239", "r552", "r807" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedTerseLabel": "Earnings attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net earnings attributable to nonredeemable noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r25", "r125", "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r74", "r412", "r818", "r819", "r820", "r873" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Nonredeemable Noncontrolling Interests [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r824" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of Reportable Segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r258", "r272", "r278", "r281", "r747" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Earnings from operations", "totalLabel": "Earnings from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r271", "r272", "r273", "r274", "r275", "r281" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r188" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r5", "r99", "r471", "r472", "r474" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Total foreign currency translation gains" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r17", "r23", "r205", "r208", "r214", "r475", "r476", "r481", "r521", "r554", "r805", "r806" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other comprehensive income (loss)", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": { "auth_ref": [ "r8", "r99", "r203", "r323" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax", "negatedLabel": "Gross reclassification adjustment for net realized losses (gains) included in net earnings" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r8", "r99", "r203", "r323" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedTotalLabel": "Total reclassification adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": { "auth_ref": [ "r6" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax", "terseLabel": "Income tax effect" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r198", "r201", "r323" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax", "terseLabel": "Gross unrealized gains (losses) on investment securities during the period" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r198", "r201", "r323" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "totalLabel": "Total unrealized gains (losses), net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": { "auth_ref": [ "r6", "r199" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax", "negatedTerseLabel": "Income tax effect" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r29", "r767" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r112" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "verboseLabel": "Other current receivables, net" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "auth_ref": [ "r11", "r19" ], "calculation": { "http://www.uhg.com/role/MedicalCostsPayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "negatedTotalLabel": "Total medical payments" } } }, "localname": "PaymentsForLossesAndLossAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r790", "r808" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r43" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Common share repurchases" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r43" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedTerseLabel": "Cash dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r41" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Cash paid for acquisitions, net of cash assumed" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r108" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r109" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchases of property, equipment and capitalized software" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": { "auth_ref": [ "r867" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.", "label": "Policyholder Benefits and Claims Incurred, Net, Health", "terseLabel": "Medical costs" } } }, "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r95", "r406" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r95", "r621" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r95", "r406" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r95", "r621", "r639", "r873", "r874" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r95", "r543", "r767" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsEarnedNet": { "auth_ref": [ "r174", "r175", "r577", "r587" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 }, "http://www.uhg.com/role/SegmentFinancialInformationDetails": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.", "label": "Premiums Earned, Net", "terseLabel": "Premiums", "verboseLabel": "Premiums, revenues - unaffiliated customers" } } }, "localname": "PremiumsEarnedNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r804" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r7" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from common stock issuances" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r42", "r592" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from issuance of long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": { "auth_ref": [ "r219", "r220", "r827" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale", "terseLabel": "Maturities of investments" } } }, "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r791", "r809" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": { "auth_ref": [ "r810", "r811", "r812" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.", "label": "Proceeds from (Repayments of) Commercial Paper", "terseLabel": "Proceeds from short-term borrowings, net" } } }, "localname": "ProceedsFromRepaymentsOfCommercialPaper", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r40", "r219", "r290", "r322" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale of Debt Securities, Available-for-Sale", "terseLabel": "Sales of investments" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r757" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Products" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r182", "r204", "r207", "r221", "r225", "r230", "r238", "r239", "r258", "r272", "r278", "r281", "r325", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r440", "r443", "r444", "r456", "r470", "r526", "r551", "r598", "r641", "r658", "r659", "r747", "r765", "r766", "r779", "r807", "r852" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings", "totalLabel": "Net earnings", "verboseLabel": "Net earnings" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r14", "r537", "r549", "r767" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, equipment and capitalized software, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r62", "r63", "r64", "r65" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "terseLabel": "Redeemable noncontrolling interests" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r44", "r595" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Repayments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r97", "r120", "r546", "r584", "r586", "r596", "r622", "r767" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r179", "r227", "r228", "r229", "r231", "r237", "r239", "r326", "r327", "r427", "r428", "r429", "r433", "r434", "r447", "r449", "r450", "r452", "r454", "r581", "r583", "r599", "r873" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r259", "r260", "r271", "r276", "r277", "r283", "r285", "r286", "r413", "r414", "r516" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 }, "http://www.uhg.com/role/SegmentFinancialInformationDetails": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue from Products and Services", "verboseLabel": "Revenue from Products and Services - unaffiliated customers" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r643", "r741", "r744" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue [Policy Text Block]" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r169" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, Remaining Performance Obligation, Amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r792" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Revenue, Remaining Performance Obligation, Percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r213", "r225", "r259", "r260", "r271", "r276", "r277", "r283", "r285", "r286", "r325", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r470", "r526", "r852" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 }, "http://www.uhg.com/role/SegmentFinancialInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r70", "r71", "r438" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r32", "r66", "r67", "r83", "r84", "r86", "r89", "r118", "r119", "r752", "r754", "r817" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "verboseLabel": "Long-Term Debt [Table Text Block]" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r458", "r459" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r57", "r59", "r517" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsAcquiredFiniteLivedIntangibleAsetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [ "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r684", "r686", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Investments [Line Items]", "terseLabel": "Schedule of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r684", "r686", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investments owned by investment company.", "label": "Schedule of Investments [Table]", "terseLabel": "Schedule of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense" } } }, "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r53", "r100" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r50", "r51", "r52", "r55" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r50", "r51", "r52", "r55" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r255", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r286", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r357", "r358", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r750", "r793", "r868" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r254", "r255", "r256", "r257", "r258", "r270", "r275", "r279", "r280", "r281", "r282", "r283", "r284", "r286" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting Disclosure" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r106" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Operating costs" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r757" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Services" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/SegmentFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r12" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.", "label": "Short-Duration Insurance and Deposit Contracts [Text Block]", "terseLabel": "Short-Duration Insurance and Deposit Contracts" } } }, "localname": "ShortDurationInsuranceAndDepositContractsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r135", "r136", "r803" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-Term Investments", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r181", "r255", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r286", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r356", "r357", "r358", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r750", "r793", "r868" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/SegmentFinancialInformationDetails", "http://www.uhg.com/role/SegmentFinancialInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r177", "r193", "r194", "r195", "r225", "r243", "r244", "r246", "r248", "r252", "r253", "r325", "r365", "r368", "r369", "r370", "r376", "r377", "r406", "r407", "r408", "r409", "r411", "r470", "r592", "r593", "r594", "r595", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r621", "r642", "r660", "r731", "r732", "r733", "r734", "r735", "r787", "r813", "r822" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheetParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r17", "r35", "r179", "r209", "r210", "r211", "r227", "r228", "r229", "r231", "r237", "r239", "r251", "r326", "r327", "r412", "r427", "r428", "r429", "r433", "r434", "r447", "r448", "r449", "r450", "r451", "r452", "r454", "r475", "r477", "r478", "r479", "r480", "r481", "r484", "r581", "r582", "r583", "r599", "r660" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r227", "r228", "r229", "r251", "r516", "r588", "r610", "r613", "r614", "r615", "r616", "r617", "r618", "r621", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r634", "r635", "r636", "r637", "r638", "r640", "r643", "r644", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r660", "r773" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails", "http://www.uhg.com/role/BasisofPresentationNotes", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheetParenthetical", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.uhg.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/InvestmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r227", "r228", "r229", "r251", "r516", "r588", "r610", "r613", "r614", "r615", "r616", "r617", "r618", "r621", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r634", "r635", "r636", "r637", "r638", "r640", "r643", "r644", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r660", "r773" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationDetails", "http://www.uhg.com/role/BasisofPresentationNotes", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheetParenthetical", "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations", "http://www.uhg.com/role/InvestmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r17", "r95", "r96", "r120", "r592", "r660", "r732" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuances of common stock, and related tax effects (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r17", "r95", "r96", "r120", "r599", "r660", "r732", "r779" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuances of common stock, and related tax effects" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r69", "r95", "r96", "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Share-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r17", "r95", "r96", "r120" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedTerseLabel": "Common share repurchases (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r17", "r95", "r96", "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "negatedLabel": "Common share repurchases" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent [Abstract]", "terseLabel": "Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r74", "r75", "r77", "r179", "r180", "r210", "r227", "r228", "r229", "r231", "r237", "r326", "r327", "r412", "r427", "r428", "r429", "r433", "r434", "r447", "r448", "r449", "r450", "r451", "r452", "r454", "r475", "r477", "r481", "r484", "r582", "r583", "r597", "r623", "r639", "r661", "r662", "r736", "r779", "r815", "r843", "r858", "r873" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedBalanceSheets", "http://www.uhg.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r579" ], "calculation": { "http://www.uhg.com/role/MedicalCostsPayableDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 }, "http://www.uhg.com/role/MedicalCostsPayableNarrativeDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.", "label": "Current Year Claims and Claims Adjustment Expense", "terseLabel": "Current year" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r579" ], "calculation": { "http://www.uhg.com/role/MedicalCostsPayableDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.", "label": "Prior Year Claims and Claims Adjustment Expense", "terseLabel": "Prior year" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/MedicalCostsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r403", "r410", "r453", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r555", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r838", "r839", "r840", "r841" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails", "http://www.uhg.com/role/InvestmentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_USStatesAndPoliticalSubdivisionsMember": { "auth_ref": [ "r759", "r870" ], "lang": { "en-us": { "role": { "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.", "label": "US States and Political Subdivisions Debt Securities [Member]", "terseLabel": "State and Municipal Obligations [Member]" } } }, "localname": "USStatesAndPoliticalSubdivisionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r527", "r759", "r870" ], "lang": { "en-us": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "U.S. Government and Agency Obligations [Member]" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.uhg.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails", "http://www.uhg.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unrealized gains and losses on investments.", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "terseLabel": "Short-Term and Long-Term Investments [Table Text Block]" } } }, "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r47", "r48", "r49", "r165", "r166", "r167", "r168" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates, Policy [Policy Text Block]" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/BasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r823" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "terseLabel": "Dilutive effect of common share equivalents" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r242", "r248" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted weighted-average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r241", "r248" ], "calculation": { "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted-average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.uhg.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org//805/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org//940-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//942-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "944", "URI": "https://asc.fasb.org//944/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(cc)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "40", "Subparagraph": "(SAB Topic 5.W)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479583/944-40-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org//946-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(c))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "16(c)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "6B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "6B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column G))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column H))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column I))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column J))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column K))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(3)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r781": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r782": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r783": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r784": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r785": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r786": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(5))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "40", "Subparagraph": "(SAB TOPIC 5.W)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479583/944-40-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 58 0000731766-23-000029-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000731766-23-000029-xbrl.zip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end